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1.1 General Introduction 

Introduction 
Historical note on genetic deafness 
In 1853, several years before Mendel's laws and many years before the general appreciation 
of his principles of heredity, the concept of dominant inheritance was brought up by an Irish 
otologist This physician, Sir William Wilde, was curious about what causes deafness, as 
many others in that era After he had succeeded to add a questionnaire on familial deafness 
to an Irish census, he was able to describe dommantly inherited hearing impairment in 
several pedigrees 1 In 1880 Arthur Hartmann, otologist in Berlin, was the first to touch on the 
concept of recessive inheritance in a book on deaf-mutism and education of the deaf He 
wondered why consanguinity amongst parents of children at schools for the deaf lead to 
more congenital deficits2 Adam Politzer, considered as the founder of contemporary 
scientific otology, emphasised in the second edition of his manual of otology3 that inheritance 
is an important cause of deafness, subscribing Hartmann's elaborations of the concepts of 
dominant and recessive inheritance 
In the first half of the twentieth century, following the rediscovery of Mendel's laws," 
studies on inherited deafness were continued on a larger scale Initially - besides studies on 
school children and isolated populations - most scientific attention was directed to hearing 
impairment as part of inherited, mainly congenital, syndromes, named and classified on the 
basis of the associated characteristics This resulted in a substantial increase in the number 
of especially syndromal descriptions, amounting to more than 400 by now5 In those studies, 
however, hearing impairment often remained unspecified The introduction of the audiometer 
in the late thirties of the past century contributed to more appropriate documentation of 
hearing impairment In the second half of the past century, numerous studies on genetic 
hearing impairment revealed a full spectrum of syndromal as well as non-syndromal (that is 
hearing impairment without associated characteristics) forms Non-syndromal forms could be 
classified by mode of transmission, age of onset, progression, severity of hearing impairment 
and type of audiogram 5 The latter is one of the mam clinical characteristics In regard of the 
audiometrie configuration, low-, mid-, and high-frequency deficits can be distinguished 
Major progress in the knowledge of genetic hearing impairment, especially of the 
non-syndromal forms, took place since 1994 Genetic linkage analyses of hearing-impaired 
families unravelled about 80 chromosomal loci and over 25 genes implicated in non-
syndromal hearing impairment6 Dommantly inherited genotypes are designated "DFNA", 
autosomal recessive types "DFNB" and the rare X-lmked types "DFN" (See Chapter 1 2) It 
turned out that different genotypes can share particular audiometrie characteristics7 Since 
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then, classification has been based on mode of inheritance and chromosomal localisation 
rather than clinical (audiometrie) characteristics. Classification based on the genotype as well 
as on comprehensive descriptions of clinical and audiologic findings is required for clinical 
diagnosis as well as genetic counselling8 (see Chapter 1.2 and Chapter 1.3). 
Genetic linkage and mutation analyses 
The conventional approach to chromosomal linkage analysis of autosomal dominant 
disorders depends on the presence of one or more multigenerational kindreds, preferably 
with 15 or more individuals showing the same disorder. This approach entails cloning a gene 
to identify the gene product (that is "positional cloning"), contrary to the "functional cloning" 
strategy, where disease genes are searched guided by the known defective protein. As yet, 
no genes implicated in sensorineural non-syndromal hearing impairment (SNHI) have been 
isolated by the latter technique. The former approach tests the segregation of the disease 
phenotype against the segregation of polymorphic markers, 200-300 of which are needed to 
screen the whole human genome (this type of search is called "genome search"). The 
probability that such a marker is linked to the disease gene is expressed as a logarithm of 
odds ("LOD score", that is the probability of the marker and pedigree data under the 
hypothesis of linkage, divided by the probability under the hypothesis of non-linkage) and 
should be > 3 in order to prove significant linkage, or < -2 to exclude the possibility of linkage 
between marker and disease gene.9 This score can be influenced by the presence of 
phenocopies (that is non-carriers that are mimicking the trait, because of environmental 
factors and/or age) or incomplete penetrance (that is some carriers of the autosomal 
dominant genotype are not clinically affected). The size of a candidate region is expressed in 
centiMorgan (cM), a unit of genetic distance that is equivalent to 1% probability of 
recombination during meiosis. One cM is equivalent, on average, to a physical distance of 
approximately one megabase in the human genome. 
After mapping a disease gene, cloning can be attempted. Once a gene is known, 
mutations can be analysed in affected individuals. Suitable putative candidate genes for 
sensorineural non-syndromal hearing impairment (SNHI) are, for example, genes known to 
have an essential function within the cochlea (e.g. TECTA,™ see Chapter 1.2). Genes 
belonging to a deafness-related gene "family" (e.g. connexins, transcription factors, myosins 
14 
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or collagens), or genes known to be expressed within the cochlea12 (eg COCH,1316 see 
Figure 1, see below and see Chapter 12) should also be considered Finally, genes 
emerging from animal model studies may be relevant, especially if they have human 
homologues (e g POU4F3?7 see Chapter 1 2) 
Cochleovestibular impairment (DFNA9/COCH) 
Phenotype 
The first (clinical) description of DFNA9 dates from 1988 Many years before genetic linkage 
was found In that year Verhagen, Huygen and Joosten published a study on an autosomal 
dominant trait in a Dutch family, in which the affected persons developed predominantly high-
frequency SNHI and vestibular areflexia after age 40 1β Follow-up examinations confirmed 
the progressive character of the combined dysfunctions and the age of onset in two affected 
persons, one of whom initially showed Memere-like symptoms (see Chapter 2 2)1920 
Many more families have been described since then showing a similar combination 
of late-onset autosomal dominant SNHI and vestibular dysfunction,1 4 1 6 2 1 3 0 with Ménière-like 
symptoms in several patients (see Chapter 22 and 2 3)20232730 Amongst the studies on 
these families are separate longitudinal and cross-sectional ones, analysing extensive 
audiometrie data obtained in a large Dutch family (see Chapters 2 1 and 2 4)2β29 These data 
give a comprehensive quantitative outline of this cochleovestibular disease Initially, there is 
a stable high-frequency offset of SNHI Only after 40 years of age, onset of progression by 
about 3 dB/year and concomitant vestibular impairment become manifest, in a variable, often 
asymmetrical fashion In 20-25 years time, the final stage of impairment is attained, with 
profound hearing impairment and vestibular areflexia As an exception, one American family 
manifested onset of progression at age 2 0 2 4 2 6 Deterioration of speech recognition scores, as 
related to age and hearing level, was one of the associated features of progression in 
hearing impairment (see Chapter 3 j ) 2 6 3 1 To date, all these families have been linked to 
DFNA9,1 3 1 6 3 2 3 3 which is still the only DFNA type showing generalised cochleovestibular 
impairment 
In general, clinical DFNA descriptions included assessment of auditory rather than 
vestibular functions Even in the face of vestibular symptoms, as are present m DFNA9, 
formal vestibular testing often tends to be missing M The hallmark of degenerative, peripheral 
vestibular impairment is vestibular hyporeflexia, eventually leading to vestibular areflexia 
16 
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Typical of vestibular areflexia are head movement-dependent oscillopsia and unsteadiness 
of gait when visual fixation is excluded ("Dandy's syndrome"). Labyrinthine-defective 
individuals tend to exhibit a broad-based gait under the latter condition, have difficulty riding 
a bicycle on a narrow track and loose their course while riding and attempting to look 
backwards over their shoulder. In addition, they show compensatory enhancement of the 
cervico-ocular and optokinetic nystagmus reflexes.35,36 In case of mild impairment, however, 
it may be difficult to detect anomalies of the vestibular labyrinth without using instrumental 
methods. Interestingly, as vertigo typically results from imbalance within the vestibular 
system,37 the Ménière-like symptoms, such as described in several DFNA9 cases, might 
result from bilateral asymmetry in onset or degree of cochleovestibular impairment. 
The first histopathological reports on DFNA9 date from 1991 and ΙΘΘΒ.24'38 Cellular 
degeneration and substitution by an acidophilic, uniformly staining ground substance in the 
spiral ligament, spiral limbus and stroma of the cnstae and maculae were found.24 Up to now, 
none of these features have been observed in any other disorder affecting the auditory or 
vestibular systems. Indeed, it was the uniqueness of the histopathological changes that led 
to the recognition of manifest cochleovestibular impairment in the three American DFNA9 
families.24,26 Already in 1986, temporal bones - acquired seven years apart - from two 
individuals bearing the same last name, were found to show this unique inner ear pathology. 
These individuals appeared to be brothers, belonging to a kindred with late-onset SNHI.39 
Identification of the other two kindreds came after initial examination of temporal bones at the 
House Ear Institute in a similar way.24,2640 The severe degeneration of cochlear and 
vestibular sensory elements and dendrites was postulated to result from 'strangulation' of 
these nerve endings by the acidophilic deposits.24 Recent transmission electron microscopic 
findings suggested the acellular deposits to consist of highly branched microfibrils and to 
interfere with normal fibrillogenesis, thus causing degradation of collagens and extracellular 
matrix components.25 
Genotype 
In 1994 the COCH gene was mapped. Together with several other genes, it was isolated 
from a human fetal cochlear cDNA library in Boston.41 In 1996, an American family with 
progressive cochleovestibular disease (see above) was the first to be successfully 
genotyped.24 Linkage was found to a locus at chromosome 14q12-13, designated DFNA9.32 
Early 1998, a large Dutch family with autosomal dominant progressive SNHI and vestibular 
17 
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symptoms was linked to DFNA9 (Dr F Ρ M Cremers, Nijmegen) as well as a large Flemish 
family (Dr G Van Camp, Antwerp) In the same year Robertson et al identified three 
missense mutations in the human COCH gene These mutations were found in the original 
DFNA9 family (1996)32 and two other American families that showed comparable clinical 
features 13 Since COCH had been mapped to chromosome 14 within the locus for DFNA9,32 
and because of its high expression in human fetal cochlear and vestibular tissue (Figure 1), it 
represented a good candidate gene 4 1 4 2 The importance of COCH mutations m DFNA9 was 
confirmed by the simultaneous identification in 1998 of a fourth mutation in several Dutch 
and one large Flemish family and, only recently, the description of a fifth mutation, in an 
Australian family 1 4 1 6 
As part of the ongoing Nijmegen studies on the genetics of hearing impairment the 
above mentioned large Dutch family was traced and investigated in 1998 (see Chapter 2 1 
and 2 4 for clinical descriptions2829) 
cen 
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Figure 2 Schematic representation of the crossover events observed in the 14q12-13 region in three 
affected individuals (111-11, 111-12 and IV-6, see Chapter 2 1 for pedigree) The critical interval as 
defined by the study of De Kok et a l , 4 resides between D14S1042 and D14S70 Marker alleles 
located on the chromosomal region thought to carry the genetic defect (filled circles) and marker 
alleles residing on chromosomal segments not containing the defect (open circles) are depicted 
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This family is living in the southern part of the Netherlands. Blood samples were collected 
and linkage to DFNA9 was found for this kindred as well as for three other kindreds rooted in 
the southern part of the Netherlands.14 One of the latter three had already been reported on 
by Verhagen et al.22 In the interval between markers D14S80 and D14S70 on chromosome 
14q12-13 informative crossovers were found in three affected individuals (Figure 2) with 
recombinations defining the telomeric and centromeric boundaries of the critical region for 
the gene defect.14 This region encompasses 11.0 cM and overlaps the previously defined 
DFNA9 region, described by Manolis et al. (see Figure 2).32 The maximal LOD score was 
4.2. 
Mutation analysis within COCH was performed, because this gene was known to be 
a good positional candidate for DFNA9. This revealed a cytosine to thymidine alteration in 
the COCH gene, resulting in substitution of serine for proline at amino acid position 51 (of a 
total of 550 amino acids) of the predicted COCH protein for all four Dutch families mentioned 
Figure 3. Geographical distribution of DFNA9/COCH in the Netherlands and Belgium. All families 
harbouring the P51S mutation in the COCH gene reside in or originate from the encircled region. 
19 
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above.13 At the same time this mutation was found in a large Flemish family and two families 
from the southern part of the Netherlands by Fransen et al.15 Clinical details on the latter two 
families have been reported by Verhagen et al. (see also Chapters 2.2 and 2.3).ÌS'2Ì23 
Following the simultaneous identification of the same P51S mutation in the 
Netherlands and Belgium, haplotype analysis was performed in search for a putative 
common founder. First, mutation analysis was attempted in 29 additional families or isolated 
patients, all from the same regions of the Netherlands and Belgium (Figure 3), having similar 
signs and symptoms. In eight of them the same mutation was present, increasing the total 
number of P51S families to 15 (Table 1).33 Haplotype analysis focused on markers flanking 
the DFNA9/COC/-/ locus. The exact order of markers flanking COCH had to be re-
established. Nine of the 15 families showed significant sharing of directly flanking 
haplotypes.33 Six of those nine even shared haplotypes for all seven markers examined, 
which was considered conclusive evidence for the existence of a common founder. 
Table 1. DFNA9/COCH families carrying the P51S mutation, haplotyped in the Netherlands and 
Belgium8 (modified after Fransen et al. 2001). 
Haplotype Origin No of Genetic Clinical 
Sharing Carriers0 References references 
4/7 The Netherlands (Nijmegen) 
4/7 The Netherlands (Nijmegen) 
7/7 The Netherlands (Nijmegen) 
4/7 The Netherlands (Nijmegen) 
7/7 Belgium (Antwerpen) 
4/7 The Netherlands (Nijmegen) 
1/7 The Netherlands (Nijmegen) 
7/7 Belgium (Antwerpen) 
7/7 Belgium (Antwerpen) 
Belgium (Antwerpen) 
Belgium (Antwerpen) 
7/7 Belgium (Leuven) 
Belgium (Antwerpen) 
Belgium (Antwerpen) 
Belgium (Antwerpen) 
*, several other Dutch families were shown to harbour the mutation, but have not been haplotyped, ", amount of 
haplotype sharing;c, includes presymptomatic carriers 
34 De Kok et al. 03Γ99 
14 De Kok et al 03/99" 
6 De Kok et al. 03/991 4 
Bom et al '99z e (Chapter 2.1), 
Ό1Μ (Chapter 2 4) 
4 
60 
4 
β 
24 
5 
1 
2 
14 
1 
1 
1 
De Kok et al. 
Fransen et al. 
Fransen et al. 
Fransen et al. 
Fransen et al. 
Fransen et al 
Fransen et al. 
Fransen et al. 
Fransen et al 
Fransen et al 
Fransen et al 
Fransen et al 
os/gg1" 
Οθ/'θθ15 
OB/'gg15 
0β/'9915 
01/'Ol33 
01/'Ol33 
01/'Ol33 
01/'Ol33 
01/'Ol33 
01/'Ol33 
01/'Ol33 
01/'Ol33 
Verhagen et al. '92^ 
Verstreken et al '9927 
Verhagen et al '88 1 θ , '91 1 9 , 
m20 (Chapter 2 2) 
Verhagen et al 'ΘΘ^,ΌΙ2 3 
(Chapter 2.3) 
-
-
-
-
Lemaire et al '01 3 0 
-
-
. 
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Low-frequency hearing impairment (DFNA6/14) 
Genotype and phenotype 
Another family investigated as part of the ongoing Nijmegen studies on the genetics of 
hearing impairment was characterised by low-frequency hearing impairment that seemed to 
be present since early childhood. Positive linkage was established at the Antwerp 
Department of Medical Genetics (UIA, dr. G. Van Camp). 
Contrary to high-frequency SNHI, isolated low-frequency impairment is rare (see 
also Chapter 1.2). Apart from a highly progressive type of SNHI in one large kindred 
(DFNAI,"3 see Chapter 1.2), only two other families, manifesting early onset, non­
progressive, low-frequency impairment, have been linked to specific chromosomal loci. Of 
the latter two, the first one, designated DFNA6, was linked to a 1.7-million base pair region 
between the markers D4S412 and D4S432 (see Figure 5 of Chapter 4.1) on chromosome 
4p16.3, with a maximum LOD score of 5 at a recombination fraction (Θ) of 0.05 for D4S412.'M 
In 1998, when analysing a new Dutch family with a phenotype similar to that of the DFNA6 
family, linkage to the 4p16.3 region was tested first and confirmed with LOD scores 
exceeding 6 for marker D4S431. Key crossovers delineated the telomeric boundary near 
marker D4S3023 and the centromenc boundary near marker D4S3007, thus defining a 
critical interval for this family that is located 1.3 cM proximal to the DFNA6 region (see Figure 
5 of Chapter 4.1). This new locus was named DFNA14.45 
Accordingly, guided by the phenotypic similarity to DFNA6 and DFNA14, linkage to 
chromosome 4p16.3 was checked first for the family included in this thesis. For markers 
D4S3023 and D4S431 maximum LOD scores of nearly 4 were obtained and the critical 
interval for this family resides between markers D4S3034 and D4S3007, ergo comprising 
both the DFNA6 and DFNA14 loci and therefore referred to as "DFNA6/14" (see Figure 5 of 
Chapter 4.1). Genetic data relating to this study are discussed in more detail in Chapter 4.1. 
The phenotypic similarity between the three families described above suggests the 
existence of a common disease gene for early-onset low-frequency SNHI. However, the 
genetic analysis of the families involved does not preclude the existence of two different, 
closely adjacent genes related to SNHI. It should be noted that this region is well-mapped 
and contains over 20 genes. These genes were identified within the context of the search for 
Huntington's disease gene (HD).46 
21 
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Aims of the study and content of this thesis 
The general aim of this thesis was to contribute to the delineation of autosomal dominant 
non-syndromal phenotypes of sensorineural hearing impairment as related to their 
genotypes, an important but as yet only partially exploited field of genetic deafness The 
following objectives have been focused on 
• to trace families with autosomal dominant hearing impairment and collect blood samples 
for chromosomal linkage and mutation analysis, 
• to outline the phenotype of the families that have been genotyped successfully in the 
course of this study by detailed descriptions of history, physical examination, audiograms, 
statistical analysis of audiometrie data, and vestibular testing, 
• to investigate aspects of speech perception in important types of autosomal dominant 
SNHI 
The results of this study are presented in five consecutive chapters Following this 
general introduction to the thesis, Chapter 1 includes two reviews on autosomal dominant 
SNHI The first one (Chapter 1 2) touches on general aspects of phenotypmg and genotypmg 
and tries to give an outline of - as well as better access to - phenotypic data of DFNA types in 
literature The second one (Chapter 1 3) particularly focuses on phenotypes related to DFNA 
loci where causative genes have not (yet) been cloned 
Chapter 2 gives a detailed clinical description of the cochleovestibular impairment 
that is typical of DFNA9/COC/-/ Chapter 2 7 is based on extensive longitudinal data of a 
large Dutch family Chapters 2 2 ana 2 3 describe longitudinal studies of two smaller Dutch 
families, paying special attention to Ménière-like symptoms in several individuals In Chapter 
24 a comprehensive cross-sectional analysis is reported of audiometrie data of clinically 
affected individuals on the one hand and young, yet asymptomatic, carriers of the disease-
causing mutation on the other hand 
Chapter 3 deals with aspects of speech perception in hereditary hearing impairment 
Speech perception scores m DFNA9 as related to age and hearing level, are descnbed and 
compared to the scores obtained in DFNA2 DFNA2 is - similar to DFNA9 - described for 
several families showing various disease mutations Hearing impairment m DFNA2 also 
shows predominant involvement and progression of the high frequencies 
In Chapter 4 a combined clinical and genetic study of a family with low-frequency 
hearing impairment is presented Detailed analyses of cross-sectional and longitudinal pure-
22 
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tone threshold data are included as well as an analysis of retrospective speech recognition 
data. The results of genetic linkage analysis are presented and discussed. 
The studies comprised by this thesis are summarised in Chapter 5, that also 
includes the overall conclusions and a general discussion. 
23 
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Introduction 
Abstract 
This review is concerned with the present state of phenotypic characterisation of known 
genotypes of non-syndromal autosomal dominant hearing impairment A brief outline of 
history and context of phenotypmg and genotypmg of hearing impairment is given with 
particular reference to the most recent developments in this field, followed by descriptions of 
DFNA1, DFNA2, DFNA5, DFNA6/14, DFNA8/12, DFNA9, DFNA13, DFNA17 and DFNA21 
Phenotypmg those known genotypes may support the ongoing search for mutations in the 
corresponding gene and enhance genetic counselling It is recommended that sufficient 
attention is given to a detailed description of the phenotype in each (newly) described 
hereditary hearing impairment disorder 
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Introduction 
In western Europe, about one in 700 children suffers from sensorineural hearing impairment 
of more than 25 dB in the better ear, more than half of which is thought to be of hereditary 
origin5 9 6 2 In 30% of patients with prelmgual hearing impairment, additional (syndromal) 
anomalies are present In non-syndromal profound childhood hearing impairment, 
inheritance is autosomal recessive in most cases (75-80%)20 Systematic studies determining 
the frequency and mode of inheritance in non-syndromal post-lingual sensorineural hearing 
impairment are not available, though many families have been described, the pattern of 
inheritance is mostly autosomal dominant2 C 6 1 7 3 7 5 
Initially, most scientific attention was directed at the syndromal forms of hearing 
impairment, because these forms could be recognised and described on the basis of the 
associated characteristics Not until the 1960s were physicians able to recognise consistent 
differences in the audiograms of separate families and distinguish between various types of 
isolated hearing impairment, thereby facilitating the study of non-syndromal hearing 
impairment Non-syndromal autosomal recessive hearing impairment has been characterised 
as being generally pre-lmgual in onset, severe to profound, stable over time and affecting all 
frequencies Non-syndromal autosomal dominant hearing impairment, however, has been 
characterised as being generally post-lingual in onset, milder, progressive in many cases, 
and often only affecting a particular frequency range The high frequencies are involved in 
many cases High-frequency hearing impairment may serve as a model for presbyacusis, the 
most frequent sensory deficit in the elderly, to evaluate its possible genetic background 4 β 7 1 
To distinguish between presbyacusis and severe high-frequency hearing impairment, specific 
norms for presbyacusis can be applied ^ 
Consistent audiometrie differences between families were found, to such an extent 
that distinctions could be made between families with low-frequency (ascending 
audiogram),3969 mid-frequency (U-shaped audiogram)57 and progressive high-frequency 
(sloping audiogram) hearing impairment2930 Komgsmark was the author of one of the first 
studies in this field With Gorlin he made the plausible suggestion that several distinct mutant 
alleles are involved in non-syndromal autosomal dominant sensorineural hearing 
impairment40 
It was not until the 1990s that assumptions about the genotype based on the 
phenotype, that is relevant clinical features (audiograms), could be confirmed by the results 
of genetic linkage analysis9 At the same time it also became apparent that different 
32 
Introduction 
genotypes sometimes shared the same phenotypic characteristics It was therefore 
recognised that a detailed phenotypic description, in particular of audiologic data, as well as 
determining the genotype involved in each family, could facilitate the classification and 
diagnosis of hereditary hearing impairment42 Up to now useful phenotypic descriptions 
relating to known genotypes have been rather scarce This is unfortunate, since a detailed 
clinical description may support the ongoing search for mutations in the corresponding gene 
and enhance genetic counselling 1 0 : Μ β 3 
This paper reviews the present state of phenotypic characterisation of known 
genotypes of non-syndromal autosomal dominant hearing impairment We have attempted to 
make previously reported clinical data more easily accessible and also include a preview on 
useful data of some forthcoming reports 
Phenotyping autosomal dominant hearing impairment 
Autosomal dommantly inherited hearing impairment can be considered to be present if the 
following three criteria are met 
• characteristic hearing impairment which (preferably) has been substantiated 
audiometrically over at least three successive generations, 
• documented male-to-male or male-to-child transmission, whereby X-lmked and 
mitochondrial inheritance patterns, respectively, are excluded, 
• as far as possible other (environmental) causes for the hearing impairment have been 
excluded 
If these criteria are met, the degree in which the expected hearing impairment is present 
(gene expression) can be assessed Penetrance can be assessed by determining whether 
genetically affected individuals have the established phenotypic characteristics 
The various types of non-syndromal autosomal dominant sensorineural hearing 
impairment can be distinguished phenotypically on the basis of age of onset (ranging from 
zero in congenital hearing impairment to an advanced age in presbyacusis), the progression 
of hearing impairment (expressed as annual threshold deterioration, ATD, in dB/year), the 
degree of hearing impairment for the better hearing ear (mild hearing impairment 
corresponds to a loss of 27-39 dB, moderate 40-69 dB, severe 70-94 dB, profound 
corresponds to a hearing loss > 95 dB)15, the shape of the audiometrie curves, whether there 
is unilateral or bilateral involvement (intra-subject variability) and on possible inter-subject 
variability within a family2 0 4 0 In addition, information on the possible association with 
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vestibular dysfunction and radiographically detectable cochleovestibular anomalies, should 
be recorded 
Genotyping autosomal dominant hearing impairment 
Until recently, hereditary hearing impairment disorders could only be defined tentatively on 
the basis of the phenotypes Today, many more genotypes than phenotypes have been 
described (Table)75 Mutations in single genes that cause non-syndromal hearing impairment 
affect hearing alone or hearing and balance, depending on their expression, which may be 
purely cochlear or cochleovestibular These non-syndromal monogenic disorders can 
particularly reveal aspects of normal/abnormal cochleovestibular function and 
development1824274865 An appealing example is DFNA2, in which the KCNQ4 gene was 
identified and found to encode a selective potassium ion channel that is preferentially 
expressed in the outer hair cells of the cochlea41 Genotyping already allows rapid 
determination of the genetic origin of hearing impairment in many cases ^ However, there is 
still much to be learned about the development, structure and function of the inner ear 
Since 1992, 31 different non-syndromal autosomal dominant forms of hearing 
impairment have been distinguished These are labelled by DFNA1 to DFNA31 (Table) In 
addition, 28 autosomal recessive forms of non-syndromal hearing impairment, DFNB1 to 
DFNB28,75 have been localised, following genetic linkage studies Only the most frequent 
form by far, DFNB1, has been characterised clinically, as being non-progressive and 
extremely variable, even within families 12 For the extremely rare X-lmked forms of non-
syndromal hearing impairment six loci, DFN1, DFN2, DFN3, DFN4, DFN6 and DFN8,75 have 
been found For the equally rare mitochondrial forms, two mutations have been found75 
Within the loci for non-syndromal hearing impairment 15 different genes have been detected 
over the last two years and presently, new genes are being isolated nearly monthly Up to 
date (clinico)genetic information about the various loci is available online via the Hereditary 
Hearing impairment Homepage (http //www dnalab-www uia ac be/dnalab/hhh)75 
Phenotypic characterisation of DFNA genotypes 
Recent progress in the field of medical genetics has enabled many families with isolated 
hearing impairment to be linked to specific chromosomal loci Thus far, each new family 
identified represented a new locus with two notable exceptions ten unrelated families have 
been linked to the DFNA2 locus and at least four to DFNA9 
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Table Autosomal dominant non-syndromal sensorineural hearing impairment disorders presented by 
their locus designation (DFNA1-31) 
Locus(year) 
DFNA1 (1992)51 
DFNA2(1994)7 
DFNA3(1994)5 
DFNA4(1995)6 
DFNA5(1995)71 
Phenotypic 
description 
47 50 
13 14 42 56 
-
-
+29-32 67 66 
DFNA6/14 (1995/99)6 2 7 4+''3 6 9 
DFNA7 (1995)16 
DFNW\2 ('1997)'" 
DFNA9 (1996)55 
DFNA10(1996)60 
DFNA11 (tgge)6 8 
DFNAiafigg?)'' 
DFNA15(igg8)7 0 
DFNA16(igg8)1 9 
DFNA17(igg7)''9 
DFNA18(1998)2 
DFNA19(1998)22 
DFNA20(1999)e 
DFNA21 (iggg)'" 
DFNA22-2575 
DFNA261 
DFNA27(199g)e 
DFNA28(1999)e 
DFNA29-3r5 
+ 2 2 37 
3.25 36 79 63 86 
-
-
+
4 5 
-
-
+
4 6 
-
-
-
+ 4 4 
-
-
-
-
-
Chromosomal 
localisation 
5q31 
1p34 
13q12 
19q13 
7p15 
4p16 3 
1q21-23 
11q22-24 
14q12-13 
6q22.3-23.2 
11q12 3-21 
6p21 
5q31 
2q24 
22q12-13 
3q22 
10 
17q25 
6p21-22 
reserved 
15q12-21 
4q12 
8q22 
reserved 
Gene 
DIAPH15* 
GJB3(Cx3lfs 
KCNQ4" 
GJB2(Cx26f 
GJBBiCxSOp 
-
DFNAS™ 
TECTA*5 
COChf4 
-
MYOTA" 
COL11A^a 
FOU4F370 
-
-
-
-
-
-
-
-
-
-
Affected 
frequencies 
low/all 
high 
high 
mid/all 
high 
low 
high/all 
mid 
high/alld 
all 
all 
mid/high 
all 
high 
high/all 
-
mid 
mid/high 
-
-
-
-
-
Onset 
(age)a 
post 
post 
pre 
post 
post 
pre 
posi 
pre 
post 
post 
post 
pre 
post 
post 
post 
post 
pre 
-
post 
-
-
-
-
-
ATD 
(dB/y) 
3-5 
1 b 
np 
Ρ 
2 low 
7 high 
np 
Ρ 
np 
3 low 
1 β high 
Ρ 
Ρ 
np 
Ρ 
Ρ 
3 
Ρ 
np 
-
1.1 
-
-
-
-
-
a
, post = post-lingual, pre = pre-lmgual, , m some families, ' 
impairment; ", unpublished (Morell) , ', unpublished (Smith) 5; 
deterioration, p, progressive, np, non-progressive 
initial progression; , concomitant vestibular 
f, present; -, absent, ATD, annual threshold 
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Figure. Plots of pure-tone threshold (dB hearing level, HL) data available for specific DFNA types. A 
(binaural) mean audiogram format is used for non-progressive (which does not exclude presbyacusis) 
types of hearing impairment. Progressive types are presented in (binaural mean) threshold-against-
age plots; predominant loss is indicated by bold lines. Italics indicate our own analyses and 
interpretations, based on previously published data. In the DFNA5 graph the dotted lines were fitted 
with onset age five years, by use of the equations as indicated; the saturation hyperbola (2-8 kHz) 
predicts asymptotic saturation at 105 dB threshold and half saturation (threshold 52.5 dB) at the age of 
11 years. In the DFNA9 graph the broken line is based on a statistical analysis of all the available 
audiograms (cases aged < 35 years, not yet genotyped). 
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Many more new DFNA loci are likely to follow66 and the identification of new genes within the 
DFNA loci and, in particular, of different allelic mutations within these genes is likely to 
facilitate the future analysis of genotype-phenotype correlations. Adequate correlation 
analysis can only be accomplished by performing complete audiovestibular examination 
(preferably with long-term follow-up) of as many potential defective-gene carriers as possible, 
from large families with a given type of hereditary hearing impairment. 
Extensive phenotypic descriptions, in addition to genotypic characterisation, are 
available for only a minority of DFNA types. Phenotypic descriptions of families with DFNA1, 
DFNA5, DFNA6 and DFNA9 had already appeared long before the associated genetic 
linkage was reported. For DFNA2, DFNA9, DFNA12, DFNA13, DFNA14, DFNA17 and 
DFNA21 extensive audiometrie descriptions from several large families have been recently 
published or are currently in press. All families described below manifested complete 
penetrance unless stated otherwise. 
DFNA 1 (chromosome 5q31): low-frequency progressive sensorineural hearing impairment 
This phenotype was first described in a large, eight-generation Costa Rican family (tracing 
back to 1754). Audiometrie evaluations were performed on 26 deaf family members, but only 
the audiograms of seven patients were published.50 In the subsequent genetic linkage study, 
99 relatives took part, 52 of whom were genetically affected.51 In this family hearing 
impairment manifested symmetrically in the low frequencies with post-lingual onset. Onset 
was in the first or second decade of life. Hearing impairment progressed to low-frequency 
losses of approximately 70 dB through adolescence. Affected adults often exhibited losses in 
excess of 100 dB at all frequencies. ATDs in the range of 3-5 dB/year were derived; 
extrapolation of regression lines suggested congenital onset for the low frequencies (offset 
estimates of about 30 dB and 15 dB, respectively, at 0.25 kHz and 0.5 kHz) and an onset 
age of about three years for the higher frequencies (1-8 kHz, Figure). 
Further characterisation of the DFNA1 phenotype illustrated the degree of variability 
in onset age and rate of progression within this family. All mutation carriers were affected by 
the age of 30 years. Electrocochleographic findings in one young patient were consistent 
with endolymphatic hydrops, suggesting a possible dysfunction of the stria vascularis within 
the cochlea, which compromises endolymph homeostasis.47 
Recently the DIAPH1 gene within the DFNA1 locus was isolated, indicating a 
common mutation in all the affected family members. This gene is thought to regulate the 
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polymerisation of actin, the major component of the cytoskeleton of the stereocilia of 
cochlear hair cells.54 
DFNA2 (chromosome 1p34): high-frequency progressive sensorineural hearing impairment 
The DFNA2 locus was established using a seven-generation Indonesian family. Audiometrie 
analysis was performed on 66 affected relatives.13 Genetic linkage analysis covered 33 
relatives, 28 of whom were affected.7 Affected family members were suffering from 
symmetrical, high-frequency, post-lingual hearing impairment and they also developed 
hearing impairment in the low-frequency range at a more advanced age. The onset of 
hearing impairment was between 11 and 38 years of age (anamnestically). Hearing 
impairment at all frequencies progressed slowly with age. The mean ATD was 0.8-1 dB/year 
for the various frequencies. This family exhibited great variability in the shape of the 
audiogram as well as in the severity of hearing impairment. Tinnitus seemed to be an 
important sign in this family, often beginning at the same time as the hearing impairment. 
The gene defect in two unrelated Dutch families,42,56 both exhibiting remote 
phenotypic similarity to the Indonesian family, was also linked to the DFNA2 locus. The 
family study by Kunst et al.42 covered six generations. Audiometrie analysis was performed 
on 26 affected family members. Genetic linkage analysis was performed on 100 relatives, 26 
of whom were affected. Affected individuals were generally suffering from symmetrical, high-
frequency, post-lingual hearing impairment that was progressive at all frequencies. Possible 
congenital high-frequency impairment was also found. The mean ATD at 0.25-8 kHz was 
approximately 1 dB/year (Figure). This family also showed great variability. 
A third Dutch family linked to the DFNA2 locus exhibited slower progression (ATD 
0.7 dB/year), but (again) significant offset thresholds (that is dB HL > 0 at birth; Figure), 
suggesting that this high-frequency hearing impairment might be partially pre-lingual.14 Three 
other families linked to DFNA2 - a Belgian72 and two American families7,67 - showed fairly 
similar general characteristics, but more rapid progression of the hearing impairment, 
exclusively or predominantly in the high frequencies, resulting in severe to profound 
impairment by the fourth decade of life. 
The differences in phenotype may be explained in part by the identification of at 
least two DFNA2 genes. Two mutations in the GJB3 gene (connexin 31) were found 
responsible for the DFNA2 phenotype in two small Chinese families89 and a mutation in the 
KCNQ4 gene, which encodes a selective ion channel, for a similar phenotype in a small 
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French family.41 The latter has, indeed, been implicated in inner ear dysfunction, as it may 
interfere with potassium ion recycling from the outer hair cells. This stresses the importance 
of this gene for normal hearing.27 Recently, the KCNQ4 gene has been analysed for 
mutations in five earlier described families.72 Three different missense mutations in three 
families with fairly similar phenotypes and one deletion mutation in the fourth (Belgian) family 
with a somewhat different phenotype were found. In the fifth (Indonesian) family no KCNQ4 
mutation could be detected. In all five families the GJB3 gene has been excluded as the 
responsible gene.8 Neither of these two genes was present in the Indonesian DFNA2 family, 
which could harbour a third gene within the DFNA2 locus.76 
DFNA5 (chromosome 7p15): high-frequency progressive sensorineural hearing impairment 
DFNA5-related hearing impairment was first found in a large, six-generation Dutch family. 
Audiometrie evaluation was performed on 86 affected relatives.29"31 Genetic linkage analysis 
included 68 family members, 36 of whom were affected.71 Symmetrical, high-frequency, post-
lingual hearing impairment was found with involvement of the low-frequency range at a more 
advanced stage. Onset was between five and 15 years of age. The follow-up study covered 
three decades in this family32,8768 and disclosed different stages of progression. In the first 
decades, there was a rapid increase of high-frequency impairment (2-8 kHz) by at least 7 dB 
per year, slowing down after the age of 30 years, with profound hearing impairment being the 
final stage (Figure). Low-frequency threshold losses (0.25-1 kHz) proceeded more slowly, by 
approximately 2 dB/year (Figure) and usually remained unnoticed until high-frequency 
impairment had reached the level of 60 dB (third and fourth decades). 
Recently the DFNA5 gene, whose function is unknown, was isolated within the 
DFNA5 locus; it exhibited a common mutation in all the affected family members.77,76 
DFNA6/DFNA14 (chromosome 4p16.3): low-frequency sensorineural hearing impairment 
The DFNA6 phenotype was first found in a three-generation American family. Audiometrie 
evaluation was performed on 18 hearing-impaired family members.69 Blood samples from 39 
family members were taken for genetic linkage analysis; 17 were found to be affected.52 
Affected individuals had symmetrical, low-frequency hearing impairment (Figure, broken 
line). The age of onset was estimated between five and 15 years. The frequencies 250, 500 
and 1000 Hz were involved, typically with hearing impairments of up to 50 dB HL. Substantial 
impairment at a young age did not necessarily imply progression to profound hearing 
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impairment as - in some individuals - hearing levels remained stable over the ensuing 
decades Given the apparent lack of progression, it is difficult to distinguish between 
congenital impairment and early, temporary, progression With advancing age, hearing 
impairment at the frequencies of 0 25-1 kHz deteriorated further, presumably on the basis of 
presbyacusis, but the thresholds were not as high as those described for DFNA1 (Figure, 
broken line) Affected family members also showed a variable degree of involvement of the 
higher frequencies, where a presbyacusis component might have been present 
Recently, a four-generation Dutch family was linked to chromosome 4p16 3 as well, 
however, in a candidate region which did not overlap with that of DFNA6 The new locus was 
named DFNA1474 Audiometrie evaluation was performed on 21 hearing-impaired family 
members 43 Genetic linkage analysis was performed on 48 relatives, 21 of whom were 
affected Affected individuals had symmetrical, low-frequency hearing impairment, possibly 
with a congenital component Estimated offset thresholds were approximately 45 dB at 0 25-
1 kHz and 25 dB at 2 kHz (Figure) None of the affected individuals seemed to demonstrate 
any signs of poor speech development or language acquisition Significant progression of 
hearing impairment occurred at all frequencies, but could not be discerned from 
presbyacusis This DFNA14 family, as compared to the above-mentioned DFNA6 family, 
showed fairly similar thresholds for the younger age groups However, beyond the age of 50 
years, thresholds were lower at the higher frequencies (1-8 kHz) 4369 Recently the FGFR3 
gene (fibroblast growth factor receptor 3, expressed in murine differentiating hair cells) has 
been referred to as a possible candidate gene for the 4p16 3 locus (DFNA6/DFNA14)26 
DFNA8/DFNA12 (chromosome 11q22-24) mid-frequency sensorineural hearing impairment 
The DFNA12 locus was determined using a five-generation Belgian family94 Audiometrie 
analysis was performed on 76 family members, 17 of whom appeared to be both clinically 
and genetically affected The family was suffering from symmetrical, pre-hngual hearing 
impairment, involving all frequencies, the mid frequencies (0 5-2 kHz) in particular (Figure) 
The onset of hearing impairment was most probably pre-hngual (anamnestically, cross-
sectional audiometrie evaluation) Hearing impairment was moderate to severe (50 dB on 
average), without any appreciable progression Inter-subject variability was considerable 21 
An Austrian family (initially assigned to DFNA8) was linked to the DFNA12 locus37 
as well, after retraction of its previously described linkage to chromosome 1575 This family 
showed a similar phenotype (Figure, broken line) Absence of substantial inter-subject 
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variability was the most striking difference compared to the former family. In addition, 
delayed speech development was reported.37 Interestingly, the average hearing deterioration 
with age in both families seemed to be less than in the general population. 
Recently, the TECTA gene was discovered, which encodes a-tectorin, a major non-
collagenous component of the tectorial membrane. This gene is affected by two neighbouring 
mutations m DFNA12 and one mutation in DFNAS.2885 A smaller degree of presbyacusis 
might result from some kind of noise-protective effect of the DFNA8/DFNA12 mutation. It can 
be suggested that the ensuing sub-optimal mechanical coupling between the tectorial 
membrane and the outer hair cells protects against overstimulation. 
A fourth TECTA mutation was found in a distant domain of the gene, in a French 
family with high-frequency hearing impairment, stressing the importance of the gene in 
autosomal dominant hearing impairment.1 The family exhibited an average progression of 
about 0.7 dB/year at 0.5-4 kHz; it can be questioned whether or not this can be distinguished 
from normal presbyacusis. Some of the affected family members had manifested delayed 
motor skill development and a possible role for TECTA within the vestibular labyrinth was 
therefore suggested.' 
DFNA9 (chromosome 14q 12-13): high-frequency progressive cochleovestibular impairment 
DFNA9 was first genetically linked in a four-generation American family.55 This locus is 
noteworthy because of its strong association with vestibular dysfunction. Audiometrie 
analysis was performed on 51 family members, of whom 16 appeared to be affected both 
clinically and genetically. The family was generally suffering from symmetrical, high-
frequency hearing impairment, extending to the lower frequencies at a later stage. The 
reported onset of hearing impairment was between 16 and 28 years of age, progressing to a 
profound loss around age 45 years. This was confirmed by the audiometrie analysis, which, 
in addition, disclosed high-frequency hearing impairment to be already present before the 
reported onset age.25 
Case reports on several members of two other American kindreds indicated onset 
ages of about 20 years in one kindred and about 40 years in the other. In one case this was 
also accompanied by proven inactivity of the vestibular labyrinths.36 For the latter family and 
the two other kindreds three different (missense) mutations of the novel COCH gene within 
the DFNA9 locus have been detected.64 A unique inner ear deposit of acidophilic ground 
substance has been described in DFNA9 patients,36 occurring at sites similar to those where 
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COCH gene expression could be demonstrated in the chicken inner ear. Khetarpal et al. 
suggested this deposit to be the cause of the severe degeneration of cochlear and vestibular 
sensory axons and dendrites. It also seems possible however, that this deposit does not 
cause structural or functional impairment, but rather is a result of it.3 
A large DFNA9-linked, four-generation Dutch kindred had similar clinical 
characteristics, with an onset age of about 40 years. However, in some cases episodes of 
much more rapid progression of low-frequency hearing impairment occurred, occasionally up 
to 24 dB/year, as compared to a mean ATD of 3 dB/year. Inter-aural and inter-individual 
variability was considerable and vestibular impairment seemed to be much more pronounced 
than in the American families mentioned above, finally resulting in bilateral vestibular 
areflexia. High-frequency thresholds deteriorated from approximately 50 dB at age 35 to 
about 120 dB at 75 years of age3 (Figure). This family, as well as three other Dutch kindreds 
with cochleovestibular impairment (one of whom has been described by Verhagen et al.82) 
were all found to have the same (missense) mutation within the COCH gene,38 as were two 
other Dutch families (also clinically described earlier, by Verhagen et al.79"81 and one large 
Belgian family,17 which is suggestive of a local founder effect for this mutation. Interestingly, 
several Ménière-like episodes were reported by some affected persons in all these, 
phenotypically very similar, kindreds83,86 (authors' unpublished data). 
DFNA13 (chromosome 6p21): mid-frequency sensorineural hearing impairment 
The DFNA13 locus was established using a large, five-generation American family with mid-
frequency hearing impairment;4 the hearing impairment was presumably congenital, varying 
from mild to (moderately) severe in degree, and with the mid frequencies most severely 
affected. Progression did not exceed normal presbyacusis.58 An extensive phenotypic 
analysis has been performed for a large, five-generation Dutch family with a hearing 
impairment trait that was recently linked to the DFNA13 locus as well.45 Audiometrie analysis 
was performed on 49 family members, 21 of whom appeared to be affected both clinically 
and genetically. They showed fairly symmetrical, possibly pre-lingual, mid-frequency hearing 
impairment with high-frequency involvement (Figure). Most individuals became aware of their 
hearing impairment in the second or third decade of life. The 1 and 2 kHz thresholds and 
those at 6 kHz and 8 kHz were approximately 40-50 dB, whereas at the other frequencies 
thresholds were approximately 30 dB. Progression in this family, from the fourth decade 
onwards, could be explained by presbyacusis. The identification of two family members, 
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aged over 40 years, with a normal phenotype who exhibited positive linkage was suggestive 
of reduced penetrance in this family45 
Recently, refined mapping of the Dutch and American DFNA13 families indicated 
linkage to a region that is centromenc to the originally published DFNA13 region 458 Within 
this region the COL 11A2 gene has been isolated, showing two different mutations in the two 
DFNA13 families Interestingly, these mutations are the first collagen mutations reported to 
be associated with non-syndromal hearing impairment It has been postulated that COL11A2 
plays an essential role in tectorial membrane structure and function5e Congenital, 
permanent, structural defects caused by COL11A2 mutations were suggested to underly the 
pre-lmgual, non-progressive hearing impairment m DFNA13 This may be fairly similar to the 
relationship between TECTA mutations and the hearing impairment phenotype m DFNA8/12 
DFNA17 (chromosome22q12-13) high-frequency progressive sensorineural hearing impairment 
This phenotype was described in a five-generation American family, following 
histopathological examination of the temporal bones of the proband, which had revealed 
cochleosaccular (Scheibe's) degeneration Audiometrie evaluation was performed on 13 out 
of 22 anamnestically screened family members46 Subsequently, this disorder was linked to 
the DFNA17 locus By then, the eight clinically affected individuals also appeared to be 
genetically affected 49 Five defective-gene carriers were evaluated audiometncally, the other 
three only anamnestically They had symmetrical, high-frequency, post-lingual hearing 
impairment, extending to all frequencies later on Although they became aware of their 
hearing impairment by the age of approximately ten to 12 years, an onset age of about four 
years was derived by regression analysis on the published threshold-on-age data (Figure) A 
mean ATD of approximately 3 dB/year was calculated after having proved that pooling of the 
regression lines was justifiable for all frequencies (Figure) Hearing impairment progressed at 
all frequencies up to moderate-to-profound (inter-subject variability in severity) impairments 
by the third decade of life Interestingly, this was the second DFNA locus, following DFNA9, 
to be both genetically mapped and histologically characterised 
DFNA21 (chfcmoecme6p21-22) mid-frequency progressive sensorineural hearing impairment 
Recently a Dutch family has been identified which most probably represented a new locus, 
DFNA21 Genetic linkage analysis has revealed this locus to largely overlap the former 
DFNA13 locus44 Audiometrie analysis was performed on 64 individuals, 17 of whom 
appeared to be affected both clinically and genetically They generally exhibited symmetrical, 
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variable, post-lingual hearing impairment In some individuals mid-frequency hearing 
impairment was detected Age of onset varied, with some individuals manifesting pre-lmgual 
onset, whereas others appeared to have onset ages of up to 45 years Progression occurred, 
with a pooled ATD of 0 7 dB/year at 0 25-0 5 kHz and 1 1 dB/year at 1-Θ kHz, ending up in 
moderate-to-severe hearing impairment Flat to downslopmg audiograms were seen at a 
more advanced age Extrapolation of regression lines revealed an onset age of about three 
years for all frequencies (Figure) Penetrance might be incomplete, as two additional 
defective-gene carriers were identified, who did not exhibit the hearing impairment 
phenotype In addition, one individual manifested the typical phenotype, but did not have the 
at-risk haplotype ** 
Conclusion 
Over the past 25 years, knowledge of hereditary hearing impairment has increased 
considerably Initially, most attention focused on syndromal hearing impairment More 
recently, great progress has been made in the field of non-syndromal hearing impairment 
Until recently, drawing up a pedigree and performing audiometrie examinations on affected 
family members to establish the phenotype of hearing impairment were the only means of 
outlining a given hereditary hearing impairment The increasing possibilities of establishing 
genotypes of hearing impairment, combined with a careful description of the phenotype, now 
greatly facilitate the classification and clinical diagnosis of such disorders It is already 
feasible, in some cases, for individual diagnoses to be based on mutation analysis 
Furthermore, increasing knowledge of the genes involved has begun to provide insight into 
the molecular mechanisms underlying normal and abnormal hearing and balance It is 
recommended that sufficient attention is given to a detailed description of the phenotype in 
each (newly) described type of hereditary hearing impairment 
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Introduction 
This chapter reviews phenotypic features of autosomal dominant traits of sensorineural non-
syndromal hearing impairment (SNHI) that have already been linked to some of the recently 
outlined DFNA loci but whose underlying genes have not yet been identified DFNA1712 is not 
included because the responsible gene (MYH9) has been identified very recently3 Details of 
the hearing-impairment phenotype were not readily accessible for the loci DFNA1Θ, DFNA19 
and from DFNA22 onwards and have therefore been omitted, see the original references and 
preliminary phenotype descriptions specified on the Hereditary Hearing impairment Homepage 
(HHH)4 and a recent review5 
Patient data were re-evaluated where possible from the original reported data or the 
original data in case the trait had been identified at the Nijmegen ORL Department The type of 
SNHI is outlined in the format of "age-related typical audiograms" (ARTA) ARTA are based on 
cross-sectional analysis of pure-tone threshold (air conduction, heanng level in dB, that is dB 
HL) on age, or on individual separate or serial audiograms obtained at certain ages Essential 
primary analysis data, such as apparent congenital offset threshold or annual threshold 
deterioration (ATD, dB/year), are specified where appropriate 
O 
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Figure 1 ARTA based on single audiometrie data in 3 affected individuals of an American family67 
Age (year) in Italics 
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DFNA4, DFNA6/14, DFNA7, DFNA 16, DFNA20 and DFNA21 
DFNA4 
Chen et al.6 described an American family with fluctuant, progressive SNHI affecting all 
frequencies, especially the mid frequencies (Figure 1). Onset was in the second decade. 
Severe to profound impairment was found by the age of 40.7 Linkage analysis localised the 
DFNA4 locus to chromosome 19q13. The myotonic dystrophy (DM) kinase gene has been 
suggested to be a strong candidate for DFNA4. See reference 7 for a possible explanatory 
mechanism of the development of SNHI on the basis of existing knowledge about this gene, in 
light of the "precocious presbyacusis" found in patients with DM.8 A second, unrelated 
American family has been reported with linkage to the DFNA4 locus.7 
Hereditary SNHI showing relatively flat thresholds is rare. There may be some 
similarity in audiometrie configuration between DFNA4 and DFNA10 (American family). 
DFNA6/14 
The DFNA6 phenotype, characterised by low-frequency SNHI (Figure 2) with early onset, was 
first described in an American family9 and later on mapped to the DFNA6 locus on 
chromosome 4p16.3.1i:i The original data were re-evaluated using cross-sectional linear 
regression analysis of (binaural mean) threshold on age. Substantial and significant offset 
1 2 4 8 kHz 
Frequency 
8 kHz 8 kHz 
Figure 2 ARTA in an American family linked to DFNA6,910 a Dutch family linked to DFNA141' and a 
Dutch family linked to DFNA6/14 (Bom et al., unpublished data). ARTA based on cross-sectional 
analysis (re-evaluation of American DFNA6 family including linear threshold-on-age regression 
analysis of the published audiometrie data). Age (year) in Italics. 
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thresholds (that is Y intercepts) were only found at the low frequencies (0 25-1 kHz) with a 
pooled value of 43 dB at age 0, these frequencies did not show any significant progression 
(ATD = 0 1 dB/year) The higher frequencies (2-8 kHz) showed significant progression (pooled 
ATD 0 7 dB/y), but no significant offset threshold (pooled offset threshold 3 dB at age 0) 
Presbyacusis-corrected thresholds did not show any significant progression (data not shown) 
A Dutch family was recently linked to a region on chromosome 4p16 3 (DFNA14) 
closely adjacent to but non-overlapping with that of DFNA6 " ,2 This family also showed early-
onset predominantly low-frequency SNHI consistent with a mean threshold of 48 dB at 0 25-1 
kHz and 32 dB at 2 kHz found at age 11-45 years (Figure 2) Affected persons showed normal 
speech development and language acquisition Progression occurred at all frequencies but did 
not differ significantly from median (P50) presbyacusis With few exceptions, vestibular function 
was intact11 
Another Dutch family was recently linked to this chromosomal region, comprising both 
the previously located DFNA6 and DFNA14 loci (unpublished data, Bom et al and Van Camp 
et al ) Again, the mam characteristic was low-frequency SNHI, however, there was mild but 
significant progression (Figure 2), also following correction for presbyacusis (data not shown) 
The combination of, presumably, stationary low-frequency SNHI and presbyacusis in 
DFNA6, DFNA6/14 or DFNA14 results in phenotypes with an ascending audiometrie con-
figuration at a young age, which evolves into a flat-type audiogram in the sixth or seventh 
decade and a down-sloping configuration at a more advanced age (Figure 2) It is of note that 
especially the ARTA for DFNA6 and DFNA14 showed fair similarity The ARTA for DFNA6/14 
clearly illustrates higher progression represented by larger threshold steps over the 
consecutive decades For a discussion of possible candidate genes see elsewhere 7 
There is no apparent similarity in phenotype between DFNA6, DFNA6/14 or DFNA14 
and any other reported type of non-syndromal SNHI The low-frequency SNHI trait mapped to 
the first locus, DFNA1, which is caused by mutations in the gene diaphanous, showed much 
more rapid progression than either of the present traits5 
DFNA7 
Fagerheim et al1 3 described a Norwegian family with a trait of postlingual, progressive SNHI 
predominantly at the high frequencies, that linked to a locus on chromosome 1q21-23, 
designated DFNA7 A detailed report on the phenotype appeared a few years later, which 
included the results of longitudinal observations on affected persons u 
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Figure 3 ARTA based on scatter plots for 0 5, 1 and 4 kHz for all patients measured Age (year) in 
Italics 
Some of them showed episodes of (initially) rapid progression, during which there could be 
considerable asymmetry in threshold between the ears Progression slowed down at a more 
advanced age (Figure 3) Normal caloric responses were obtained A discussion of the linkage 
data and possible candidate genes can be found elsewhere 15 The phenotype of DFNA7 is 
somewhat similar to those of DFNA2/KC/V04, DFNA5/DF/V/45 and DFNA24 (personal 
communication by F M Hafner, 1999) It is of note that initially rapid progression that later 
slows down is typically found m DFNA5/DFNA5, but not m DFNA2JKCNQ45 
DFNA16 
The 16th locus (DFNA16) for autosomal dominant SNHI was identified in a linkage analysis of 
a hearing-impairment trait in a Japanese family 16 The trait showed rapid progression in SNHI, 
especially at the high frequencies (Figure 4) and, in addition, the intriguing feature of large 
threshold fluctuations that appeared to respond favourably to steroid therapy There was 
substantial m-phase binaural cofluctuation in threshold noted Tinnitus was an associated 
feature but not vertigo Imaging of the temporal bones in some cases did not show any 
abnormal findings Onset of SNHI occurred at the end of the first or the beginning of the 
second decade of life The original report elaborates on possible theoretical explanations of the 
fluctuations and considers some interesting putative candidate genes 16 
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Figure 5 ARTA based on single audiograms published for two affected men 17 Age (year) in Italics 
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Given a lack of sufficient audiometrie data, it is difficult to compare the DFNA16 
phenotype to other autosomal dominant SNHI phenotypes 
DFNA20 
Morell et al '7 recently reported the localisation of DFNA20 to chromosome 17q25 The 
associated SNHI trait was only crudely outlined, it showed relatively late onset at age 20, and 
predominantly affected the high frequencies in a fairly similar way to presbyacusis but 
"shifted earlier by about 30 years"17 The two audiograms included m the original report are 
reproduced in modified form in Figure 5 Attempts to fit P50 ISO 7029 norms for presbyacusis 
(men)18 to the threshold data demonstrated that a shift of some 40 years is needed to 
reasonably fit the high-frequency thresholds but that such shifts would greatly underpredict 
the thresholds at the lower frequencies in the present DFNA20 trait Such observations not 
only show that the degree of SNHI m DFNA20 is beyond normal presbyacusis, but also that 
the type of SNHI is a more complex one than simple 'precocious presbyacusis', a low-to-mid 
frequency component is probably also needed to model the age-related threshold findings 
more properly A candidate gene approach was adopted for DFNA20, but no strong 
candidates were identified 17 
Somewhat similar audiograms to those typical of DFNA20 can be found in affected 
persons of similar ages with other progressive high-frequency SNHI traits, such as 
DFNA2/KCNQ4 or DFNA15/POL/4F3 19 
DFNA21 
Kunst et a l 2 0 mapped the 21 s t locus (DFNA21) for autosomal dominant SNHI to chromosome 
6p21-22 in a Dutch family The hearing-impairment trait showed variable onset and was 
probably prehngual in some cases but postlingual with onset ages of up to 45 years in others 
Progression was significant and resulted in moderate-to-severe SNHI with a flat threshold at 
young ages and gently downsloping audiometrie configurations at a more advanced age 
(Figure 6) The pooled ATD was about 0 7 dB/year at 0 25-0 5 kHz and 1 1 dB/year at 1-Θ 
kHz Correction for median presbyacusis18 confirmed that there was progression beyond 
normal presbyacusis at the low and mid frequencies (data not shown) However, substantial 
overcorrection was found at 4 and particularly 8 kHz, that is the phenomenon that P50 
presbyacusis correction results in decreasing thresholds at increasing ages 
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Figure 6 ARTA based on cross-sectional regression analysis (threshold on age) of a Dutch family 20 
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There is some phenotypic similarity to DFNA10 and DFNA15/POL/4F3, although the 
latter type of SNHI eventually becomes more severe at the high frequencies, that is more 
steeply sloping 19 There is also some similarity to the SNHI phenotype found in the 7472insC 
mtDNA mutation, which also shows gently sloping audiometrie configurations Finally, there 
may be some similarity in audiometrie configuration to those found in other types of 
progressive high-frequency SNHI, provided that these are not too steeply sloping, such as in 
OFUh2JKCNQ4 However, the latter type of SNHI consistently showed a substantial 
congenital offset threshold, which is apparently lacking m DFNA21 
Comment 
The phenomenon of "presbyacusis overcorrection" was specifically mentioned above in 
relation to DFNA21 However, this phenomenon appears to occur not only in some of the 
other SNHI traits covered here (DFNA6 and DFNA6/14), but also in DFNA2/KC/V04, 
DFNA5/DFNA5, DFNA9/COCH, DFNA10/EV/W,2122 DFNA13/COL11A2 and the trait caused 
by a 7472insC mtDNA mutation The phenomenon suggests that the SNHI trait involved 
shows progression at the high frequencies that behaves in a competitive way with regard to 
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presbyacusis In other words, hereditary hearing deterioration apparently (also) involves 
cochlear elements (for example, hair cells and afferent neurons) that would otherwise be 
compromised in "normal" presbyacusis Remarkably, the above list of loci/genes does not 
only cover traits with high-frequency SNHI, but also traits with low-frequency or mid-
frequency SNHI This issue certainly merits further special attention in future phenotype 
studies 
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Cochleovestibular impairment 
Abstract 
Objectives analysis of genotype-phenotype correlation 
Study design family study 
Methods auditory and vestibulo-ocular functions were examined in a Dutch family with 
autosomal dommantly inherited sensorineural hearing impairment, caused by a 208C->T 
mutation in the COCH gene, located in chromosome 14q12-13 (DFNA9) Linear regression 
analysis of individual longitudinal hearing threshold data (n=11 ) on age was performed 
Results 15 of the 16 genetically affected persons could be evaluated They all developed 
hearing and vestibular impairment symptoms - and in many cases also cardiovascular disease 
- in the fourth to fifth decade At the low frequencies (0 25-2 kHz) hearing impairment started at 
the age of about 40 years and showed an average annual progression of approximately 3 dB, 
finally resulting in profound hearing impairment In two exceptional cases, annual progression 
attained levels of up to 24 dB At the high frequencies (4-8 kHz), the average threshold 
deteriorated from about 50 dB at the age of 35 years to about 120 dB at the age of 75 years 
(which amounts to 1 8 dB annual threshold deterioration) All affected individuals tested 
showed normal ocular motor functions The patients older than 46 years generally showed 
absence of the vestibulo-ocular reflex, but their cervico-ocular reflex was enhanced compared 
with normal subjects, whereas those aged 40-46 years showed either severe vestibular 
hyporeflexia or unilateral caloric areflexia 
Conclusion these findings suggest a gradual development of cochleovestibular impairment 
caused by the new mutation found 
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Introduction 
Inherited sensorineural hearing impairment can be classified into two forms syndromic and 
nonsyndromic The latter form accounts for about 75%12 of all cases of congenital hearing 
impairment and is highly heterogeneous, nearly each family maps to a unique chromosomal 
locus Prelmgual nonsyndromic hereditary hearing impairment is diagnosed in approximately 
one m 700 newborns,3 of which 75% is autosomal recessive, 20% to 25% autosomal 
dominant, and up to 5% X-lmked or mitochondrial2 
Thorough genotypic and phenotypic analysis can provide the necessary definition and 
delineation of types of monogenic hearing impairment4 More than 40 human chromosomal 
loci associated with nonsyndromic hearing impairment have been reported in recent years, 
including more than 15 autosomal dominant (DFNA) loci5 More than eight different genes 
have been identified since 1997, including late-onset progressive types with high-frequency 
involvement In some studies moderate or subclinical hearing impairment was detected in 
individuals heterozygous for autosomal recessive gene defects68 It is possible that 
heterozygous recessive gene defects or DNA variants in dominant deafness genes are risk 
factors for presbyacusis 
A large multigenerational nonconsangumeous Dutch kindred is presented, showing 
progressive hearing and vestibular impairment with a relatively late onset, ultimately leading 
to profound deafness and vestibular areflexia 
Materials and methods 
We examined auditory and vestibulo-ocular functions in 16 affected members of a Dutch family 
of about 200 members (family W98-011, Figure 1) In addition, six deceased individuals 
seemed to be affected Thus a total of 22 affected individuals were identified The pattern of 
inheritance was autosomal dominant with apparently full penetrance 
Possible exogenic, nonhereditary causes of hearing and vestibular impairment were 
excluded Family history data were obtained and the pedigree was drawn Prior written consent 
was obtained to retrieve previous audiograms and relevant medical information All 119 
persons participating in this study underwent otoscopy Special attention was paid to vestibular 
impairment symptoms, as well as possible syndromic features Seven persons with vestibular 
areflexia were also examined by a neurologist 
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Figure 1. Pedigree of family W98-011. Solid symbols mark affected individuals, amongst whom are 
several deceased individuals (1-1, II-2, II-6, ΙΙ-Θ, 11-10 and 111-19). 
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Blood samples for genetic linkage analysis were collected from 16 presumably affected 
individuals and 103 presumably unaffected individuals, in which chromosomal markers for the 
15 known loci for nonsyndromic autosomal dominant hearing impairment were screened first, 
guided by the pattern of inheritance in the pedigree Linkage to the DFNA9 locus was found 
and mutation analysis was performed9 
Audiograms were obtained from all individuals, according to International Standards 
Organization (ISO) standards,1011 including air-conduction and bone-conduction levels The 
method of ISO 702912 was followed to calculate for each patient individually the 95m percentile 
(P95) threshold values for presbyacusis at each frequency in relation to the patient's age and 
sex Because of lack of other known causes, thresholds above the P95 value in the better ear 
were initially considered as inherited sensorineural hearing impairment The final selection 
comprised the mutation carriers only Previous audiograms were retrieved from elsewhere, 
including affirmative audiograms from three deceased (presumably affected) individuals 
Linear regression analysis was performed in those cases where a sufficient number 
of serial audiograms (covering at least three years) was available It was tested whether 
there was significant progression (that is where the regression coefficient, in this report called 
the annual threshold deterioration [ATD] and expressed in decibels per year, was significant) 
The Y intercept was called the offset (threshold) and, in case of this being a negative value, 
an onset age was calculated (X intercept) Where appropriate, regression lines were 
compared using the F test (one-way ANOVA options included in the Prism computer 
program (PC version 2 0, GraphPad, San Diego, CA) to detect any significant differences 
The Prism program tests the slopes first and subsequently the intercepts, but it abandons 
testing as soon as a significant difference is detected, pooled values are calculated where 
possible The level of significance used was 0 05 
Gaze positions were tested to investigate whether there was any gaze-evoked 
nystagmus Saccades, smooth pursuit, and horizontal optokinetic nystagmus responses 
were elicited and analyzed as reported earlier13 Vestibular tests (velocity-step tests and 
caloric tests) were conducted with the patient in the dark with the eyes open It was 
evaluated whether there was any spontaneous nystagmus Velocity-step tests were 
performed with a rotatory chair (Toenmes GmbH, Freiburg im Breisgau, Germany) The 
postrotatory nystagmus response was analyzed with a computer method Only the time 
constant is specified as a key response parameter in the cases with severe hyporeflexia (P5-
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Ρ95,11-26 s). The cervico-ocular reflex was elicited in the dark by applying sinusoidal 
stimulation to the body with the head fixed in space.14 
Results 
Affected persons reported an age of onset for hearing impairment symptoms ranging from 36 
to 63 years. Hearing impairment was characterized by variable - in most cases rapid -
progression to profound sensorineural impairment (Figure 2). Affected individuals showed no 
evidence for other factors predisposing toward hearing impairment, except in case IV-37, 
where ear surgery had taken place previously. In most individuals, vestibular symptoms and 
hearing impairment symptoms started simultaneously. 
IV-WR u s » , ^ IV-ML « IV-MH ^ IV·» L ^ IV-M Η M S « ,
 Λ
 IV-« L 
IV-39H U S « ,
 Λ
 IV-36L ^ IV.« R u s » , ^ IV-M L ^ »37 Π u s » , ^ KIT L 
Figure 2. Individual audiograms (R, right ear; L, left ear) of 15 affected family members, ordered by the 
age at which the most recent audiogram was obtained (see key to symbols next to each graph). Air-
conduction threshold in decibels hearing level (dB HL). HIS, hearing impairment symptoms (age, y); 
VA, vestibular areflexia (age, y). 
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The former symptoms consisted of head-movement-dependent oscillopsia and imbalance 
when walking in the dark, patients also reported having difficulties when riding a bicycle, 
especially when attempting to look over their shoulders With their eyes closed, they 
generally exhibited a broad-based gait 
Several affected individuals had a history of hypertension (cases III-23, III-24, III-26, 
III-37, IV-46, IV-48 and IV-50), stroke (cases 111-18, 111-19, III-24 and III-26), or ischaemic 
heart disease (cases III-23, III-35 and III-37) Hence ten out of 15 individuals exhibited 
cardiovascular disease 
One individual (case III-24) had recently experienced an episode of glossopharyngeal 
neuralgia One individual (case III-2) exhibited mild symmetric distal polyneuropathy One 
individual (case 17-46) had a mild cervical myelopathy Apart from these incidental findings, 
no consistent neurological deficits other than vestibular impairment were found 
Linkage analysis mapped the gene defect underlying cochleovestibular impairment in 
this family to an 11 O-centiMorgan (cM) region overlapping the DFNA9 interval15 on 
chromosome 14q12-13 Sequence analysis revealed a 208C->T mutation (exon 4) in the 
COCH gene, resulting m a P51S substitution in the predicted protein in all affected 
individuals of the family, this mutation was not found in unaffected family members or in 200 
control individuals 9 
All audiograms obtained from the genetically affected family members included in this 
study are presented in Figure 2 Case IV-37 was excluded because of previous ear surgery 
All identified carriers of the mutation demonstrated sensorineural hearing impairment At a 
relatively young age (generation IV, note that in Figure 2 cases are ordered by the age at 
which the most recent audiogram was obtained), considerable sensorineural hearing 
impairment at the highest frequencies was already present, audiograms showed down-
sloping hearing impairment in most cases In addition, sensorineural hearing impairment at 
the lower frequencies had developed at a more advanced age The patients in generation III 
showed moderate to severe hearing impairment with (eventually) an almost flat threshold or 
residual hearing (that is functional hearing only at the low frequencies) In three of the six 
probably affected, deceased individuals audiograms could be retrieved, they all exhibited 
severe losses typical of the general audiometrie picture in this family Audiometncally, 
remarkable variability and asymmetry were seen in the progression of heanng impairment 
with increasing age (Figure 2) 
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Regression analyses of longitudinal threshold-on-age data were performed only for 
those age intervals where (approximately) linear homogeneous progression occurred. 
Relevant parameter values are presented in the Table. The estimates obtained for the 
longitudinal annual threshold deterioration (ATD) at the frequencies 0.25 to 2 kHz varied from 
2 to 4 dB in most instances. In two exceptional cases (111-26 and IV-46) ATDs of up to 24 dB 
were found. ATDs for the frequencies 4 to 8 kHz were smaller in all cases in which those 
deteriorations could be evaluated. Estimates for onset age could be obtained only for the low 
frequencies in most cases; estimates were in the range of approximately 35 to 50 years, 
except in case 111-23, in which the extrapolated onset age was about 18 years. Case IV-46 
had an apparent onset age of between 25 and 40 years at all frequencies. In case III-35, an 
onset age of zero years was extrapolated for the high frequencies, but the raw data (not 
shown) clearly indicated nonlinear, increased progression following onset at about 45 years 
of age. 
Table. Relevant results of the longitudinal analyses (i.e. linear regression analysis for η > 2) of the 
binaural mean threshold in relation to age applicable to cases with suitable observation intervals. 
Case age inlerval (y) η ATD (dB/y)a Onset age (y)a Offset (dB)b 
II-2 
II-18 
11-23 
11-24 
11-26 
11-29 
11-33 
11-35 
11-37 
11-43 
5Θ-72 
52-Θ0 
55-73 
65-70 
44-47 
53-69 
66-71 
51-69 
46-67 
49-66 
56-69 
7 
θ 
7 
3 
3 
10 
4 
9 
1Θ 
7 
9 
lo 3, hi 0 
l o i 
lo 2 
lo 4 
R lo 5, L lo 24 
lo' 3, hi' 2 
lo 3 
lo 4 
lo 3, hi 1 
lo 3, hi 2 
lo 3, hi 1 
lo 46 
l o i e 
lo 50 
Lio 44 
lo '41 
lo 51 
lo 45 
lo 34, hi 0 
lo 36, hi 19 
lo 47 
R 7/58,185/129 
R 28/na, L 51/na 
R na, L na 
R na, L na 
R 28/na, L na/23 
R na, L na 
R na/72, L na/89 
(nonlinear) 
R na, L na 
R 117/49, L20/na 
Mean lo 3.0, hi 18 lo 41 
IV-46 42-48 13 lo 6-16, hi 4-5 lo 36-41, hi 27-30 R na, L na 
a
, pooled regression estimate, ", 4 kHz/8 kHz ; lo, low frequencies (0.25-2 kHz, ', 0 25-1 kHz); hi, high frequencies 
(4-8 kHz, *, 2-8 kHz); R, right ear, L, left ear, na, not applicable (i.e negative value), significant difference from 
zero in bold 
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In case 111-37 extrapolation produced an apparent onset age of about 20 years for hearing 
impairment at 4 to 8 kHz, but given the amount of scatter in the raw data, this estimate 
seems inaccurate. 
In five cases backward extrapolation of the 4 to 8 kHz regression lines (that is toward 
the Y axis) yielded an offset threshold (positive intercept) in at least one ear, for one of these 
frequencies (Table). This offset differed significantly from zero in two measurements. These 
findings suggest sensorineural hearing impairment at 4 to 8 kHz being present well before 
the presumed age at onset of hearing impairment in the lower frequencies, as well as 
vestibular impairment. More appropriate analysis of these findings may be performed after 
having genotyped the youngest family members. 
All available threshold data are shown in Figure 3, with separate trend lines for each 
of the two sets of low and high frequencies. It should be noted that formal regression 
analysis of the data shown was not permitted, because of the replications (that is the 
presence of longitudinal individual measurements and separate entries for the two ears in 
most cases). At 0.25 to 2 kHz, we assumed an average trend with onset at 40 years of age 
and progression by 3 dB/year (see mean values in the Table). At the 4 to 8 kHz frequencies, 
we assumed an average threshold trend from 50 dB at the age of 35 years to 120 dB at the 
age of 75 years (that is average annual progression about 1.8 dB, see Table). 
Vestibulo-ocular examination was performed on all affected family members (Figure 
2), except in cases IV-37 (previous ear surgery) and 111-18 (not fit to undergo the tests). All 
cases had normal ocular motor function. In generation III, all affected family members (aged 
over 60 years), except for one individual (case III-2) had an absent vestibulo-ocular reflex, 
but their cervico-ocular reflex was enhanced compared with normal subjects, which is typical 
of labyrinthine-defective patients.'4 In case III-35 the same findings had been obtained seven 
years earlier. In case III-2, severe hyporeflexia of the vestibulo-ocular reflex was evident, but 
with a well-developed cervico-ocular reflex; this individual had relatively late onset of hearing 
impairment symptoms. Similar vestibular findings were obtained in generation IV in cases IV-
48 and IV-54 (aged 45 and 40 years, respectively). These three cases showed a very short 
vestibulo-ocular reflex time constant (1-4 s). In generation IV, only case IV-46 (aged 47 
years) showed bilateral vestibular areflexia, whereas cases IV-39 (aged 46 years) and IV-50 
(aged 43 years) exhibited unilateral caloric areflexia. 
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Figure 3. Plots of all the available threshold-on-age data for each frequency with "trend lines" (bold) 
For each ear (o, right; x, left), longitudinal data points are connected by thin lines. The trend line for 
each of the frequencies 0.25-2 kHz is based on the mean values (slope and onset age) in the Table. 
The trend line for each of the frequencies 4 and 8 kHz has a mean slope of 1.8 dB/year (Table) and 
was arbitrarily drawn at an offset level of 50 dB at age 35 years 
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Discussion 
This clinical study of a family (family W98-0119) with the DFNA9/COCH mutation revealed 
distinct characteristics of cochleovestibular impairment. 
Considerable intersubject and interaural variability in the development of hearing 
threshold with advancing age were found (Figure 2 and Table). Most of the progression 
occurred at the low frequencies (3 dB/year, Figure 3). At the high frequencies, sensorineural 
hearing impairment may have been due to presbyacusis. In the Table annual increases in 
threshold levels of about 1 to 2 dB are shown for the high frequencies in cases where this 
could be evaluated. We simulated average presbyacusis by plotting P50 presbyacusis 
threshold values12 for each frequency at several equidistant ages over the age interval of 50 
to 70 years. We calculated virtual values for annual threshold deterioration (ATD) and related 
these values to median presbyacusis values by linear regression analysis for these 
hypothetical threshold data. The resulting values were between 0.7 dB/year (women) and 1.4 
dB/year (men) at 4 kHz and between 1.3 and 1.8 dB/year at 8 kHz. These estimates are in 
the same range as most of the ATD values estimated for the high frequencies in the Table. 
Vestibular areflexia was found from the age of 47 years (case IV-46) onward, 
whereas at a younger age (40 to 46 years) the affected individuals showed either severe 
hyporeflexia or unilateral caloric areflexia. Those younger subjects are likely to develop 
vestibular areflexia as well. 
The DFNA9 family reported on by Manolis et al.15 displayed onset of low-frequency 
hearing impairment at about 16 to 28 years of age, which seems earlier than in the family in 
the present study. Khetarpal et al.16 reported that in this kindred onset age was about 20 
years of age, whereas in another family it would be about 40 years. From previous reports15' 
17
 we derived individual annual threshold progression values in the range of 3 to 8 dB, 
predominantly at the low frequencies. Some of our cases exhibited more rapid progression 
(up to about 24 dB/year), especially at the beginning of the observation period. Given this 
finding, the possibility cannot be excluded that in some of the previously described cases 
such progression was only transient and escaped detection. 
Three distinct COCH mutations pertaining to three American families with 
nonsyndromic autosomal dominantly inherited hearing impairment - different from the 
mutation in the family of the present study - were described by Robertson et al.18 The P51S 
mutation in the family in the present study was also found in three additional Dutch families 
(families W98-065, W98-066, and W98-094).9 All families originated from the southern region 
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of the Netherlands. One of them has previously been described by Verhagen et al.19 (family 
W98-094)9. A Flemish family with the P51S mutation has recently been studied by Fransen 
et al.,20 who also found this mutation in two other previously described Dutch families21'23. 
Only one American patient with DFNA9-linked sensorineural hearing impairment had proven 
hypoactive labyrinths at age 49 and inactive labyrinths at 53 years (case IV-3, kindred 2).16 
Cardiovascular disease was a prominent additional finding in the family in the present 
study, as in a family described by Verhagen et al.21 The latter family was recently shown to 
have the present DFNA9/COCH mutation.20 
Some histopathological descriptions of DFNA9 have been reported. Khetarpal et al.16 
and Robertson et al.18 discovered an acidophylic mucopolysacchande-containing ground 
substance in the cochleas, maculas and cristas of DFNA9 patients, as well as severe 
degeneration of vestibular and cochlear sensory elements and dendrites. These depositions 
occurred at sites similar to those where COCH gene expression is seen in the chicken inner 
ear.18 Such a deposition may cause functional impairment in a straightforward manner - in 
terms of "strangulating" nerve endings - as has been hypothesized by Khetarpal et al.15 It 
also seems possible, however, that this deposition does not cause structural or functional 
impairment, but rather is a result from it. Nevertheless, more conclusive pathophysiological 
explanations require further study. 
Conclusions 
The findings presented in this family study suggest a gradual development of 
cochleovestibular impairment caused by a 208C->T mutation in the COCH gene located in 
chromosome 14q12-13 (DFNA9). The gross characteristics of this trait are progressive 
middle-age onset (at the age of approximately 40 years) low-frequency hearing impairment 
of about 3 dB/year and high-frequency threshold increases from approximately 50 dB 
hearing level at the age of 35 years to approximately 120 dB hearing level at the age of 75 
years. At the time of onset of low-frequency hearing impairment, development of vestibular 
areflexia starts as well. 
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Cochleovestibular impairment 
Abstract 
Objective: to describe the decline of vestibulocochlear function in a man with 
vestibulocochlear dysfunction caused by a P51S mutation within the COCH gene on 
chromosome 14q12-13 (DFNA9). 
Methods: a follow-up of more than 15 years was performed in a single case. Clinical 
investigations were supplemented by oculomotor, vestibular, and auditory tests. 
Results: a 50-year-old man had had progressive sensorineural hearing impairment and 
dysequilibrium for 15 years; he had been asymptomatic at the age of 35 years. He suffered 
from instability in the dark, head movement-dependent oscillopsia, paroxysmal positional 
vertigo, and vertigo with and without nausea. Hearing impairment started unilaterally, 
predominantly in the high frequencies. He also reported tinnitus. Disease progressed to 
severe bilateral high frequency hearing impairment and vestibular areflexia. Fluctuation of 
vestibulocochlear function was documented and mentioned by the patient. 
Conclusions: our patient proved to suffer from an autosomal dominant vestibulocochlear 
disorder caused by a COCH gene mutation. The remarkable medical history has some 
features in common with Meniere's disease, however, there are also different clinical and 
neurophysiological features. In the family phenotypic variability is present. 
Θ5 
2.2 
Introduction 
Several years ago Verhagen et al.12 described a family with autosomal dominant progressive 
vestibulocochlear dysfunction resulting in sensorineural hearing impairment and vestibular 
areflexia. The patients reported vague dizziness, blurred vision, dysequilibrium in the dark, 
and progressive hearing impairment. Symptoms seemed to start at about 40 years.12 In 
1991, Khetarpal et al.3 described two families with progressive autosomal dominant hearing 
impairment and vestibular symptoms. Linkage analysis in one of these kindreds showed 
cosegregation of the disease with a 9-cM interval on chromosome 14q12-13, which locus 
was designated DFNA9.4 
We were able to follow up an initially asymptomatic member of our family in whom a 
P51S mutation of the COCHgene within the DFNA locus was recently detected (Figure 1).5 
Methods 
Saccades, smooth pursuit, and horizontal optokinetic nystagmus responses were elicited and 
analyzed as reported previously.16 For velocity-step tests (performed with 
electronystagmography in complete darkness, with eyes open, by suddenly stopping from 
constant rotation at 907s velocity), a rotatory chair (Toennies GmbH, Freiburg im Breisgau, 
Germany) was used. The nystagmus response was analysed with a computer method.7 The 
cervico-ocular reflex was elicited in the dark by applying sinusoidal stimulation to the body 
with the head fixed.8 Bithermal (30°C and 440C) caloric stimulation was applied to both ears.9 
Pure-tone audiograms (air and bone conduction levels) were obtained in a sound-treated 
room according to common clinical standards and International Organization of 
Standardization norms. We used linear regression analysis of longitudinal threshold-on-age 
data to analyze progression in hearing impairment. Progression was considered significant if 
the slope - designated as annual threshold deterioration and expressed in decibels per year -
was significantly greater than zero. We tested whether Y intercepts (extrapolated threshold at 
age zero) differed significantly from zero. Onset age (X at Y=0) was calculated for the lines 
with a negative Y-mtercept. Regression lines were pooled where possible, following F tests 
between the separate slopes and intercepts (Prism program, PC version 2.0, GraphPad, San 
Diego, CA). 
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Figure 1. Core part of the pedigree1 and confirmation of the P51S mutation in the three siblings by 
restriction digestion. Crosses indicate examined; arrow, present patient. Polymerase chain reaction 
(PCR) was performed as described previously, and the 295-base pair (bp) PCR product was digested 
with the restriction enzyme Dde I.5 In healthy control subjects, the 295-bp PCR product is cut into two 
fragments of 247 and 48 bp, respectively (lane 5). In heterozygous patients carrying the P51S 
mutation (lane 6), two additional bands of 143 and 104 bp are visible on agarose gel electrophosesis, 
as the P51S mutation creates an extra Ode I site. The restriction assay proves that the three patients 
from the family described herein are carriers of the P51S mutation (lanes 2-4). Lane 1 represents 100-
bp ladder; lane 7, undigested PCR product; lane 8, blank. 
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Table. Velocity-step tests. 
reference range 
Nystagmus to the right 
1983 
1985 
1986 
1992 
1998a 
1998b 
Nystagmus to the left 
1983 
1985 
1986 
1992 
1998a 
1998b 
Initial 
Velocity, 7s 
30-65 
40 
30 
45 
20 
33 
absent 
45 
30 
50 
18 
15 
absent 
response 
response 
Time 
Constant, s 
11-26 
26 
32 
34 
38 
12 
26 
24 
22 
53 
16 
Total Amplitude, 
degrees 
465-1135 
1040 
960 
1530 
760 
404 
1170 
720 
1100 
954 
229 
Report of a case 
At the first examination, in 1983, a 35-year-old man (Figure 1, case IV-11 on pedigree)1 had 
no complaints. His audiogram and the results of oculomotor and vestibular function tests 
were normal. Follow-up two and three years later disclosed a vestibulo-ocular reflex with a 
long time constant, but the patient had no complaints (Table). Six years later, he had 
developed instability, especially in the dark. On a few occasions he had vertigo, sometimes 
with nausea, lasting for several days and he noticed head-movement-dependent oscillopsia. 
He also reported slowly progressive hearing impairment in the right ear. The vestibulo-ocular 
reflex showed a long time constant and a low gain (Table). Audiograms only showed minor 
high-frequency sensorineural hearing impairment: about 10-40 dB hearing loss at 1-8 kHz. 
In 1995, we saw the patient again because of benign paroxysmal positional vertigo 
during positioning on the left side, which was confirmed by a positive Dix-Hallpike test. He 
also noticed episodic vertigo, not related to positioning, that lasted for several weeks. Initially, 
nausea and vomiting were present. During these episodes, he did not experience more 
pronounced hearing impairment or tinnitus. 
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Early m 1998, at the age of 50 years, the patient had another episode of vertigo, 
nausea and vomiting, combined with head movement-dependent oscillopsia In the 
meantime, hearing impairment symptoms had become more prominent, affecting the left ear 
as well as the right At that time, he also mentioned having had tinnitus on both sides for 
about a year Vestibular testing showed hyporeflexia with unilateral caloric weakness of the 
left labyrinth (slow phase velocity at culmination of caloric nystagmus response of 15°/s to 
30°C and 5c/s to 440C), combined with a hyperactive response to hot-water caloric testing 
(71 "/s versus cold-water response 107s) of the right ear A few months later, he had a similar 
episode Two months later, our tests disclosed vestibular areflexia and increased 
sensorineural hearing impairment about 10 to 60 dB hearing impairment downslopmg from 1 
to 8 kHz bilaterally The patient had a well-developed cervico-ocular reflex (COR) and 
optokinetic nystagmus response level (gain near unity at 207s and 407s stimulation), 
optokinetic after-nystagmus (OKAN) could not be elicited Six months later, he stated that his 
complaints had not changed, but he had had no more episodes of vertigo or nausea 
Clear threshold fluctuation only at 4 kHz was seen in the left ear, between the ages of 
35 and 38 years Longitudinal analysis disclosed significant progression at 0 5, 4 and 8 kHz, 
significant (negative) Y-mtercepts were detected at 4 and 8 kHz The pooled regression lines 
for 0 5 to 2 kHz and 4 to 8 kHz showed a common onset at age 28 years, and annual 
treshold increases were 0 9 dB/year and 2 3 dB/year, respectively (Figure 2) 
Comment 
Our patient showed progressive sensorineural hearing impairment with at least one instance 
of (partial) threshold fluctuation Vestibular function showed some fluctuation between the 
ages of 35 and 38 years, but without complaints Vestibular function gradually deteriorated at 
a more advanced age and was completely lost in the 50th year of life Vestibular symptoms 
clearly developed from the age of 38 years onward and consisted of episodic and 
paroxysmal vertigo, followed by instability, especially in the dark, combined with head 
movement-dependent oscillopsia We were able to confirm by longitudinal observation that 
the progressive vestibulocochlear dysfunction, with predominantly high-frequency hearing 
impaiment and, finally, vestibular areflexia, in the other affected members of the patient's 
family developed from about 40 years of age 
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Figure 2 Binaural mean pure-tone threshold (decibel hearing level dB HL) plotted against age The 
thin lines are the corresponding regression lines for the separate frequencies The bold lines represent 
pooled regression for the right and left ear at 0 5 to 2 kHz (dashed line) and 4 to 8 kHz (dotted line) 
respectively 
Clearly enhanced cervico-ocular reflex and optokinetic nystagmus, as well as absent 
optokinetic after nystagmus at the time of vestibular areflexia, were in line with earlier 
observations The cervico-ocular reflex and optokinetic nystagmus are compensatory for the 
vestibulo-ocular reflex loss θ , 0 
A similar progressive hearing impairment was described by Khetarpal et a l 3 in three 
cases from two kindreds, the first kindred showed an onset in the early part of the third 
decade, while the other kindred showed an onset at about 40 years Only in one case (case 
IV-3, kindred 2)3 was vestibular function tested, showing a vestibular function loss at about 
50 years of age 
The disorder of this family was genetically linked to a locus on chromosome 14q12-
13, designated DFNA94 In the family described by Manohs et al," as well as one of the two 
kindreds described by Khetarpal et al ,3 Robertson and colleagues11 described missense 
mutations in the human COCH gene In a large Dutch family with DFNA9, a new P51S 
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mutation in the COCH gene was found The onset of hearing impairment ranged from 36 to 
62 years of age, starting at the high frequencies Several cases showed vestibular 
areflexia 12 In a large Belgian family with the same mutation, hearing impairment and 
vestibular symptoms started between 20 and 56 years of age The same mutation in the 
COCH gene was found in the present case as well as cases IV-9 and IV-10 (see Figure 1 
and the pedigree1)5 
The cause of the dysfunction is still unclear Khetarpal et a l 3 discovered an 
acidophyllic mucopolysaccharide-contaming substance, especially m cochleas, maculas and 
cnstae of patients with DFNA9, as well as severe degeneration of vestibular and cochlear 
sensory axons and dendrites These areas correspond with areas in the chicken inner ear 
that show high levels of COCH expression 11 It was suggested that the mucopolysaccharide 
deposit could cause strangulation of nerve endings.3 
Such strangulation might result in aberrant stimulation, ephaptic transmission, or 
triggering of primary vestibular afferent nerve fibers, giving rise to release from inhibition at 
the beginning of the disease, followed by vestibular hyporeflexia developing into complete 
areflexia due to nerve fiber degeneration It also seems possible that an initial release from 
inhibition is caused by predominant involvement of efferent vestibular nerve endings, which 
is later followed by deafferentation when the afferent nerve endings are involved The 
peculiar caloric response findings were similar to those previously reported as being 
associated with Meniere's disease These signs can be interpreted as being caused by 
release from contralateral inhibition 13 In one other family linked to DFNA9, fluctuating 
hearing impairment has been documented 5 In the same family, some patients reported 
periodic vertigo, sometimes with nausea Our family showed phenotypic variability also The 
father, grandfather, and oldest brother of the patient described herein (II-7, 111-16 and IV-9, 
see Figure 1 and the pedigree1) had no fluctuations or Ménière-like symptoms, but his sister 
(IV-10) mentioned unilateral tinnitus and an episode of vertigo2 The cause of the phenotypic 
variability and the gene product are unknown It may well be that some patients who are 
suspected to suffer from Meniere disease in fact have DFNA9, a possibility that may now be 
assessed by screening for COCH mutations5 
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Cochleovestibular impairment 
Abstract 
Cochleovestibular impairment was evaluated, in relation to age, in a longitudinal follow-up 
study on a Dutch family with a DFNA9 trait caused by a P51S mutation in the COCH gene on 
chromosome 14q12-13. 14 cases were genotyped. The onset age of progressive impairment 
reported by the mutation carriers was between age 35 and 45 years. Pure-tone thresholds 
deteriorated by about 2-7 dB/year (mean 3.8 dB/year) in a variable, often asymmetrical, 
fashion. One mutation carrier developed recurrent episodes of vertigo accompanied by 
nausea and vomiting, resembling Meniere's disease. Two others developed special 
susceptibility for motion sickness and appeared to have a hyperactive vestibulo-ocular reflex. 
More advanced stages of vestibular impairment, that is vestibular hyporeflexia and complete 
vestibular areflexia, were eventually found in a number of cases. DFNA9/COC/-/ should be 
considered as a possible cause in patients developing combined progressive cochlear and 
vestibular impairment, or suspected hereditary Ménière-like disease, from around middle 
age. 
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Introduction 
Among the autosomal dominant non-syndromal types of hearing impairment (that is with prefix 
"DFNA"1), DFNA9 has several unique features. It is the only DFNA type of hearing impairment 
with concomitant vestibular impairment.23 Its typical histopathological features have been 
established in temporal bone studies4 5 long before it was found to be linked to the DFNA9 
locus on chromosome 14q12-13M and the responsible COCHgene was identified.7'" Similar 
to other DFNA types (for example, DFNAG1), some of the clinical reports on the phenotypic 
features of DFNA9/COCH12'17 antedated the linkage reports. The former reports included one 
report on the family underlying the present report,13 which is caused by a P51S mutation in the 
COCH gene.7 Most of the Dutch and Flemish families harbouring this mutation7811"13151β 
probably have a common founder, except for the present one.11 
This report describes clinical follow-up features in carriers and non-carriers of this 
mutation in this family. Together with other long-term follow-up studies,1419 it helps to further 
outline the natural history of this trait. 
0 0 
0 0 0 0 
113 114 III 5 116 
0 0 0 0 0 0 0 0 0 0 0 0 
1111 1112 1113 1114 1115 1116 1117 III θ 1119 III 10 M i l l III 12 
X X X X X X X 
• · D Ο • O O D B 
IV 3 IV 4 IV 5 IV 6 IV 7 IVB IV 9 IV 10 IV 11 
Χ χ χ χ χ χ 
D · · Ο · D D O 
VI V2 V3 V4 V5 V6 V7 VB 
Figure 1. Pedigree of the family. Square, man; circle, woman. Slashed symbol, deceased person. 
Filled symbol, affected; open symbol, not affected. A cross above the symbol indicates that mutation 
analysis of the COCH gene (DFNA9) has been performed; it was positive for the P51S mutation in all 
cases with a filled symbol and negative in all cases with an open symbol (Table 1). 
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Patients and methods 
This study included 20 family members. They all had audiometry and vestibular 
examinations. In 14 of them COCH gene mutation analysis was performed (Figure 1 and 
Table 1). 
Saccades, smooth pursuit and horizontal optokinetic nystagmus responses were 
elicited and analysed as reported previously.1320 For velocity-step tests (performed with 
electronystagmography in complete darkness, with eyes open, by suddenly stopping from 
constant rotation at 907s velocity), a rotatory chair (Toennies GmbH, Freiburg im Breisgau, 
Germany) was used. The nystagmus response was analysed with a computer method.21 The 
cervico-ocular reflex was elicited in the dark by applying sinusoidal stimulation to the body 
with the head fixed.22 Bithermal (30 and 44 "C) caloric stimulation was applied to both ears.23 
Pure-tone audiograms (air and bone conduction levels) were obtained in a sound-
treated room following common clinical standards. Linear regression analysis (Prism 
programme, PC version 3.02, GraphPad, San Diego, USA) of longitudinal individual 
threshold-on-age data was applied to analyse progression in hearing impairment. Slope was 
called annual threshold deterioration (ATD) and expressed in dB/year. Individual regression 
lines were compared between the different frequencies for each ear, separately, using the 
Prism programme's analysis of covariance (ANCOVA) option. Individual slopes (ATDs) were 
pooled per ear for most, or all, frequencies if that was allowed for (ANCOVA, Ρ > 0.05). 
Slope evaluation was confined to the apparently (most) progressive phase observed during 
follow up. It was not attempted to evaluate onset age from the available individual 
longitudinal threshold data, because pre-symptomatic data were lacking in the apparently 
affected cases recognized in the previously performed part of the study, whereas 
progression was insufficiently covered in the mutation carriers that had been measured 
already while still being pre-symptomatic. 
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Results 
The outcome of history-taking, vestibular function tests and mutation analysis is 
presented in Table 1. 
The audiograms showed generally a fairly flat pure-tone threshold in the first four or 
five decades and a down-sloping threshold from the fifth or sixth decade onwards (Figure 2). 
Case IV-1, who showed a large tympanic drum perforation in the left ear, had experienced 
otorrhoea for decades and was found to have a large air-bone gap in that ear (Figure 2). 
Table 1. Age, mutation and cochleovestibular function data. 
Case 
III-1 
III-7 
III-9 
111-11 
IV-1 
IV-2 
IV-3 
IV-4 
IV-5 
IV-6 
IV-7 
IV-8 
IV-11 
V-1 
V-2 
V-3 
V-5 
V-6 
V-7 
V-8 
Agea 
(year) 
65 
6Θ 
67 
64 
56 
66 
57 
51 
49 
46 
53 
47 
37 
44 
47 
44 
37 
28 
25 
23 
COCH 
mutation 
na 
na 
na 
na 
na 
+ 
+ 
+ 
-
+ 
-
+ 
-
+ 
+ 
+ 
-
na 
Hearing 
impairment11 
+ 
+ 
+ 
+ from 30 
+ from 40 
+ from 40 
+ 
-39,+ 45 10 51 
+ noise dips 
-
+ tinnitus 34-37 
-
+ 
- 31 lo 38, + 44 
+ 37 
-
-
-
Vestibular 
funclion" 
A 
A 
A 
vertigo' from 35, 
Ν 37, Β 39, A 52 
A 56 
problems from 40, A 53 
A from 44 
η 39 to 45, Β 51 
U 37 to 49 
Β 34 to 46 
η 
mss, Η 37 
η 
A 47 
η 31, Η 38, η 44 
mss, Η 24 to 37 
η 15 to 28 
η 
η 
a
 at the last examination, , with corresponding age (years); z, Ménière-like symptoms, A, areflexia, B, bilateral 
calonc weakness, H, hyperactive vestibulo-ocular reflex, mss, motion sickness susceptibility, n, normal, U, 
unilateral caloric weakness, +, present, -, absent; na, nol applicable 
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Figure 2. Audiograms (air conduction threshold, dB HL) for the right (R) and left (L) ear. Note that the 
cases are ordered (from left to right, top to bottom) by age at the last visit. In case IV-t the dashed line 
indicates the bone conduction threshold. 
Follow-up analysis in the four cases with suitable serial audiograms (Figure 3) revealed 
interesting phenotypic differences between the patients relating to signs and symptoms, as 
well as to age-related progression. Some mutation carriers showed hearing impairment 
symptoms by the end of the fourth decade. The reported onset of hearing problems in most 
cases was between 34 and 45 years of age (Table 1). COCH mutation carrier IV-3 mainly 
showed high-frequency (> 4 kHz) hearing impairment at age 44, but from the age of 50 
onwards he developed increasing impairment in the lower frequency range. At age 57, he 
had bilaterally down-sloping thresholds at 80 dB or worse (Figures 2 and 3). Hearing 
impairment was variable and often asymmetrical in progression with advancing age (Figures 
2 and 3 and Table 2). 
The annual treshold deterioration (ATD), which could be pooled for most or all 
frequencies, varied between about 2 and 7 dB/year (mean close to 4 dB/year; Table 2). A 
value of about 2 dB/year pertained to either beginning progression (Figure 3 and Table 2; 
case IV-4 R) or progression averaged over a fairly wide age interval encompassing progres­
sion (Figure 3 and Table 2; case IV-2, R and L). The highest ATD values (about 5-7 dB/year; 
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Table 2) related to either the initial phase of high progression (Figure 3 and Table 2; case III-
11, R > L) or a fairly prolonged phase of high progression (Figure 3 and Table 2; case IV-3, 
R). It can be noted that gross threshold fluctuations around the regression line were present 
apparently in some cases (Figure 3; case IV-2, 4 kHz, R and L; case IV-3, 4-Θ kHz, R). 
Several patients (111-11, IV-1, IV-3) already had vestibular complaints (dizziness, 
vertigo, head movement-dependent oscillopsia, instability in the dark) by the end of the fourth 
or the beginning of the fifth decade (Table 1). Case 111-11 had Ménière-like signs and 
symptoms (episodic vertigo accompanied by nausea and vomiting) starting at the age of 35 
and recurring up to age 49,7 which were lacking in others. This was also the youngest patient 
(age 39) with confirmed severe bilateral vestibular impairment. The youngest age recorded 
for complete vestibular areflexia was 44 years (case IV-3). 
All patients examined had normal ocular motor tests. All patients suffering from 
complete vestibular areflexia that were tested (cases IV-1, IV-2, IV-3, V-2) had well-
developed optokinetic and cervico-ocular responses. 
Agoty) 
Figure 3. Serial audiograms (threshold on age, per frequency) in four mutation carriers. Connection 
lines dotted. Continuous lines correspond to slope (ATD) presented in Table 2, in some cases 
pertaining to a limited age range (see text for details). 
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Table 2 
Case 
III 11 
IV.2 
IV 3 
IV 4 
Follow-up analysis in four évaluable mutation carriers 
Overall mean 
Age 
(year) 
37-45a 
43-64 
44-57 
45-52c 
η 
3 
5 
7 
2 
Freq range 
(kHz) 
0 5-Θ 
0 5-Θ 
0 25-8b 
0 25-8 
ATD (dB/year) 
R ear 
7 0 
2 1 
4 7 
1 9 
3 8 (Ft, L) 
L ear 
4 8 
2 5 
3 1 
4 0 
Individual annual threshold deterioration (ATD) values were derived lor each ear (R, right, L, left) from (n) 
longitudinal monaural threshold data (shown in Figure 3), within the age and frequency ranges indicated The 
overall (that is across-subjects, binaural) mean ATD value calculated from these separate values is included 
a
, limited range because of apparent nonlmeanty (see Figure 3), b, R ear, L ear 0 25-4 kHz, c, limited range 
because of apparent onset age (see Figure 3) 
Remarkably, mutation carrier V-3 still had fully normal vestibular function at age 44 
(note that she had shown hyperreactivity at age 38, Table 1), whereas hearing was clearly 
impaired by that age with pure-tone thresholds beyond the 95'h percentile of presbyacusis at 
0.25-2 kHz and 8 kHz (Figure 2). 
Two other mutation carriers without apparent hearing impairment (IV-11 and V-5) had 
recently had symptoms of motion sickness susceptibility when both examined at age 37-38. 
Vestibular examination disclosed vestibular hyperactivity in both of them. Case V-5 already 
had a vestibular examination 13 years previously, with a finding of much milder, vestibular 
hyperreactivity. Audiograms disclosed pathological threshold elevation at 8 kHz in one or two 
ears in both cases. 
Cases IV-5 and IV-6 (in Verhagen et al.,13 case 4 and 5) were found to have some 
type of vestibular impairment, at their first examination at ages 34 and 37 years respectively. 
Case IV-5 had had heavy noise exposure and showed dips of about 30 and 55 dB at 4 kHz. 
Case IV-6 had fully normal hearing. Repeated vestibular and auditory testing did not disclose 
any substantial change in findings over a period of more than ten years. Mutation analysis 
demonstrated that they do not have the COCH mutation (Table 1). 
In contrast, their sister, IV-4, did not show any hearing impairment (Figure 2) or 
vestibular impairment at her first examination at the age of 39, but later developed 
cochleovestibular impairment (Tables 1 and 2). At the age of 45, she had high-frequency (12-
14 kHz) hearing impairment but still normal vestibular function.13 At age 51, she had 
developed substantial hearing impairment at all frequencies binaurally, except for 1-2 kHz in 
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the right ear and 1 kHz in the left ear (Figure 2), as well as bilateral labyrinthine weakness; 
she was found to carry the COCH mutation. 
Vascular disorders, such as hypertension, heart infarction and stroke were found in 
many members of this family (III-1, III-7-9,111-11, IV-1-3, IV-7, V-2).13 
Discussion 
Four different COCH mutations have been described up to now.7810 Three of the four 
mutations have been identified in three different American families.10 Several of the Dutch 
and Flemish families are likely to have a common founder, however, except for the present 
family." Based on mutation analysis, we were able to describe the natural history of the 
DFNA9/COCH trait in this family. Two cases suspected initially to be affected did not develop 
any substantial progression of cochleovestibular dysfunction and it turned out that they did 
not have a COCH mutation. 
Considerable inter-subject and inter-aural variability in the development of hearing 
impairment was found in the present study. Although pathological threshold elevation was 
first found at the high frequencies, progression, as derived from individual threshold-on-age 
data, did not differ significantly between the frequencies and varied between 2 and 7 dB/year 
(mean 3.8 dB/year, Table 2). Remarkable threshold fluctuations were observed in some 
cases. 
Manolis et al.6 reported onset of hearing impairment at about 16 to 28 years of age in 
an American DFNA9 family with a different COCH mutation. Hearing impairment progressed 
by about 3 dB/year. Khetarpal et al.4 reported an onset age of about 20 years in one family 
and about 40 years in another. 
Progressive vestibular impairment is a prominent feature of DFNA9, however, with 
remarkable inter-subject variability in signs and symptoms. An American patient had 
"bilateral hypoactive to inactive labyrinths" at ages 49 years and 55 years.4 Similar to the 
present report (Table 1), Bom et al. found vestibular areflexia in all cases over 60 years of 
age; their youngest patient with areflexia was 47 years old. Their youngest patient with 
remarkable vestibular impairment was 40 years of age,18 similar to the present family (39 
years). Ménière-like presenting symptoms have been described before in other DFNA9 
patients.719 In the present family, only one case had Ménière-like symptoms, whereas in 
other families with the same mutation, over a quarter of the cases had such symptoms.7 
Motion sickness susceptibility was an intriguing symptom in two of the present patients, 
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which appeared to be associated with hyperreactivity of the vestibulo-ocular reflex. The 
cause of this feature is unknown in these cases, but as a matter of fact in DFNA9/COC/-/ it 
may precede later findings of vestibular hyporeflexia or areflexia.19 
Compensation for the vestibulo-ocular deficit, as found in our patients, is partially 
possible, that is only in the low-frequency range, by enhancement of optokinetic and cervico-
ocular reflexes, which favour gaze stabilisation in conditions relating to visually-guided eye 
movements and head movement relative to the trunk, respectively.2224 The optokinetic reflex, 
but not the cervico-ocular reflex, can be effective - with the limitation indicated above - during 
en bloc (that is head fixed on trunk) rotation of the labyrinthine-defective subject in a visual 
environment. The frequency content of active head movements, however, often is too high to 
really benefit from such an enhanced cervico-ocular reflex. Therefore, most labyrinthine-
defective subjects report that they can read signs and texts best when standing still. 
The pathophysiological mechanism underlying DFNA9/COC/-/ is still obscure, 
although Khetarpal et al.45 found abnormal glycosaminoglycan-like depositions in the inner 
ear of DFNA9 patients, at sites homologous to those at which cochlin is expressed in the 
chicken's inner ear,10 associated with dendritic degeneration of inner-ear sensory nerve 
fibres.451617 Similar findings have been described by Merchant et al.25 Electron microscopy 
revealed that the spiral ligament was enriched with a highly branched non-banded 
microfibrillar substance with glycosammoglycan granules and absence of the normal 67-nm-
thick straight periodically banded bundles of type II collagen.26 The parts of cochlin, that is 
the protein expressed by the COCH gene, affected by mutations in DFNA9/COCH patients, 
correspond to previously observed structural elements. For example, the P51S mutation 
affects a highly conserved proline residue, adjacent to a conserved beta strand, of the so-
called LCCL module of cochlin. The various COCH gene mutations seem to cause misfolding 
of the LCCL module and this, in turn, may lead to deposition of the misfolded proteins.27 A 
role in endolymph (ion) homeostasis has also been suggested.7 
Similar to the present family (see Verhagen et al.),13 a high prevalence of vascular 
disorders (heart infarction, hypertension and stroke) was also found in the family described 
with the same COCH mutation by Bom et al. (15 out of 20 individuals).18 A gene related to 
vascular disorders may be located in the vicinity of the COCH gene. However, as yet, no trait 
loci underlying hypertensive cardiovascular disease have been found on human 
chromosome 14q12-13.28 It is also possible that the cardiovascular signs and symptoms, in 
one way or another, are the result of the COCH mutation. Cochlin contains two regions 
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homologous with the von Willebrand type A domains,9 the latter of which are relevant to 
haemostasis27 This might represent a possible link to the increased prevalence of heart and 
brain infarctions found in several DFNA9 families,1318 and could be a topic of future research 
In summary, DFNA9/COC/-/ should be considered as a possible cause in patients 
with combined progressive cochlear and vestibular failure, or patients suspected to have 
hereditary Ménière-like disease DFNA9/COC/-/ is the probable cause if progressive 
vestibular impairment goes with non-syndromal, progressive autosomal dominant hearing 
impairment Further studies on the intriguing functions of the COCH gene, and its protein 
product cochlm, which is extensively expressed within the inner ear,29 are needed 
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Abstract 
Hearing threshold was analyzed cross-sectionally for each frequency in relation to age in 88 
members of a large Dutch family with cochleovestibular impairment caused by a P51S 
mutation in the COCH gene within the DFNA9 locus (chromosome 14q12-13). The 
participants in this study were 34 mutation carriers and 54 non-carriers (control group). A 
sigmoidal dose-response curve with a variable slope was used to fit the carriers' threshold-
on-age data. Progression started at about 40 years of age and only lasted for some 20-25 
years; the associated average progression was 2.9 dB/year for all frequencies. However, 
some hearing impairment was already present before, predominantly at the high frequencies. 
The mean thresholds in the young carriers (aged < 33 years) were significantly higher (by 4-
13 dB) than those in age-matched young non-carriers at 2-8 kHz. Presumably, mutation 
carriers have a congenital offset threshold (10-29 dB) at these frequencies. 
m 
24 
Introduction 
Progressive cochleovestibular impairment, DFNA9, is one of the few types of nonsyndromic 
autosomal dominant hearing impairment (prefix "DFNA", numbered in chronological order of 
discovery) that occurs in more than one family.1 For DFNA9, a locus on chromosome 14q12-
13,2 three distinct mutations have been found within the COCH gene in three American 
families.3 In the Netherlands and Belgium one other COCH mutation (that is P51S) has been 
identified in at least 15 separate families. Haplotype analysis provided evidence for the 
existence of a common founder for most of these families in this part of Europe." A fifth 
mutation was identified recently in an Australian family.5 
All the reported DFNA9/COCH families manifested progressive cochleovestibular 
disease, starting from an age of about 40 years onwards,615 except for one American family 
and the Australian family that showed an onset age of about 20 years.51113 Sensorineural 
hearing impairment progressed by about 3 dB/year for the first four mutations,111314 leaving 
only residual hearing by the sixth or seventh decade of life (the fifth decade for the latter 
American family; perhaps this also applies to the Australian family). Vestibular impairment 
progressed to vestibular areflexia (not formally tested or convincingly documented in the 
American and Australian families) before the seventh decade in most cases.14 In the initial 
stage of the disease, some patients showed Ménière-like symptoms.1016 
The present paper describes an extensive cross-sectional analysis of hearing 
threshold-on-age data in a large Dutch family harboring the P51S mutation in the COCH 
gene (DFNA9).17 Up to now, progression has been only retrospectively assessed from 
individual longitudinal threshold-on-age data in obviously affected cases.610,1417 Inclusion of 
data obtained from young mutation carriers could be useful to pinpoint the onset of 
progression in hearing impairment and detect any early, presymptomatic features, if present. 
The possibility of extensive genotyping provided the opportunity to collect such data for the 
present study in a systematic way, including young, still asymptomatic mutation carriers and 
compare these to similar data obtained from a large group of relatives not carrying the 
mutation. 
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Figure 1 Pedigree Filled symbols (squares, men, circles, women) indicate mutation carriers (1-34, 
deceased subjects are not numbered), open symbols indicate non-carriers (marked 1'-54') 
Patients and methods 
This study included 88 members of a family that has been linked to DFNA9 recently, showing 
a P51S mutation in the COCHgene 17 Following mutation analysis, 34 of them appeared to 
be mutation carriers (Figure 1, Nos 1-34) The other 54 individuals were non-carriers (Figure 
1, Nos 1'-54'), who were used as a control group 
At least one reliable audiogram was obtained for the present cross-sectional analysis 
in this family - from both ears of each participant - in a sound-treated room, using 
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conventional clinical methods and ISO norms as outlined previously.14 In those cases where 
serial audiograms were available, the most recent audiogram exhibiting measurable 
thresholds was selected. Air conduction threshold - measured in dB hearing level (HL) in 
both ears - was included if values of at least five out of the six frequencies 0.25, 0.5, 1,2,4 
and 8 kHz were available. 
At each frequency, regression analysis (binaural mean air conduction threshold on 
age) was performed using a commercial program (Prism PC version 3.02, GraphPad, San 
Diego, CA). Progression (here called annual threshold deterioration, ATD, and expressed in 
dB/year) is equivalent to the (local) slope of the fitted regression line or curve. 
For the non-carrier group, a second-degree polynomial was fitted to the threshold-on-
age data. This type of equation was used because it is well known that normal threshold-on-
age data only pertaining to presbyacusis can be suitably fitted using a parabolic equation.16 
I 100-1 
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o 
(fi 
ω 
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at slope / 
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1/2 (Top-Bottom) 
Log (Age) 
Figure 2. Schematic plot of a sigmoidal dose-response curve with variable slope describing threshold 
as a function of age on a logarithmic scale. The thin dashed lines represent the Bottom and Top 
threshold levels. The age-related parameters (Χ,ο, Χ«, and Xgo) are indicated by the vertical dotted 
lines. 
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For the carrier group, a sigmoidei dose-response curve was fitted to the threshold-on-
age data (Figure 2) The fitting equation is V = Bottom + (Top - Bottom)/(1 + td'^so l09X>H) 
The variable Y represents the threshold (dB HL), and X is age (year) The parameters Top 
("saturation" threshold) and Bottom (offset threshold) are the plateau levels (dB HL) 
connected by the sigmoidal curve, covering the age interval that shows progressive 
impairment Half-saturation age (Χ5ο) is the age at which the threshold is halfway (at 50%) 
between Bottom (at 0%) and Top (at 100% saturation) The ages Χ,ο and Xgo are the ages 
corresponding to the points of the sigmoidal curve where the threshold attains 10% and 90% 
of the whole (0-100%) trajectory, respectively, Xr0 is defined as onset age The parameter Η 
(Hill slope, slope factor or Hill coefficient, see the Prism user's manual and Motulsky19) 
controls the slope of the sigmoidal curve between ages Χ,ο and Xgo (see equation for slope in 
Figure 2) Estimates of Χ,ο and X90, with standard errors and 95% confidence limits, were 
derived by including the equation logX^ = logXw + log9/H, or logXx = logXgo - log9/H, 
respectively, in the nonlinear fitting procedure 
To find a practical measure of progression on a linear age scale (ATD), a linear 
regression line was fitted to the threshold data for ages at between Xw and Xgo The slope of 
this line (regression coefficient) is equivalent to the ATD These ATDs were compared 
between the frequencies using the Prism program's analysis of covanance (ANCOVA) option 
and frequencies were pooled as much as was allowed for 
At ages well below the apparent onset age of progression, linear regression analysis 
was performed on the threshold-on-age data pertaining to each separate frequency This 
was done to confirm the absence of significant progression - that is regression coefficient not 
significantly different from zero - within this age range in both the group of carriers and the 
group of non-earners If progression was absent, the mean threshold at each frequency was 
compared between the young-age subgroups using Student's t test, if necessary including 
Welch's correction for unequal variances (detected with Bartlett's test) The level of 
significance used was Ρ = 0 05 
Results 
The pedigree is shown in Figure 1 Carrier No 12 (filled symbol) was excluded from the 
present analysis because of previous ear surgery Carrier No 18 was excluded because this 
person did not show hearing impairment at the age of 44 years and therefore might represent 
non-penetrance 
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Figure 3. Plots of binaural mean hearing threshold (air conduction, dB HL) versus age (linear scale; in 
years) for each frequency (out-of-scale measurements excluded). In the non-carriers, the threshold 
(crosshair symbol) is fitted with a parabolic curve (dashed). The carriers' threshold (circle) is fitted with 
a sigmoidal curve (bold). The straight line (dashed in bold) near the curve is included only to indicate 
that all slopes could be pooled with an ATD of 2.9 dB/year (see text). 
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Table. Non-linear regression analysis data (sigmoidei model) of threshold on age in the carriers. 
Parameter/ 
variable 
Frequency 0 25 0 5 1 2 4 8a θ" 
η 
Bottom 
Top 
Η 
Xw 
Xso 
X90 
ATD e 
SD,« 
32 
U.T±2BC 
7 3 0 ± 7 7 
9 7 ± 3 β 
40 6 (35-47)" 
50 8 (46-57) 
63 7 (49-Θ2) 
2.6 (0 5-4 7) 
9 8 
32 
9 . 1 ± 2 8 
72 5 ± 7 4 
9.9 ± 3 8 
40 7 (35-47) 
50.5 (46-56) 
63.1 (49-81) 
2 6 (-0 1-5 2) 
1 0 0 
32 
7 . 2 ± 3 2 
7 5 3 ± 8 4 
9 8 ± 3 9 
40 6 (35-47) 
50 5 (45-56) 
63.2 (49-82) 
2.2 (-1 5-5 9) 
11 2 
32 
8.8 ± 3 6 
83.3 ± 9 9 
8 7 ± 3 4 
38 9 (33-46) 
50 0 (44-56) 
64 3 (48-86) 
1 5 (-2 3-5 4) 
1 1 8 
32 
13.1 ± 3 5 
9 5 9 ± 3 7 
9 8 ± 2 3 
32 8 (29-37) 
41 1 (39-43) 
51.5 (45-58) 
3.1 (2 2-3 9) 
1 0 2 
31 
27.4 ±4.1 
1 0 0 . 7 ± 4 5 
1 0 4 ± 3 2 
33.2 (29-38) 
40 9 (38-14) 
50 6 (43-59) 
3.3 (2 0-4 6) 
12 1 
32 
26.2 ± 4 6 
1 1 2 3 ± 6 3 
7 7 ± 2 3 
32 1 (27-38) 
42.8 (39-17) 
57.0(46-71) 
ne 
1 2 3 
a
, excluding out-of-scale measurements,b, including out-of-scale measurements as 130 dB HL,c, ± 1 SE (standard 
error),d, 95% confidence interval,e, linear scale, *, bold = significant difference from zero; ne, not evaluated. 
Descriptions: Bottom = offset threshold, in dB HL; Top = saturation threshold, in dB HL, Η = hillslope, Xw = age at 
10% saturation, in year, X5o= age at 50% saturation, in year; Xgo^ age at 90% saturation, in year, ATD = annual 
threshold deterioration; SD,es = residual standard deviation 
The non-carriers (open symbols) Nos. 1', 2', 16', 17', 22' and 23' were excluded from the 
analysis because their audiograms disclosed high-frequency impairment. In most of these 
cases heavy noise exposure was documented. 
Threshold-against-age plots for the separate frequencies are shown in Figure 3. The 
dashed curve shows the second-degree polynomial fitted to the non-carriers' data (crosshair 
symbols). For the carrier group (circles), the fitted sigmoidal regression curve (bold; see 
Methods) is shown. The dashed straight line (bold) is only included for age between Xw and 
Xgo to indicate the ATD (slope; pooled for all frequencies). The fitted parameter values are 
included in the Table. It is clear from Figure 3 that there is mixed scattering of data points 
pertaining to the two groups at younger age, whereas there is a gradually increasing 
separation between the respective data points, at all frequencies, from about 40 years 
onwards. 
In the carrier group, the plateau level characteristics of the sigmoidal curve (bold) are 
clearly seen at age below onset age (Bottom) and at an advanced age (Top). The former 
was especially seen at the lower frequencies, the latter at the highest frequencies. It should 
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be noted that the Bottom level differed significantly from zero at all frequencies (Table). It is 
remarkable that - between these plateau levels - clear, significant progression (Table) was 
limited to an age interval of only 20-25 years. 
Testing between frequencies in the mutation carriers disclosed some differences in 
the fitted parameter values (Table). The Bottom level at 8 kHz was significantly higher than at 
0.25-4 kHz. The Top level at 4-8 kHz was significantly higher than at 0.25-2 kHz. Onset age 
(XJO) at 4-8 kHz was significantly lower than at 0.25-1 kHz, while half-saturation age (X50) at 
4-8 kHz was significantly lower than at 0.25-2 kHz. However, there was no significant 
difference in Xgo between the frequencies. The Hill slope (H) was not significantly different 
between the frequencies. The mean slope on a linear age scale, that is the ATD at X,o < age 
< Xgo, did not differ significantly between the frequencies; the pooled ATD was 2.9 dB/year. 
Exclusion of out-of-scale measurements at 8 kHz may have biased the threshold data 
and thus influenced the fitted parameter values. It appeared that by including an arbitrary 
threshold value of 130 dB HL for those measurements, only minor changes were caused in 
8 0 -
100-
120 Λ 
-o- Carriers 
-D- Non-carriers 
.25 .5 1 
-1 Γ" 
4 8 kHz 
Frequency 
Figure 4. Mean thresholds in audiogram format at age < 33 years in the carriers and non-carriers. Bars 
indicate 1 standard deviation. All thresholds differed (Student's t test) significantly from zero. 
Threshold differences between the groups were not significant (ns) at 0.25-1 kHz and significant (S) at 
2-Θ kHz. 
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the values of the parameters Xw, X50 and Χχ (Table). 
In the absence of significant progression at age < 33 years, that is well below onset 
age (see Table), the mean thresholds of the carriers and non-carriers could be used for 
further evaluation. At all frequencies the mean thresholds differed significantly from zero 
(Student's t distribution), which emphasizes the presence of substantial offset levels, even in 
the non-carrier group. A significant difference in mean threshold between the groups was 
found at 2-Θ kHz (Figure 4). In the carrier group, the thresholds at 2, 4 and 8 kHz were about 
10, 15 and 29 dB, respectively, that is about 4, 8 and 13 dB higher than the corresponding 
thresholds in the non-carrier group. It is of note that the latter showed fairly high threshold 
levels of about 5-15 dB HL. 
"Age-related typical audiograms", audiogram-like plots showing age related threshold 
changes, were derived from the fitted sigmoidal curves in Figure 3 and are shown in Figure 5 
for fixed ages. The apparent residual hearing for the lower frequencies at an advanced age is 
compatible with the notable high-frequency predominance in impairment, with significant 
offset levels. 
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Figure 5. "Age-related typical audiograms" in the mutation carriers (without presbyacusis correction) 
with air conduction thresholds at fixed ages (Italics). The dashed line at age 45 years marks the 
steepest downsloping configuration, at the frequencies 2-4 kHz. 
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Discussion 
In a large Dutch DFNA9/COCH family the presence or absence of the P51S mutation was 
assessed in most individuals that were thought to be affected or known to be at risk. The 
inclusion of a number of young mutation carriers, as well as non-earners of any age, enabled 
the present data analysis. The results of this analysis (see Figure 3 and Table) supported the 
existence of a substantial, stable offset level (Bottom) at the initial stage of the disease - that 
is congenitally or at a young age - especially at the high frequencies. They corroborated the 
occurrence of only residual hearing (Top) as a probable end-stage condition. Progression 
from subnormal hearing levels (Bottom) to profound hearing impairment (Top) appeared to 
be confined to an intermediate stage covering 20-25 years around middle age. This 
progression is likely to have started at an age of about 40 years, as shown below, and 
exhibited the same average degree (ATD 2.9 dB/year) at all frequencies. 
The question can be raised as to whether the apparent difference in onset age 
between the high and the low frequencies might have been caused by presbyacusis. To 
evaluate this, the threshold was "corrected" by subtracting the median (50,h percentile, P50) 
presbyacusis threshold value - specified by the ISO 7029 norm18 according to each person's 
age and sex - and the analyses were repeated (results not tabulated). Such a correction 
resulted in an increase in onset age of about 4 years at 4-8 kHz. Combining this shift with the 
original means and 95% confidence limits for Xw at these frequencies (Table), presumable 
corrected confidence limits could be derived (data not shown). The latter did not show 
convincing separation anymore between the high frequencies (4-8 kHz) and the others. 
Therefore, onset age was assumed to be the same for all frequencies. The best possible 
estimate for this onset age, that is with minimal influence of presbyacusis, would seem to be 
the mean value at 0.25-2 kHz, that is about 40 years (Table). 
Below age 33 years, significant progression in hearing impairment was lacking in both 
carriers and non-carriers. The mean threshold level for this age range (Bottom) was higher in 
the carrier group at all frequencies, significantly differing from the non-carriers at 2-8 kHz. 
Thus, high-frequency impairment in the carriers might be the first indication that a given 
young person at risk harbors the COCH mutation. A reliable distinction from non-carriers, 
however, is not possible (see Figure 3), implying the need for performing mutation analysis. It 
is remarkable that also the non-carrier group manifested substantially elevated thresholds at 
these frequencies (Figure 4). We have no explanation for the latter finding. 
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The results of the present cross-sectional analysis of heanng threshold in relation to 
age (Table) were fairly similar to those of the previously reported longitudinal analysis of 
several clearly affected family members u That report assumed the existence of an offset 
level at 4-8 kHz of about 50 dB at age 35 years The present findings confirmed the 
existence of such an offset at the high frequencies, now also including 2 kHz, however, at 
lower levels (Figures 3 and 4) The previous report suggested that progression was lower at 
4-8 kHz than at the lower frequencies, but the present approach did not produce any 
significant difference in slope (ATD) between the frequencies 
We wondered what might explain the, on the one hand, relatively late onset of 
progression and, on the other hand, apparently congenital presence of hearing impairment at 
the high frequencies in DFNA9/COCH Destruction of auditory and vestibular nerve endings, 
peripheral axonal degeneration, loss of dendrites and hair cells might all be secondary to 
"strangulation" Such an effect has been suggested to be caused by the histopathologically-
assessed, unique glycosammoglycan-like depositions, or disrupted fibnllogenesis within the 
labyrinth311132021 It seems likely that destruction increases with increasing age, thus 
explaining progression A threshold mechanism pertaining to a minimum degree of 
destruction causing tangible progression might account for the late onset 
Alternatively, the late-onset, progressive type of sensorineural hearing impairment 
typical of DFNA9/COCH may be explained by haploinsufficiency (a lack of normal gene 
product, cochlm in this case, due to inheritance of the normal gene from only one parent) 
This would then be combined with special vulnerability, or "dose dependency", of hearing at 
the high frequencies Hearing ability at those frequencies would already suffer from a low 
dose of normal cochlm from early life onwards Hearing impairment would increase and 
extend to the lower frequencies when the dose of normal cochlm declined with increasing 
age 
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Speech recognition in progressive sensorineural hearing impairment 
Abstract 
Objective: to analyze the relationship between pure-tone hearing threshold and speech 
recognition performance in DFNA2/KCNQ4 and DFNA9/COCH, two types of high-frequency 
nonsyndromic hearing impairment. 
Design: case series with cross-sectional analysis of phoneme recognition scores related to 
age and hearing level. 
Setting: university hospital. 
Patients: 45 members of four separate families, all carrying one of three different mutations 
in the KCNQ4 gene at the DFNA2 locus (1p34); 42 members of seven separate families, all 
carrying the same P51S mutation in the COCHgene at the DFNA9 locus (14q12-13). 
Results: the deterioration of speech recognition dropped to a 90% score at a higher level of 
hearing impairment (pure-tone-average at 1, 2 and 4 kHz) in DFNA2 patients (65 dB) than in 
DFNA9 patients (46 dB). 
Conclusion: at similar levels of hearing impairment, DFNA2//CC/VQ4-affected patients 
showed better speech recognition performance than DFNA9/COCH-affected patients. 
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Introduction 
Autosomal dominant nonsyndromic types of hereditary sensorineural hearing impairment can 
be identified by genetic linkage and mutation analysis The corresponding chromosomal loci 
are genetically designated DFNA, followed by a number in order of discovery (DFN = 
deafness, A = autosomal dominant inheritance)1 One locus may harbor one or more 
disease-causing genes The discovery of such genes and their function may enhance our 
understanding of the pathophysiology of the inner ear Concurrently, clinical studies are 
necessary to relate the latter to the resulting phenotype 
Clinical studies on DFNA2/KC/V04-affected families and DFNA9/COC/+affected 
families have demonstrated fairly similar high-frequency sensorineural hearing impairment 
and progression2 , 6 In addition to sensorineural hearing impairment, DFNA9-affected 
patients also develop vestibular failure6 1 6 The DFNA9-affected families studied in the 
Netherlands and Flanders all have the same mutation in the COCH gene, corresponding to a 
P51S substitution in the expressed protein, cochlm , 2 1 7 1 8 The function of cochlm is still 
unknown In the four Dutch DFNA2-affected families, three different mutations (W276S, 
G321S, L274W) of the KCNQ4 gene were found 1 9 2 0 KCNQ4 encodes a potassium (K+) 
channel that is predominantly expressed in the basolateral membrane of cochlear hair 
cells2 1 2 2 
The present study focuses on the relationship between speech recognition 
performance on the one hand and age and pure-tone hearing threshold on the other hand in 
two different types of nonsyndromic, autosomal dominant, sensorineural hearing impairment 
The two, DFNA2JKCNQ4 and DFNA9/COCH, are both characterized by progressive, 
predominantly high-frequency hearing impairment 
Patients and methods 
This study compared speech recognition data between DFNA2//CC/V04-affected patients and 
DFNA9/COCH-affected patients Speech recognition data for patients with DFNA2 were 
obtained from 45 carriers of a mutation in the KCNQ4 gene There were 30 patients from two 
families with a W276S mutation (G V C , unpublished data, 2000),2519 ten patients with a 
G321S mutation,319 and five patients with a L274W mutation 4 2 0 Speech recognition data for 
patients with DFNA9 were obtained from 42 carriers of the P51S mutation in the COCH 
gene, from six Dutch families6 1 1 1 7and one Flemish family 1 3 1 β 
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Audiometry was performed according to common clinical standards For speech 
recognition, standard monosyllabic Dutch word lists were presented at either ear2 3 
Performance-intensity curves relating to the phoneme recognition score were analyzed for 
the right ear only The last-visit speech reception threshold (SRT, in decibels sound pressure 
level [dB SPL] for 50% phoneme score) and the maximum phoneme recognition score 
(percentage correct), at which the pure-tone-threshold at 1, 2 and 4 kHz could be measured, 
were used 
Plots of SRT versus pure-tone-average at 1, 2 and 4kHz (PTA124 kHZ) were used 
with linear regression analysis to check for the reliability of the phoneme recognition scores 
The Chauvenet criterion24 and the residual standard deviation (SD) were used to identify and 
exclude outlying values 
Because a comparison of speech recognition scores between the patient groups may 
be complicated by underlying differences in sensorineural hearing threshold, the thresholds 
at each frequency for "modal-age" patients between the groups were compared, using the 
Student t test These patients were selected from each group by requiring their age to be 
within the limits of the percentiles Ρ37 5 and P62 5 of the corresponding age distribution 
Nonlinear regression analysis of the maximum phoneme recognition score on 
log(age) and on logiPTAi 2 4 KHZ) was performed using the Prism PC version 3 02 program 
(GraphPad, San Diego, CA) Cross-sectional and individual longitudinal performance-age 
(percentage recognition versus age) and performance-impairment plots (percentage 
recognition versus PTA124kHz) were fitted with a sigmoidal dose-response function with a 
variable slope Y = 100% / (1 + io"09*,*, l°9X>'H"15lope l o g 9 ) , where Y is phoneme score, X is 
either age or PTA, 2 4 KHZ, X90 is the value of X where Y = 90%, and HillSlope is the slope 
factor on a log scale of X The fitted values of X90 and HillSlope were used to test between 
curves relating to the patient groups, using the Student f test (with the Welch correction if the 
Bartlett test detected unequal variances) 
To simplify the results and allow for additional testing, "local average" slope (that is on 
a linear scale) for X> X90 was obtained by using a linear regression line as an approximation 
of the corresponding part of the fitted sigmoidal curve Slope was the deterioration rate in the 
performance-age plot, whereas it was the deterioration gradient in the performance-
impairment plot X90 was the onset age for the performance-age plot and onset level for the 
performance-impairment plot Regression lines were compared between the groups using 
analysis of covanance (ANCOVA) to find out whether slopes and intercepts were significantly 
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different Again, the Chauvenet criterion24 was used in combination with the residual SD to 
detect outlying values 
Individual longitudinal data were available in 18 DFNAii/KC/N/CM-affected and 23 
DFNA9/COCH-affected patients Analyses constituted plotting of serial phoneme recognition 
scores against age and PTA, 2 4 kHz, and comparing these to the curves fitted to the 
corresponding cross-sectional data A 5% lower normal limit established at the Nijmegen 
Otorhmolaryngology department (P L M H , unpublished data, 2000) was used to see 
whether there were scores that raised suspicion of retrocochlear dysfunction 
The phenotype of the DFNA2/KC/\/04-affected patients may be influenced by the 
nature of the mutation that is present in the family In addition, even for patients carrying the 
same mutation, differences in other genes (genetic background) may also influence the 
phenotype It was, therefore, checked whether there were significant differences in score 
behavior between either the different DFNA2/K,CA/04-affected families or the different 
DFNA9/COCH-affected families 
Results 
In each group, the SRT showed an excellent correlation with the corresponding PTA, 2 4 kHz 
(n = 33-44 after exclusion of three outlying values, r = 0 8-0 9, residual SD = 9-13 dB) This 
corresponds fairly well with the residual SD found by Bosman and Smoorenburg23 Mean 
pure-tone thresholds for a representative, "modal-age" selection from each group, that is, 
cases with P37 5< age < P625 (percentiles in the frequency distribution of age), generally did 
not differ significantly at any frequency 
The Figure shows cross-sectional performance versus age plots (A and B) and 
combined performance-impairment plots (Figure C) Onset age was 34 years in 
DFNAa/KC/VCM-affected patients and 43 years in DFNA9/COCH-affected patients The local 
average deterioration rate in DFNA2-affected patients was 0 3% per year, while in DFNA9-
affected patients, it was 1 8% per year (Figure A and B) There was no significant difference 
in HillSlope between the plotted curves in Figure C However, the local average deterioration 
gradients were significantly different (0 5% per decibel versus 1 2% per decibel) The latter 
finding is related to the significant difference in onset level that can be detected (65 versus 
46 dB), as well as the observation that there is a clear separation between the data points 
(Figure C) In other words, at a given level of impairment, DFNA2//<'C/N/04-affected patients 
showed higher scores than DFNA9/COC/-/-affected patients 
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Figure Speech recognition score against age (A, DFNA2-affected patients, B, DFNA9-affected 
patients) and pure-tone average (PTA) at 1, 2 and 4 kHz expressed in decibels hearing level (dB HL, 
C, DFNA2 versus DFNA9) in DFNA2/K'C/V04-affected patients (circles) and DFNA9/COCH-affected 
patients (triangles) Small symbols indicate outlying values 
Individual longitudinal analyses produced fairly similar results to the cross-sectional 
analysis (data not shown) Four of the DFNA9/COCH patients had scores below the normal 
limit which would have been suggestive of retrocochlear dysfunction Some of these scores 
renormahzed during follow-up None of the DFNA^KC/VCW-affected patients had any scores 
suggestive of retrocochlear dysfunction No significant differences in score behavior between 
either the different DFNA2/KC/V04-affected families or the different DFNA9/COCH-affected 
families were found (data not shown) 
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Discussion 
The marked difference in speech recognition performance as related to sensorineural 
hearing level between DFNA2/KC/\/04 and DFNA9/COCH, both characterized by 
predominantly high-frequency sensorineural hearing impairment, is an appealing finding in 
this study Better recognition scores in the DFNA2-affected patients are remarkable, 
especially in light of recent findings that the mouse homologue of KCNQ4 is abundantly 
expressed in the central auditory pathways25 KCNQ4 is thought to play a role in the K+ 
recycling pathway of the inner ear2126 Three of the four studied families with 
DFNA^KCA/CM-affected patients had different mutations, but fairly similar speech 
recognition The L274W and W276S mutations produce changes in the pore region of the 
expressed K+ channel protein, whereas the G321S mutation exerts an effect just outside the 
pore region, however, apparently to a similar phenotypic effect20 
On the other hand, the DFNA9/COCH-affected patients had poorer speech 
recognition scores compared with age and sensorineural hearing level (Figure C) The 
American DFNA9-affected patients - with a V66G mutation within the COCH gene2728 -
however, showed an even greater drop in recognition scores "' The latter had earlier onset 
(at age 20 years) and anacusis at around age 45 years Combined speech performance-
impairment plots of the recognition scores (not shown) are suggestive of poorer scores in the 
American V66G earners However, our longitudinal analyses also disclosed the existence of 
temporarily poor scores in some of our DFNA9/COCH-affected patients Such poor scores 
may have been related to Ménière-like paroxysms 1112 
Histopathologic findings reported for one American COCH/V66G-mutation carrier 
comprised general destruction of the cochlear and vestibular sensory elements, including 
hair cells and dendrites (cochlea, crista and macula), as well as accumulation of an acellular 
substance (glycosammoglycan) throughout the labyrinth 15 These findings were similar to 
those reported previously in DFNA9/COC/+affected patients1629 In chicken, COCH 
expression was found in fairly similar places where the deposits were found in human 
patients2e It has been postulated that "strangulation" of cochlear and vestibular nerve 
endings occurs 151629 Alternatively, the possibility was suggested that normal fibnllogenesis 
is disrupted by an excess in microfibrillar substance, which results in degradation of 
collagens and extracellular matrix components 15 It is also possible that cochlm - which is 
expressed in the stroma underlying the sensory structures of the inner ear28 - has a role in ion 
homeostasis, for example, recycling of K+ ions from the hair cells to the endolymph 12 
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In the present study, DFNA^/CCWQ-i-affected patients seemed to have better speech 
recognition scores than DFNA9/COCH-affected patients (Figure C), the difference could not 
be explained by underlying differences in pure-tone thresholds Cochlear KCNQ4 expression 
was initially thought to be confined to the outer hair cells 21 However, recent findings in the rat 
have shown that it is also expressed in inner hair cells and the spiral ganglion 22 The 
strongest KCNQ4 expression - that is, in normally hearing animals - was found in inner hair 
cells in the lower cochlear turns and in outer hair cells in the upper turns Thus 
DFNA2/KC/\/04-related high-frequency sensorineural hearing impairment, which is 
associated with primary dysfunction of the lower cochlear turns, might be attributed to a lack 
of expression of K* channels, especially in inner hair cells Relative sparing of function of 
outer hair cells in the lower turns, thus preserving their function as "cochlear preamplifier" in 
fine tuning mechanisms,30 might account for the better speech recognition in 
DFNA2//CC/V04-affected patients On the other hand, the poor recognition scores in 
DFNA9/COCH patients might be explained by the generalized, histopathologic, 
vestibulocochlear changes,15162829 already mentioned earlier, and, in part, by its Memeriform 
features1112 
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Abstract 
Objective: to delineate the phenotype and genotype of an autosomal dominant low-frequency 
sensorineural nonsyndromic hearing impairment trait in relation to similar traits. 
Study design: family study, including retrospective case reviews. 
Setting: tertiary referral center. 
Patients: hearing impairment was documented in 11 family members in five generations, 
eight of whom were alive and participated in this study. 
Intervention: diagnostic. 
Main outcome measures: (clinical study) medical and otologic history and examination, 
retrieval of previous audiograms, pure-tone audiometry and statistical analysis of audiometrie 
data; (genetic study) linkage analysis of blood samples in 18 clinically affected and non-
affected family members. 
Results: hearing impairment was present since early childhood, mainly affecting the low 
frequencies (mean threshold 45 dB HL at 0.25-1 kHz); speech recognition was hardly 
affected during the first three decades of life. Higher frequencies became involved with 
increasing age, thus causing a flat-type audiogram at middle age and downslopmg 
audiograms after age 60 years. Progression was mild but significant at all frequencies (0.5 
dB/year at 0.25 kHz to 1.3 dB/year at 8 kHz) and persisted after applying "correction" for 
normal presbyacusis. The trait was linked to chromosome 4p16.3, in a region comprising 
both the previously located, closely adjacent DFNA6 and DFNA14 loci for low-frequency 
hearing impairment. 
Conclusion: a new family (designated "Dutch II") was identified with a low-frequency hearing 
impairment trait showing linkage to chromosome 4p16.3 (DFNA6/14). The occurrence of 
progression of hearing impairment beyond presbyacusis in the present study is 
unprecedented for DFNA6/14 traits. 
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Introduction 
Hearing impairment is the most common form of sensory dysfunction, with nearly one in two 
persons developing an auditory deficit, that is threshold > 25 dB hearing level (HL), by age 
80 1 Its cause is multifactorial, including environmental and genetic factors Sensorineural 
nonsyndromic hearing impairment (SNHI) accounts for about 70% of all hereditary auditory 
deficits reported1 It is categorized by mode of inheritance (DFNA, dominant, DFNB, 
recessive, DFN, X-lmked) The loci within each subcategory are numbered in chronological 
order of identification To date 40 DFNA types have been found,2 illustrating the enormous 
heterogeneity of nonsyndromic hearing impairment3 More detailed reports of phenotype 
based on underlying genotype are needed to facilitate clinical diagnosis of hereditary hearing 
impairment4 
Phenotypically, SNHI can be roughly subdivided into predominantly high-, mid-, or 
low-frequency types To date three families with low-frequency hearing impairment have 
been linked to three different chromosomal loci DFNA1, DFNA6 and DFNA14567 The latter 
two, with closely adjacent but non-overlapping loci, have fairly similar phenotypese910 
DFNA1, however, is highly progressive and leads to profound deafness by the third decade 
in most of the affected family members 1112 
This is a report on a clinical and genetic study of a Dutch family with low-frequency 
SNHI 
Patients and methods 
A Dutch family (35 individuals, designated "Dutch II") manifesting low-frequency 
sensorineural nonsyndromic hearing impairment (SNHI) was examined, including the 
spouses (cases IV-7, IV-10 and IV-12, Figure 1) of the affected individuals in generation IV 
Medical history was taken and otorhmolaryngological examination, including otoscopy, was 
performed History taking focused on possible causes of acquired hearing impairment 
Furthermore, attention was paid to vestibular impairment symptoms and the exclusion of 
syndromic features 
Audiometrie analysis 
Pure-tone audiograms (in dB HL) were obtained from all participants with a DSA 84 portable 
audiometer (Madsen, Taastrup, Denmark) 
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Figure 1 Pedigree of the family with autosomal dominant, low-frequency hearing impairment. The 
haplotype for the chromosome four genetic markers is indicated below the subject symbols. Black bars 
represent the haplotype linked to the hearing impairment trait. 
Previous audiograms were retrieved, including audiograms of one deceased individual (case 
UM) and speech recognition data for most cases. ISO 7029 norms13 were applied to 
establish 95'h percentile (P95) threshold values for presbyacusis at each frequency in relation 
to the patient's age and sex. Individuals with thresholds in the better ear worse than the P95 
value were considered affected in absence of other causes. 
The definition of the audiometrie configuration (right ears only) was based on linear 
regression analysis of threshold on log(frequency). A slope significantly different from zero 
was taken to substantiate the corresponding audiometrie configuration, provided that it was 
found more often among the audiograms tested than could be expected according to 
binomial distribution statistics (tail probability Ρ < 0.05). 
All speech audiograms included the maximum phoneme recognition score in a 
performance-intensity plot using standard Dutch CVC word lists (consonant-vocal-consonant 
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syllables) For each ear, the maximum recognition score was plotted against the average 
pure-tone threshold at 0 5, 1 and 2 kHz (PTAos 12 KHZ) Individual data points in this plot were 
compared with scatter plots for normative data (authors' unpublished data) and related to the 
regression line fitted to those normative data plots 
Cross-sectional analysis 
Cross-sectional analysis of threshold-on-age data was performed for each frequency in all 
affected individuals (last audiogram, binaural mean) At 0 25, 0 5, 1, 2, 4 and θ kHz, 
progression was measured by the difference in mean threshold between a cluster of younger 
patients (from generations IV and V) and a cluster of older patients (from generations III and 
IV) Subsequently, it was tested (Student's t test) whether this difference was significant If 
this was the case, the testing procedure was repeated, after "correction" of the threshold 
data for presbyacusis Correction consisted of subtracting the appropriate median (50,h 
percentile, P50) threshold, specified by the ISO 7029 norm13 in relation to the patient's age 
and sex, from the original individual threshold As ISO 7029 is not defined for age > 70 years, 
the forelast measurement in case 111-1 (obtained at age 70 years) was selected for the 
analyses 
Predicted audiograms for this trait ("age-related typical audiograms", ART A) were 
derived from age-related mean thresholds and the derived annual progression (in dB HL, not 
corrected for presbyacusis), using linear interpolation and extrapolation 
Longitudinal analyses 
Linear regression analysis (threshold on age) was performed using longitudinal hearing-
threshold data for each separate frequency The level of significance used was Ρ = 0 05 
Regression analysis and statistical testing were performed using a commercial program 
(Prism, version 3 02, GraphPad, San Diego, CA) Regression lines were compared using the 
program's analysis of covanance (ANCOVA) option Slopes were pooled if that was allowed 
for (P > 0 05) In this case, the program tested between intercepts to conclude whether or not 
the regression lines were likely to be parallel (equal slopes, different intercepts) or identical 
(equal slopes and intercepts) 
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Genetic linkage analysis 
Blood samples from family members were collected after informed consent, and DNA was 
extracted by standard techniques Short tandem repeat genetic markers were analyzed by 
polymerase chain reaction in the presence of a radioactively (32P) labeled primer Alleles 
were separated by high resolution Polyacrylamide gel electrophoresis and visualized by 
autoradiography Chromosome 4 was first considered for linkage because of the trait's 
apparent similarity to the DFNA6/14 phenotype 
LOD scores were calculated with the Linkage software package14 using the following 
parameters autosomal dominant inheritance, penetrance 100%, gene frequency 1/1000, 
phenocopies 0%, allele frequencies 1/N with Ν being the observed number of alleles in the 
pedigree 
Results 
18 individuals were examined The pedigree (Figure 1) comprised 11 affected family 
members, eight of whom were still alive An autosomal dominant pattern of inheritance was 
recognized Affected individuals stated that hearing impairment was present since early 
childhood, predominantly affecting the low frequencies, but without the specific need for 
hearing aids at younger age No pronounced delay in speech and language development 
had been noticed There were no reports of tangible progression in hearing impairment 
during the first three decades of life No other causes of sensorineural hearing impairment 
were found None of the affected individuals reported vestibular symptoms 
Audiometrie analysis 
Figure 2 shows the audiograms of affected individuals The age at measurement ranged 
from five to 79 years The general audiometrie configuration was low-frequency SNHI 
Linear regression analysis of last-visit audiograms (data not shown) produced a 
significantly positive audiogram slope (dB/octave) in four out of the six younger cases (V-13, 
V-12, IV-9 and V-10) At middle age (51-56 years, cases IV-8 and IV-11), audiogram shapes 
flattened, without significant threshold slopes, except for the right ear in case IV-11, with 
mainly negative slopes Because of this atypical behavior case IV-11 has been excluded 
from the cross-sectional analysis below The threshold of the oldest affected person (MM) 
showed no significant "across-frequency" slope at age 70, and a significantly downslopmg 
audiogram at age 79 years 
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Figure 2. Individual (serial) audiograms for right, R, and left, L, ears (threshold in dB HL) In eight 
genotyped persons and one deceased subject (111-1). Cases are ordered by the age at which the most 
recent audiogram was obtained (see the key to each panel). Dashed lines Indicate bone conduction 
thresholds in those cases where considerable air-bone gaps were present (case V-13 had grommets 
In the left ear; unknown cause In case IV-11). 
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Figure 3 Cross-sectional analysis (see Methods) The binaural mean air-conduction threshold (Table 
1, dB HL, circles and continuous line) and the corresponding threshold values resulting from 
presbyacusis correction ("-P50", asterisks and dashed line) are plotted against the patient's age (year) 
The slope of these lines was used as a measure of progression (Tables 1 and 2) S, significant, ns, 
not significant) 
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Table 1 Cross-sectional statistics (significant values in bold, other studies in Italics) 
Frequency (kHz) 0 25 0 5 1 
Cluster of younger patients (age 13-32 years, average 23 years) 
Mean (dB HL) 
SD (dB HL) 
Vanderbilf (age 6-36 years, average 19 years) 
Mean (dB HL) 
6 
45 
9 
6 
48 
7 
6 
41 
14 
6 
27 
20 
6 
14 
10 
6 
13 
θ 
42 45 39 18 14 
Kunst et al (age 11-45 years, average 29 years) 
Mean (dB HL) 45 49 49 32 17 11 
Cluster of older patients (age 56 and 70 years, average 64 years, case IV-11 excluded) 
η 2 2 2 2 2 2 
Mean (dB HL) 66 69 71 74 64 68 
SD (dB HL) 2 2 9 5 19 11 
Progression and Ρ value for Student's f test (based on young versus old) 
Progression (dB/year) 0 5 0 5 0 7 1 1 12 1 3 
Rvalue 0.025 0.006 0.036 0.002 0.002 0.0003 
Previous speech recognition scores could be evaluated in six cases (data not shown) 
Case V-13 had normal scores of 95-100% relative to the threshold level at age 6-11 years 
(two measurements) At age 12-13 years the scores were above average (2 measurements) 
Cases V-8, V-10 and V-12 all had one speech recognition score recorded at age 17-
22 years The scores were still within the 90-100% range and about average as compared to 
normative data in relation to threshold 
Cases IV-8 and 111-1 each had two speech recognition scores recorded at ages 46 
and 56, and 71 and 79 years, respectively Given the threshold level, the scores were above 
average for the right ear and about or below average for the left ear in both cases 
Cross-sectional analysis 
Figure 3 shows the cross-sectional analysis of threshold-on-age data, plotted separately for 
each frequency Since the wide age gap between the cluster of younger patients and that of 
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older patients precluded regression analysis, Student's t test was applied to evaluate 
progression in hearing impairment. Progression was significant at all frequencies (Table 1 
and Figure 3). Average progression varied from 0.5 dB/year at 0.25-0.5 kHz to 1.3 dB/year at 
θ kHz. After applying correction for presbyacusis, binomial distribution statistics 
demonstrated that two out of six frequencies maintained significant progression at the Ρ = 
0.05 level (0.5 and 4 kHz; or all six at the Ρ = 0.125 level, varying from 0.3 to 0.8 dB/year; 
Table 2). This "genuine" (that is resistant to correction for presbyacusis) progression was 
only mild: it would amount to an average of about 20 dB in 45 years time. 
From the threshold data (Table 1), predicted audiograms (ARTA) were derived for 
age 0-70 years (Figure 4), depicting the general course of hearing impairment throughout 
life. 
Longitudinal analyses 
Longitudinal regression analyses of hearing impairment in relation to age (data not shown) in 
two cases (V-13 and IV-11, eight and five longitudinal observations, respectively) in only one 
ear, did not show significant progression. In one case (V-12, five measurements), 
progression (about 2 dB/year) was significant in both ears at 1 -2 kHz between age 7 and 20 
years. Evaluation of four other cases (V-11, V-10, V-8 and IV-8, three measurements in all 
cases) did not reveal any obvious progression. 
Table 2. Cross-sectional statistics, corrected for presbyacusis (significant values in bold). 
Frequency (kHz) 0 25 0 5 1 2 4 θ 
Cluster of younger patients (age 13-32 years, average 23 years) 
η 6 6 6 6 6 6 
Mean (dB HL) 45 48 41 27 14 12 
SD (dB HL) 9 7 15 21 10 θ 
Cluster of older patients (age 56 and 70 years, average 64 years, case IV-11 excluded) 
η 2 2 2 2 2 2 
Mean (dB HL) 60 61 63 60 35 26 
SD (dB HL) 5 2 5 2 2 16 
Progression and Ρ value for Student's f test (young versus old; Pso-corrected data) 
Progression (dB/year) 0 3 0.3 0 5 0.Θ 0.5 0 4 
Ρ value 0.095 0.036 0.067 0.076 0.025 0 125 
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Figure 4. Predicted audiograms for age 0-70 years (ARTA, see Methods). 
Given the scarcity of individual longitudinal data and the apparently low progression, 
pooling of regression lines was performed. ANCOVA (Methods) revealed that for the low 
frequencies (0.25-1 kHz) all lines could be pooled and were parallel at a slope of 0.5 dB/year. 
Similar results were obtained for all frequencies (0.25-8 kHz) taken together. 
Genetic linkage analysis 
Ten genetic markers in eight affected family members, three spouses, and six unaffected 
individuals were analyzed. These markers cover a region of approximately 22 cM on the 
short arm of chromosome 4, comprising both the DFNA6 and the DFNA14 region (Figure 5). 
All markers originate from a single genetic map.15 Two-point LOD scores were calculated for 
each marker, and highly significant LOD scores of 3.58 and 3.61 were obtained for marker 
D4S3023 and D4S431 respectively (Table 3), proving genetic linkage of the family to this 
chromosomal region. 
Subsequently, a haplotype of the region was constructed for each genetically 
analyzed family member. In none of the affected family members, a recombination had 
occurred in the haplotype linked to the hearing impairment trait (solid bar; Figure 1). 
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Figure 5. Genetic map of the chromosome four genetic markers used in this study. The localization of 
the critical regions for the previously published DFNA66 and DFNA147 loci, as well as for the present 
DFNA6/14 family, is indicated on the right of the genetic map. 
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Table 3. LOD scores for ten different markers (key values in bold). 
Markers Recombination fractions (Θ) 
D4S3034 
D4S412 
D4S2957 
D4S432 
D4S3023 
D4S431 
D4S2935 
D4S3007 
D4S394 
D4S3009 
0.00 
- oo 
- 0 06 
0 85 
2 41 
3.58 
1 Θ1 
3.61 
- oo 
- CO 
0 01 
1 56 
- 0 06 
0 83 
2 36 
3.52 
1.77 
3 55 
1.56 
1 56 
- 0 74 
0.05 
2 02 
- 0 06 
0 76 
2 19 
3.27 
1 61 
3.30 
2.02 
2.02 
0 47 
0 1 0 
2 02 
- 0 06 
0.67 
1 95 
2.94 
1 40 
2 97 
2 02 
2.02 
0 81 
0.20 
1.66 
- 0.05 
0.48 
1.44 
2 22 
0.95 
2 26 
1 66 
1.66 
0.87 
0 30 
109 
- 0 02 
0 28 
0 86 
1 42 
0 49 
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109 
0 64 
0 40 
0 42 
- 0 01 
0 08 
0 27 
0 53 
0.12 
0 55 
0.42 
0.42 
0 27 
In unaffected individuals IV-1, IV-3 and IV-5, however, the linked haplotype was partly 
present. If complete penetrance of the hearing impairment trait is assumed, these results 
place the genetic defect in an interval flanked by markers D4S3034 and D4S3007. This 
region comprises both the previously located DFNA66 and DFNA14 region.7 
Discussion 
A new family ("Dutch II") is described with documented early-onset autosomal dominant low-
frequency hearing impairment in three generations. Hearing impairment was present since 
early childhood. Although the low-frequency deficit was about 45 dB HL at 0.25-1 kHz (Table 
1), speech recognition performance in the younger DFNA6/14 patients (age < 30 years) was 
still close to normal with scores ranging between 90 and 100%. Marked delay in speech and 
language development, or any subjective progression, was not noted over the first three 
decades of life. There was no specific need for hearing aids at younger age. This 
observation, and the relatively good speech recognition scores found during the first three 
decades of life, might be explained by the particular importance of hearing preservation in 
the higher frequencies to speech and language development in hearing impaired individuals; 
as appeared to be the case in this family. 
Interestingly, cross-sectional analysis revealed mild but significant progression at all 
frequencies (0.5-1.3 dB/year; Table 1), also after "correction" for normal presbyacusis (about 
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O 5 dB/year, Table 2) The largest progression was found at the high frequencies (Table 1, 
Figure 3) - causing flat-type audiograms at middle age, and downsloptng audiograms after 
age 60 years - illustrated by the predicted audiograms (ARTA) in Figure 4 
Longitudinal regression analyses in seven cases displayed systematic progression in 
only one family member Pooling of individual regression lines, however, revealed an 
average slope of about 0 5 dB/year for all frequencies 
The present mean threshold data were compared to those pertaining to clusters of 
the younger patients of the other two DFNA6/14 families reported previously The American 
DFNA6 family,8 the DFNA14 family (designated "Dutch I") described by Kunst et a l , 0 and the 
present DFNA6/14 family all showed fairly similar low-frequency thresholds (Table 1) Kunst 
et al10 expected a flat-type audiogram to occur in their family by age 55 years The 
Vanderbilt group8 found concomitant high-frequency impairment above age 50 years in their 
study of two, probably related, kindreds, suggesting flat-type audiograms to occur as well In 
a follow-up study on the same American family, Hall et a l 9 found low-frequency thresholds to 
exceed 50 dB with advancing age Contrary to the present DFNA6/14 family, however, the 
Dutch DFNA14 family manifested no progression beyond presbyacusis 10 The American 
DFNA6 family data8 were re-analyzed in a similar way and neither appeared to show any 
significant progression beyond presbyacusis (data not shown) 
This study adds a third family with low-frequency hearing impairment to the previous 
two families linked to chromosome 4p16 3 Genetically the previous families were linked to 
two non-overlapping, closely adjacent regions This suggests the possibility of two different 
nearby genes that - when mutated - lead to the same phenotype It is equally possible that 
there is only a single gene responsible for this phenotype In this case the two separate 
regions are an artifact caused by a phenocopy, a double recombination or a mutation in a 
genetic marker7 Since the new family has a critical region that covers those of both 
previously reported families, both the possibilities stipulated above remain equally realistic 
Identification of the gene(s) and disease causing mutation(s) involved might provide for a 
final outcome 
In conclusion - apart from the unprecedented but mild progression beyond 
presbyacusis found in the present study - DFNA6/14 forms a homogeneous DFNA subtype, 
showing linkage to the same chromosomal region where a single or possibly two related 
responsible genes must reside For familial low-frequency phenotypes first focusing the 
genetic analysis on chromosome 4p16 3 seems a rational approach that may reduce the 
amount of linkage elaborations 
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5.1 Summary and conclusions 

Summary and conclusions 
Summary 
Hearing impairment, the most common form of sensory dysfunction, has vast implications 
world-wide. It affects one in two persons by age 801 and in regard of an ever-growing life 
expectancy throughout most parts of the world, millions of people are implicated in this trait. 
Congenital hearing impairment can be caused by one single gene defect (Mendelian 
inheritance) or by environmental (e.g. intra-uterine) factors. Late-onset hearing impairment is 
supposed to be multifactorial: both genetic factors (e.g. susceptibility of genes) and 
environmental factors play their part in this complex entity. Of the latter, infectious factors 
become more properly controlled, but noise exposure seems to increase. 
In a majority of cases hereditary hearing impairment is of a non-syndromal, i.e. purely 
cochlear or cochleovestibular nature. Similarly to general age-related hearing impairment 
(presbyacusis), non-syndromal, autosomal dominantly inherited hearing impairment (prefix 
"DFNA") often starts postlmgually and typically affects a specific frequency range first, most 
often the high frequencies. As described in Chapter 1, originally, hereditary hearing 
impairment was classified on the basis of affected frequencies. The rapid development of 
genetic linkage analysis in this field gave rise to a new classification system (see Chapter 1). 
At the beginning of this study in 1998, only the loci DFNA1-13 were known. To date, 40 
DFNA loci have been described and many more are being expected to follow, illustrating the 
enormous heterogeneity of sensorineural non-syndromal hearing impairment (SNHI). 
In this study, as part of a long-term research project on the topic of hereditary hearing 
impairment at the Nijmegen Department of Otorhinolaryngology, 12 different families have 
been included. The phenotypes of these families have been described in relation to the 
genotypes found in the course of this study. The description of the genotype-phenotype 
correlation of several other large families that have been investigated during this study (not 
included in this thesis) still awaits conclusive results of ongoing genetic linkage studies. 
In Chapter 2 the clinical characteristics of three Dutch families carrying the P51S 
mutation within the COCH gene at the DFNA9 locus on chromosome 14q12-13 are 
described; one large family was analysed longitudinally and cross-sectionally, the other two 
only longitudinally. First, auditory and vestibular functions were tested extensively in 15 
mutation carriers of the large family, all showing marked clinical symptoms. Linear regression 
analysis of individual hearing threshold data on age was performed. Hearing impairment 
showed onset in the fourth to fifth decade of life, and progressed by 3 dB/year to profound 
hearing impairment. Vestibular impairment up to and including areflexia developed 
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concomitantly. In two exceptional cases annual threshold progression attained levels of up to 
24 dB. Interpolation and extrapolation of the trend shown by the high-frequency (4-8 kHz) 
data suggested hearing levels of about 50 dB already to be present by age 35 and to 
increase by nearly 2 dB/year to 120 dB HL at age 75. Considerable inter-subject and inter-
aural variability in onset age and progression were noted. Following onset, patients first 
tended to show severe bilateral vestibular hyporeflexia or unilateral caloric areflexia. Later on 
they were found to have completely lost all vestibulo-ocular responses and to have 
developed an enhanced cervico-ocular reflex. 
As compared to the first study, the results found in the other two families confirmed 
the general picture of predominantly high-frequency hearing impairment, progressing by 2-7 
dB/year after onset around age 40 and finally affecting all frequencies, combined with 
pronounced vestibular impairment. In addition, Ménière-like symptoms were reported in 
several cases that were followed for a period of up to 15 years. Apart from head movement-
dependent oscillopsia and instability in the dark, features typical of vestibular impairment, 
such as paroxysmal positional vertigo, episodes of vertigo with or without nausea and 
development of special susceptibility to motion sickness (cinesia) were noted. Tinnitus was 
reported in one case, associated with initially unilateral hearing impairment. 
Following the first three DFNA9 studies, the large cross-sectional study showed 
hearing impairment already to be present in the high frequencies prior to onset of 
progression. This study included as many young, as yet asymptomatic mutation carriers as 
possible. The mean thresholds at 2-8 kHz in young mutation carriers (< 33 years) were 
significantly higher than those in age-matched young non-carriers, suggesting the presence 
of a congenital offset threshold at these frequencies in DFNA9. Furthermore, it was 
demonstrated that progression (by nearly 3 dB/year) only lasted 20-25 years, following onset 
at about age 40 years, thus covering an age range between 40 and 65 years. 
Chapter 3 focuses on speech perception in hereditary hearing impairment. It 
describes the findings obtained in an analysis of the relationship between pure-tone hearing 
threshold and speech recognition performance. A comparison is made between four 
DFNA2//<C/\/04 and seven DFNA9/COCH families, the two most frequent (that is 
multifamilial) DFNA types. Both DFNA types share progression and predominance of high-
frequency hearing impairment, two features that are often found in autosomal dominant 
hearing impairment traits. In this study the deterioration of speech recognition was found to 
cause a drop to a 90% score at a higher level of hearing impairment ( P T A ^ K H Z ) in DFNA2 
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patients (65 dB) than in DFNA9 patients (46 dB) Some DFNA9 patients showed transient 
poor scores suggestive of possible retrocochlear dysfunction, none of the DFNA2 patients 
showed such features 
Finally, Chapter 4 comprises a clinical and genetic study of a Dutch family showing 
predominantly low-frequency hearing impairment A comparison was made with other 
families characterised by this relatively rare phenotype The study included data analysis of 
pure-tone audiometry in all patients and of retrospective speech recognition data in most of 
them Cross-sectional and longitudinal analyses of audiometrie data were performed 
Hearing impairment appeared to be present since early childhood, mainly affecting the low 
frequencies (0 25-1 kHz, mean threshold 45 dB) No pronounced delay in speech and 
language development had been noticed Speech recognition scores found during the first 
three decades of life were relatively good The higher frequencies became involved with 
increasing age, thus causing a flat-type audiogram at middle age and downslopmg 
audiograms after age 60 years There was mild but significant progression of hearing 
impairment at all frequencies, also after "correction" for presbyacusis Genetically, the trait 
was linked to chromosome 4p16 3, in a region comprising both the DFNA6 and DFNA14 loci 
for (stable) low-frequency hearing impairment 
Conclusions 
The general aim of this study was to contribute to our knowledge on genotype-phenotype 
correlations in autosomal dominant SNHI 
The first objective was to trace families with autosomal dominant hearing impairment 
Genetic analysis was successful in several, but not yet all, of the families studied, unlinked 
families are not included in this thesis One specific mutation, P51S, was newly identified in 
the COCHgene within the DFNA9 locus on chromosome 14q12-132 This mutation appeared 
to be present in all DFNA9 families in the Netherlands and Belgium that have been identified 
over the past 25 years, thus enabling further genetic study that provided strong evidence for 
the existence of a common founder with the mutation in this part of Europe Last year, also 
biochemical and immunological studies on COCH and its expressed protein cochlm have 
been published The P51S and most other mutations were shown to cause misfoldmg of the 
so-called LCCL module of cochlm, possibly leading to deposition of the misfolded proteins 
Alternatively, mutations might cause loss of the hypothesised host-defence function of 
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cochlin.34 An auto-immune cause of SNHI, as postulated for Meniere's disease,5 is 
supported by evidence for cochlin to be a target-antigen of anti-inner ear antibodies.6 
Another finding, described in this thesis, was the linkage of a third family to the 
DFNA6/14 locus for low-frequency hearing impairment, further stressing the importance of 
the 4p16.3 chromosomal locus for this phenotype. Only very recently - and thus beyond the 
scope of this thesis - hearing impairment in this DFNA6/14 family appeared to be associated 
with an A716T mutation in the WFS1 (Wolfram syndrome 1) gene.7 In addition, four other 
mutations related to the same autosomal dominant, low-frequency phenotype were found in 
this gene, which was already known to be associated with the autosomal recessive Wolfram 
syndrome, characterised in particular by juvenile-onset diabetes mellitus and optic atrophy.7 
The second objective was to outline the phenotype of the newly genotyped (that is 
DFNA9 and DFNA6/14) families, in relation to similar traits. For DFNA9 it can be concluded 
that the P51S mutation causes late-onset, progressive cochleovestibular impairment, 
resulting in profound deafness and vestibular areflexia within 25 years after onset. Given the 
similar onset age and rate of progression at all frequencies, the predominance of high-
frequency involvement in DFNA9/COCH must be due to the pre-existent impairment (that is 
present before onset of progression), as was found for the high frequencies in young 
mutation carriers. In general, this picture is paralleled by other studies on DFNA9/COCH, 
even where different mutations are involved. Predominantly high-frequency impairment in 
early childhood has been found also in DFNA2 traits (see Chapter 1-2). In the case of 
DFNA2/KCNQ4, however, progression was to occur already from early childhood onwards. It 
is remarkable that in DFNA9/COCHthe predominantly high-frequency impairment apparently 
is stationary from early-childhood onwards, until onset of progressive hearing impairment 
occurs at all frequencies from age 40 onwards (see Chapter2-4). 
For the DFNA6/14 family described in this thesis it can be concluded that - similar to 
the previously described DFNA6 and DFNA14 families - the 4p16.3 chromosomal locus is 
associated with congenital low-frequency hearing impairment, without a marked delay in 
speech and language development. The mild progression in hearing impairment beyond 
normal presbyacusis found in the present DFNA6/14 family is unprecedented for DFNA6/14 
traits. As the genotypic overlap found was yet suggestive of the existence of one responsible 
gene for hereditary low-frequency hearing impairment, the above described identification of 
mutations in the WFS1 gene does actually confirm this for all families that are presently 
known. 
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The third objective was to investigate aspects of speech perception in important types 
of autosomal dominant SNHI In a comparative study DFNA2/KCNQ4 patients showed 
notably better speech recognition performance than DFNA9/COCH patients As the 
difference could not be explained by differences in pure-tone threshold, underlying 
differences in pathophysiological mechanisms might account for it (see Chapter 3 1) Also 
described in this thesis was the preservation of speech perception in younger DFNA6/14 
patients This relatively good performance might follow from the particular importance of 
hearing preservation in the higher frequencies to speech and language development in 
hearing impaired individuals 
In addition, it can be noted that as well DFNA9 as DFNA6/14 represent clinically 
distinct entities within hereditary hearing impairment Taking also in account the possibility of 
mutation analysis, now feasible for both types, implementation of this knowledge in clinical 
practice is well-supported 
General discussion 
The increasing possibilities of establishing genotypes in hearing impairment, combined with a 
careful description of the phenotype, now facilitate the classification and clinical diagnosis of 
such disorders In some cases it is already feasible to base individual diagnosis on mutation 
analysis An appealing example is connexm 26, the gene causing the autosomal recessive 
type of hearing impairment DFNB1 ,e which accounts for up to 50% of hereditary prelmgual 
SNHI in some populations9 Molecular diagnostic analysis (including the whole connexm 26 
gene), with special attention to one very common mutation, 35delG, has already become 
clinical practice in genetic counselling, providing many parents of hearing impaired children 
with etiological answers Also DFNA9 mutation analysis, particularly in the Netherlands and 
Belgium, is now being used as a routine diagnostic tool, providing for genetic counselling in 
families with hereditary hearing impairment and, in addition, offering a differential diagnostic 
tool in Memere-like disease In the same region of Europe, KCNQ4 mutation analysis might 
have some merit, but is complicated by the occurrence of more than one mutation, its less 
distinctive phenotype and the lower prevalence WFS1 mutation analysis, as mentioned 
above according to low-frequency hearing impairment m DFNA6/14, is the latest addition to 
the molecular diagnostic options in non-syndromal hearing impairment 
Moreover, molecular diagnosis is now possible in case of syndromal hearing 
impairment where the disease gene has been identified, such as Alport syndrome, Pendred 
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syndrome and Waardenburg syndrome. In case of Usher syndromes, where several but not 
all genes have been identified, molecular diagnosis is more complicated. One mutation 
(2299delG, in the USH2A gene), associated with Usher syndrome type II, however, is very 
frequent in Europe.10 If feasible, mutation analysis could contribute to a diagnosis in an early 
stage of life, which is important for adequate treatment and individual counselling. The latter 
might be helpful to an appropriate choice of schools and profession. 
Furthermore, increasing knowledge of the genes involved has begun to provide 
insight into the molecular mechanisms underlying normal and abnormal hearing and balance. 
In the future this may pave the way for targeted treatment of hearing impaired individuals. In 
the last decade gene therapy as an important treatment device has been increasingly 
investigated. In gene therapy genetic material is transferred Into cells in order to compensate 
for the absence of a protein or to modify the function of a protein. For this, identification of 
appropriate genes and cell types is mandatory. Then, a transport vehicle ("vector") for these 
therapeutic genes into the target cells is needed to exhibit a desired effect. Starting in 1990, 
several clinical trials of gene therapy took place and currently over 200 trials including more 
than 2,000 patients are underway.11 A recent example of this is a phase-one trial in six 
patients with severe haemophilia A. In this trial, culture-grown autologous dermal fibroblasts, 
"transfected" with a plasmid (as a non-viral vector) containing sequences of the gene that 
encodes factor VIII, were injected into the omentum during laparoscopy. In four of the six 
patients, plasma levels of factor VIII rose, without serious adverse effects and lasting up to 
ten months.12 Cancer, infectious diseases (e.g. AIDS) and single gene defects are the major 
fields where gene therapy is currently investigated. 
However, recent setbacks in gene therapy have tempered the initial enthusiasm. The 
main obstacles have been the lack of sustained expression of the introduced genetic material 
(as above for factor VIII), the host's immune response to the foreign material and problems 
with vector systems.13 There are two gene delivery strategies in current use: viral (retro-, 
herpes-, adeno- or adeno-associated virus; and recently lenti- and vaccinia virus as vectors) 
and non-viral (direct microinjection into the scala tympani via the round window,14 soaked in 
gelfoam against the round window membrane,15 in conjunction with calcium phosphate or 
coupled to cationic lipids as liposomes16). 
Until now, most research focused on virus-based technology, exploiting the natural 
infectivity of viruses. Only recently, the potential of gene therapy in the treatment of hearing 
impairment started to be exploited. The relative isolation of the cochlea assists the progress 
of organ-targeted transfection to manipulate known defective genes, using the knowledge of 
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hereditary hearing impairment acquired during the last decade. However, not yet at the 
clinical stage, by now several vectors have been successfully transfected into the cochlea, 
potentially effecting gene transfer.17 A significant step forward was the germline gene transfer 
of the myelin basic protein gene in shiverer mice, having a single gene defect for this protein, 
restoring absent brainstem auditory evoked potentials.18 In the eye, another organ providing 
easy access for targeted gene transfection, function was restored very recently, in a canine 
model for autosomal recessive childhood blindness. Adeno-associated virus, carrying the 
wildtype RPE65 gene, was delivered intra-ocularly in order to correct dysfunction of the 
retinal pigment epithelium. This dysfunction was caused by a 4bp (base-pair) deletion, 
rendering the flPE65gene inactive.19 
Finally, two other fields of potential interest are worth mentioning. Application of 
neurotrophic factors to the cochlea might play a role in the maintenance of auditory neurons. 
For example, in vitro therapy with brain-derived neurotrophic factor, carried by a defective 
herpes virus vector, was able to promote sprouting of auditory neurons.20 Then, hair cell 
regeneration is a further target of interest. Already from the late eighties of the past century 
onwards, many studies on experimental avian models have shown the regenerative 
properties of hair cells, e.g. after noise damage.21 More recently, similar findings in 
mammalian vestibular epithelium raised the possibility of mammalian hair cell regeneration,22 
but apparently not within the organ of Corti.23 Last year, in vitro transfection of rodent 
postnatal cochlear and utricular expiants using a plasmid expressing Mathl was described. 
This is one of the genes implicated in ear morphogenesis and hair cell differentiation and led 
to robust production of extra hair cells in this case.2,1 
At present, despite some success, several important questions remain unanswered. 
Long-term maintenance of early gene-therapeutic effects should be proven, including the 
absence of serious adverse effects. It should also be determined until what age and to what 
degree regeneration or repair of sensorineural function will be possible. Then, in vitro results 
should be re-tested in vivo and the animal models should be translated into clinical studies, 
for which refinement and investigation of alternative vectors is needed. Further identification 
of genetic factors that underlie the various hearing impairment phenotypes and unravelling 
the related pathophysiological mechanisms is another essential condition. Finally this might 
offer hearing impaired individuals a scope beyond counselling. 
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Samenvatting en conclusies 
Samenvatting 
Slechthorendheid, het meest voorkomende zintuigdefect, heeft wereldwijd belangrijke 
gevolgen. Het treft één op de twee personen ouder dan 80 jaar1 en daardoor miljoenen 
mensen. Gezien de nog steeds groeiende levensverwachting in de meeste delen van de 
wereld zal dit aantal nog toenemen. De slechthorendheid kan al vanaf de geboorte aanwezig 
zijn. Oorzaak is dan veelal één enkel gendefect, overervend volgens de wetten van Mendel. 
Soms echter spelen omgevingsfactoren een belangrijke rol, bijvoorbeeld tijdens de 
embryonale ontwikkeling. In andere gevallen ontstaat slechthorendheid pas later in het 
leven. Vaak spelen dan zowel genetische factoren - bijvoorbeeld de mate van kwetsbaarheid 
van het gen - als omgevingsfactoren een rol. Belangrijke omgevingsfactoren zijn infecties -
die steeds meer teruggedrongen lijken te worden - en gehoorbeschadiging door lawaai. Dit 
laatste lijkt juist steeds vaker voor te komen. 
In het merendeel van de gevallen is erfelijke slechthorendheid niet-syndromaal 
(zonder andere lichamelijke symptomen), met slechts aantasting van het gehoororgaan 
(cochleair), of van zowel gehoor- als evenwichtsorgaan (cochleovestibulair). Evenals 
ouderdoms-slechthorendheid (presbyacusis) begint niet-syndromale, autosomaal dominant 
overervende slechthorendheid (bekend als "DFNA") vaak na de spraakontwikkeling. 
Gewoonlijk zijn aanvankelijk slechts specifieke frequenties binnen het totale gehoorbereik 
aangedaan. Dit zijn veelal de hoge tonen. Zoals beschreven in Hoofdstuk 1 werd erfelijke 
slechthorendheid vroeger ingedeeld op grond van de aangedane frequenties. De snelle 
ontwikkeling die de genkoppeling binnen dit werkterrein doormaakte, heeft echter geleid tot 
een classificatie op basis van het geassocieerde chromosomale locus. Bij het begin van 
deze studie in 1998 waren slechts de genloci DFNA1 tot en met DFNA13 bekend. 
Momenteel zijn reeds 40 DFNA loei beschreven. Gezien de grote heterogeniteit in niet-
syndromale, perceptieve slechthorendheid wordt verwacht dat er nog vele zullen volgen. 
In het kader van het Nijmeegse KNO-onderzoek naar erfelijke slechthorendheid 
werden bij de studie die ten grondslag ligt aan dit proefschrift twaalf verschillende families 
onderzocht. Steeds werd het fenotype (de waarneembare eigenschappen van een individu) 
beschreven in relatie tot de - in de loop van het onderzoek gevonden - genotypen (de 
genetische samenstelling van een individu). Voor de beschrijving van de genotype-fenotype 
correlatie bij een aantal andere grote families die zijn onderzocht in het kader van dit 
proefschrift, is het wachten nog op de definitieve genkoppelingsresultaten. 
1Θ1 
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In Hoofdstuk 2 worden de klinische kenmerken van drie Nederlandse families met 
een P51S mutatie in het COCH gen beschreven Dit gen ligt binnen het DFNA9 locus op 
chromosoom 14q12-13 Een grote familie is zowel longitudinaal (alle opeenvolgende 
gegevens per individu) als "cross-sectioneel" (de laatst bekende gegevens van alle 
afzonderlijke individuen gecombineerd) geanalyseerd De andere twee families zijn alleen 
longitudinaal geanalyseerd In eerste instantie werden de gehoor- en evenwichtsfuncties van 
vijftien dragers van de mutatie uit voornoemde grote familie, allen met duidelijke klinische 
symptomen, gemeten Met de individuele gehoordrempels (de laagste geluidsmtensiteiten, 
uitgedrukt in decibel, die nog werden waargenomen) werd een lineaire regressie-analyse 
naar leeftijd uitgevoerd De slechthorendheid bleek te beginnen rond het veertigste jaar, 
toenemend met drie decibel per jaar tot ernstige slechthorendheid Tegelijkertijd trad schade 
aan het evenwichtsorgaan op, met uiteindelijk totale uitval In twee uitzonderlijke gevallen 
werd een progressie tot 24 decibel per jaar gemeten Interpolatie en extrapolatie van de 
trend in hoogfrequent (hoge tonen, 4 en 8 kHz) gehoorverlies deed het bestaan vermoeden 
van gehoordrempels van 50 decibel rond het vijfendertigste jaar, toenemend met bijna twee 
decibel per jaar tot 120 decibel rond het vijfenzeventigste jaar Tussen het Imker- en 
rechteroor van de onderzochte personen, maar ook tussen verschillende personen, werden 
aanzienlijke verschillen in begmleeftijd en mate van progressie gevonden Steeds was 
daarnaast sprake van beiderzijds duidelijk verminderde prikkelbaarheid van het 
evenwichtsorgaan of enkelzijdige calorische onpnkkelbaarheid (vestibulaire areflexie) BIJ 
onderzoek van de vestibulo-oculaire reflex bleek het evenwichtsorgaan uiteindelijk met meer 
prikkelbaar te zijn, maar wel was er sprake van versterkte nekreflexen (cervico-oculaire 
reflex) 
De bevindingen bij de andere twee families bevestigden het algemene beeld van de 
eerste studie In aanvang was er sprake van een hoogfrequent gehoorverlies, dat zich later 
uitbreidde naar alle frequenties (toenemend met twee tot zeven decibel per jaar en 
beginnend rond het veertigste jaar) Deze klachten gingen gepaard met een geleidelijke 
uitval van het evenwichtsorgaan Voorts werden bij meerdere familieleden - die gedurende 
vijftien jaar gevolgd werden - symptomen van de ziekte van Meniere beschreven Naast 
hoofdbewegmgsafhankelijke oscillopsie (heen en weer bewegen van het beeld van de 
omgeving) en een onstabiel gevoel in het donker werden ook meer typische 
evenwichtsklachten waargenomen, zoals aanvalsgewijze, positie-afhankelijke duizeligheid, 
1Θ2 
Samenvatting en conclusies 
perioden van duizeligheid met of zonder misselijkheid, of bewegingsziekte (kinetose). Eén 
patiënt had oorsuizen bij een aanvankelijk éénzijdig gehoorverlies. 
Na de eerste drie longitudinale DFNA9-studies liet de grote cross-sectionele studie 
duidelijk zien dat er reeds een hoogfrequent verlies bestond vóór de aanvang van de 
progressieve slechthorendheid. Deze studie bevatte gegevens van zoveel mogelijk jonge en 
nog asymptomatische dragers van de genmutatie. De gemiddelde gehoordrempels bij 2 tot 8 
kHz bij de jongste dragers van de mutatie (< 33 jaar) waren significant hoger dan die van 
even oude familieleden zonder de mutatie, hetgeen op het bestaan van een aangeboren 
drempelverhoging voor deze frequenties bij DFNA9 kan wijzen. Daarnaast werd aangetoond 
dat de periode van progressief gehoorverlies (bijna 3 decibel per jaar) niet meer dan 20 tot 
25 jaar duurde. Gezien het feit dat uit onderzoek is gebleken dat de progressie rond het 
veertigste jaar begint, strekt deze episode zich aldus uit over het leeftijdsinterval van 40 tot 
65 jaar. 
Hoofdstuk 3 houdt zich specifiek bezig met het spraakverstaan 
(woordverstaansvaardigheid) bij erfelijke slechthorendheid. Het geeft een analyse van het 
verband tussen de gehoordrempels bij toonaudiometrie en de spraakverstaansscores 
(percentage goed verstane woorden, uitgezet als functie van de geluidsintensiteit). Hiertoe 
werd een vergelijking gemaakt tussen vier families met DFNA2/KCNQ4 en zeven met 
DFNA9/COCH, de twee meest voorkomende (namelijk in meerdere families) DFNA typen. 
Beide DFNA typen laten progressief gehoorverlies zien en worden in eerste instantie 
gekenmerkt door aantasting van de hoge frequenties. Deze twee fenomenen komen veel 
voor bij autosomaal dominant overervende slechthorendheid. Uit deze studie bleek het 
spraakverstaan van DFNA2 patiënten, in vergelijking met DFNA9 patiënten, pas bij een 
groter gehoorverlies (65 versus 46 decibel) tot een score van 90% te dalen. Enkele DFNA9 
patiënten lieten tijdelijk relatief slechte scores zien, die suggestief waren voor mogelijke 
retrocochleaire pathologie (perceptieverlies met oorzaken buiten het slakkenhuis); bij geen 
van de DFNA2 patiënten werden zulke verschijnselen gezien. 
Hoofdstuk 4 tenslotte, bevat een klinische en genetische studie van een Nederlandse 
familie met laagfrequente (lage tonen) slechthorendheid. Ook werden deze families 
vergeleken met andere families met dit relatief zeldzame fenotype. De studie betrof een 
analyse van toonaudiometrische gegevens bij alle patiënten en van retrospectieve gegevens 
betreffende het spraakverstaan bij de meeste patiënten. Er werden cross-sectionele en 
longitudinale analyses van audiometrische gegevens uitgevoerd. De slechthorendheid bleek 
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sinds de vroege jeugd aanwezig te zijn, waarbij vooral de lage frequenties waren aangedaan 
(0,25 tot 1 kHz, met een gemiddelde drempel van 45 decibel) Er was geen merkbare 
vertraging in spraak- en taalontwikkeling opgetreden De spraakverstaansscores waren 
relatief goed gedurende de eerste drie decades Op latere leeftijd raakten de hogere 
frequenties aangedaan, hetgeen leidde tot een vlak audiogram op middelbare leeftijd en een 
aflopend audiogram na het zestigste jaar Er was een matige, maar significante progressie 
van de slechthorendheid bij alle frequenties, ook na "correctie" voor presbyacusis (aftrekken 
van de normaalwaarde voor leeftijd en geslacht van de gemeten individuele gehoordrempel) 
Genetisch werd de aandoening gekoppeld aan chromosoom 4p16 3 in een gebied dat zowel 
de chromosomale loei voor (stabiele) laagfrequente slechthorendheid type DFNA6 als type 
DFNA14bevat 
Conclusies 
Het hoofddoel van deze studie was een bijdrage te leveren aan de kennis van genotype-
fenotype correlaties bij autosomaal dominant overervende, niet-syndromale, perceptieve 
slechthorendheid 
De eerste doelstelling was het opsporen van families met autosomaal dominant 
overervende slechthorendheid Genetische analyse was succesvol in een aantal van de 
onderzochte families, families waarvoor nog geen koppeling is gevonden, zijn met 
opgenomen in dit proefschrift In het kader van dit onderzoek is een nieuwe mutatie binnen 
het DFNA9 locus op chromosoom 14q12-13 gevonden Het betrof de P51S mutatie van het 
COCH gen 2 BIJ nader onderzoek bleek deze mutatie aanwezig te zijn bij alle DFNA9 families 
die de afgelopen 25 jaar in Nederland en België gevonden zijn Dit gegeven leidde tot verder 
genetisch onderzoek, met sterke aanwijzingen voor het bestaan van een 
gemeenschappelijke voorouder met voornoemde mutatie in dit deel van Europa In het 
afgelopen jaar zijn ook biochemische en immunologische studies gepubliceerd over COCH 
en het eiwit cochlme dat door dit gen tot expressie wordt gebracht De P51S en de meeste 
andere mutaties bleken een verkeerde ruimtelijke vouwing van de zogenaamde LCCL 
module van cochlme te veroorzaken met mogelijke stapeling van het verkeerd gevouwen 
eiwit als gevolg 34 Door Immunologen wordt een rol van cochlme bij bepaalde afweerreacties 
verondersteld, die aangetast zou kunnen worden door COCH-mutaties Het feit dat cochlme 
een belangrijk antigeen blijkt te zijn voor antihchamen gericht tegen het binnenoor zou 
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kunnen wijzen op een auto-immuun oorzaak van perceptieve slechthorendheid 5 Deze 
mogelijkheid is ook wel geopperd voor de ziekte van Meniere 6 
Verder werd bij een nieuwe familie genkoppeling aangetoond met het DFNA6/14 
locus voor laagfrequente slechthorendheid Hiermee werd een derde familie toegevoegd aan 
het aantal bekende families met dit locus Deze bevinding benadrukt het belang van 
chromosoom 4p16 3 voor dit fenotype Pas zeer recent bleek - en daardoor valt dit buiten het 
bestek van dit proefschrift - dat de slechthorendheid in deze DFNA6/14 familie geassocieerd 
is met een A716T mutatie in het WFS1 (Wolfram syndroom 1) gen Tevens werden in dit gen 
nog vier andere - aan hetzelfde laagfrequente fenotype gerelateerde - mutaties gevonden 
Van dit gen was al langer bekend dat het geassocieerd is met het autosomaal recessief 
overervende Wolfram syndroom Dit syndroom heeft juvemele diabetes mellitus en 
progressieve opticus atrofie als belangrijke kenmerken 7 
De tweede doelstelling was het fenotype van de nieuw gegenotypeerde families 
(DFNA9 en DFNA6/14) te beschrijven, ook in relatie tot soortgelijke aandoeningen Met 
betrekking tot de in dit proefschrift beschreven DFNA9 families kan worden geconcludeerd 
dat de P51S mutatie later in het leven optredende, progressieve, cochleovestibulaire 
verhezen veroorzaakt, resulterend in ernstige slechthorendheid en evenwichtsuitval binnen 
25 jaar na aanvang Gezien de voor alle frequenties overeenstemmende aanvangsleeftijd en 
de gelijke mate van progressie, moeten de prominente verliezen van de hoge frequenties bij 
DFNA9/COC7-/ geweten worden aan de pre-existente verhezen (dus aanwezig voor aanvang 
van progressie) In de loop van dit onderzoek werden deze pre-existente verhezen inderdaad 
aangetoond voor de hoge frequenties bij jonge dragers van de mutatie In hoofdlijnen komt 
het door ons beschreven beeld overeen met de bevindingen bij andere DFNA9/COCH 
studies, zelfs daar waar het andere mutaties betreft Hoogfrequente verhezen op jonge 
leeftijd werden ook gevonden bij DFNA2 (zie Hoofdstuk 1 2) Echter in het geval van 
DFNA2//<,C/VQ4, was reeds sprake van progressie vanaf de vroege jeugd Het is opvallend 
dat bij DFNA9/COC/-/ de in aanzet aanwezige hoogfrequente slechthorendheid blijkbaar 
stabiel is vanaf de vroege jeugd, totdat de progressieve slechthorendheid vanaf het 
veertigste jaar voor alle frequenties aan het licht treedt (zie Hoofdstuk 2 4) 
Met betrekking tot de in dit proefschrift beschreven DFNA6/14 familie kan worden 
geconcludeerd dat het chromosomale locus 4p16 3 geassocieerd is met aangeboren 
laagfrequente slechthorendheid, zonder opvallende vertraging in de spraak- en 
taalontwikkeling Deze bevindingen stemmen overeen met het beeld bij de eerder 
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beschreven families met DFNA6 en DFNA14 BIJ de huidige DFNA6/14 familie werd beperkte 
progressie van de slechthorendheid, die evenwel de gewone presbyacusis overstijgt, 
gevonden Deze progressie was nog met eerder beschreven voor DFNA6/14 families Was 
de beschreven overlap in genotype al suggestief voor het bestaan van een verantwoordelijk 
gen voor laagfrequente slechthorendheid, met de hierboven aangehaalde beschrijving van 
mutaties in het WFS1 gen is dat voor de tot nu toe bekende families ook aangetoond 
De derde doelstelling was het onderzoeken van aspecten van spraakverstaan bij 
belangrijke vormen van autosomaal dominant overervende, met-syndromale, perceptieve 
slechthorendheid In een vergelijkende studie laten DFNA2/KCNQ4 patiënten een duidelijk 
beter niveau van spraakverstaan zien dan DFNA9/COCH patiënten Daar het onderscheid 
met verklaard kan worden uit verschillen in toonaudiometrische drempels, zou de verklaring 
wellicht gezocht kunnen worden in onderliggende verschillen in pathofysiologische 
mechanismen (zie Hoofdstuk 3 1) Ook beschreven in dit proefschrift is het relatief intact 
blijven van het spraakverstaan bij de jongere DFNA6/14 patiënten Het is bekend dat het 
intact blijven van de hoge frequenties van groot belang is voor het spraakverstaan Het 
relatief goede niveau van spraakverstaan bij de jongere DFNA6/14 patiënten zou hierdoor 
verklaard kunnen worden 
Tenslotte kan nog opgemerkt worden dat zowel DFNA9 als DFNA6/14 klinisch 
duidelijk te onderscheiden entiteiten binnen de erfelijke slechthorendheid 
vertegenwoordigen Voorts is nu voor beide vormen mutatie-analyse mogelijk Hiermee zijn 
voor deze twee ziektebeelden goede diagnostische mogelijkheden beschikbaar gekomen 
Algemene discussie 
De groeiende mogelijkheden voor het vastleggen van genotypen, gecombineerd met een 
zorgvuldige beschrijving van het fenotype, maken momenteel classificatie en klinische 
diagnostiek van erfelijke slechthorendheid beter mogelijk In sommige gevallen kan al 
individuele diagnostiek op basis van mutatie-analyse uitgevoerd worden Een sprekend 
voorbeeld is connexme 26, het gen dat de autosomaal recessieve vorm van 
slechthorendheid DFNB1 veroorzaakt8 en dat mogelijk verantwoordelijk is voor de helft van 
de gevallen van erfelijke, prelinguale slechthorendheid (slechthorendheid die optreedt voor 
de ontwikkeling van de spraak bij kinderen) in sommige populaties9 Moleculaire diagnostiek 
- van het totale connexme 26 gen, met speciale aandacht voor een zeer veel voorkomende 
mutatie, 35delG - wordt al klinisch toegepast bij erfelijkheidsvoorlichtmg en biedt veel ouders 
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meer inzicht in de oorzaak van de slechthorendheid bij hun kind Vooral in Nederland en 
België wordt ook mutatie-analyse bij DFNA9 gebruikt als routme-diagnosticum ten behoeve 
van erfelijkheidsvoorlichtmg Hierdoor is tevens differentiaaldiagnostiek met Memeriforme 
stoornissen mogelijk Daarnaast biedt, in voornoemde landen, mutatie-analyse van KCNQ4 
enige mogelijkheden Deze mutatie-analyse wordt echter bemoeilijkt door het voorkomen 
van meer dan éen mutatie, door een fenotype dat zich minder onderscheidt en door de 
lagere prevalentie Mutatie-analyse van WFS1, zoals eerder aangehaald met betrekking tot 
de laagfrequente slechthorendheid bij DFNA6/14, is de laatste toevoeging aan moleculair-
diagnostische mogelijkheden bij met-syndromale, erfelijke slechthorendheid 
Voorts is moleculaire diagnostiek mogelijk bij een aantal vormen van syndromale 
slechthorendheid waarvoor het betrokken gen al is gevonden, zoals het Alport syndroom, het 
Pendred syndroom en het Waardenburg syndroom BIJ de Usher syndromen, waarvan nog 
met in alle gevallen het gen is geïdentificeerd, is moleculaire diagnostiek ingewikkelder Een 
mutatie (2299delG, in het USH2A gen), geassocieerd met Usher syndroom type II komt 
evenwel zeer frequent voor in Europa en biedt daardoor goede mogelijkheden voor 
diagnostiek ι α In voorkomende gevallen kan mutatie-analyse bijdragen aan een diagnose in 
een vroege fase van het leven, hetgeen van belang is voor een adequate behandeling en 
individuele voorlichting Dat laatste zou van nut kunnen zijn bij een passende opleidmgs- en 
beroepskeuze 
Niet in de laatste plaats heeft de toegenomen kennis omtrent de betrokken genen 
nieuwe inzichten verschaft m de moleculaire mechanismen die ten grondslag liggen aan 
afwijkingen in de functie van gehoor en evenwicht In de toekomst zou dit de weg kunnen 
effenen voor een gerichte behandeling van slechthorenden In het afgelopen decennium 
werd daartoe in toenemende mate gentherapie als mogelijke behandelmethode onderzocht 
Hierbij wordt erfelijk materiaal bij cellen ingebracht ter compensatie van een ontbrekend eiwit 
of ter modificatie van de eiwitfunctie Allereerst moeten hiervoor geschikte genen en celtypen 
in kaart worden gebracht Vervolgens is er een transportmiddel (een "vector") nodig om deze 
therapeutische genen bij de beoogde cellen naar binnen te smokkelen voor het gewenste 
effect Vanaf 1990 hebben diverse klinische studies plaatsgevonden, momenteel lopen er 
bijna 200 studies die in totaal meer dan 2000 patiënten omvatten 11 Een recent voorbeeld 
hiervan is een fase I studie bij zes patiënten met ernstige hemofilie type A In deze studie 
werd een cellijn van autologe huidfibroblasten - "getransfecteerd" met een plasmide (als een 
met-virale vector) met sequenties van het gen dat codeert voor factor VIII - geïnjecteerd in 
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het omentum tijdens laparoscopie BIJ vier van de zes patiënten stegen de plasmaspiegels 
van factor VIM, zonder ernstige bijwerkingen, een effect dat tot tien maanden aanhield 12 
Kanker, infectieziekten (zoals AIDS) en afwijkingen bepaald door een enkel gen zijn 
momenteel de belangrijkste onderzoeksterreinen met betrekking tot gentherapie 
Het aanvankelijke enthousiasme rond gentherapie is wel wat bekoeld door recente 
tegenslagen Belangrijke hindernissen zijn het uitblijven van aanhoudende expressie van het 
ingebrachte genetische materiaal (zoals hierboven, bij factor VIM), de afweer van de gastheer 
tegen lichaamsvreemd materiaal en problemen met vectorsystemen 13 Op dit moment 
worden er twee methoden gebruikt voor het ter plaatse afleveren van genen in cellen viraal 
(retro-, herpes-, adeno- of adeno-geassocieerd virus, en recentelijk ook lenti- en 
vaccimavirus als vectoren) en met-viraal (micro-injectie direct in de scala tympam via het 
ronde venster,14 gedrenkt in gelfoam tegen het ronde venster,15 gebonden aan calcium-
fosfaat, of gebonden aan positief geladen lipidedeeltjes zoals liposomen16) Tot nu toe is het 
meeste onderzoek gericht op virale technieken, waarbij het natuurlijke besmettingsvermogen 
van virussen wordt gebruikt 
Pas de laatste tijd is er onderzoek op gang gekomen naar de mogelijkheden voor 
gentherapie bij de behandeling van erfelijke slechthorendheid De relatief geïsoleerde ligging 
van de cochlea is behulpzaam bij de ontwikkeling van orgaangerichte transfectie, ter 
manipulatie van gendefecten en met gebruikmaking van de kennis over erfelijke 
slechthorendheid die het laatste decennium is verworven Zo zijn er nu al, hoewel nog met 
klinisch toepasbaar, verschillende vectoren in de cochlea getransfecteerd, hetgeen een 
mogelijkheid biedt voor gentransfer17 Een belangrijke stap voorwaarts was het inbrengen 
van genen uit een cellijn van "myelin basic protein" m shiverer muizen, met een monogene 
afwijking voor dit eiwit Hierna bleken de eerst afwezige (auditief opgewekte) hersenstam-
potentialen (BER-metmg) te zijn hersteld ,e In het oog - een ander orgaan dat goed 
toegankelijk is voor het gericht inbrengen van genen - werd onlangs functieherstel bereikt 
van de visus bij honden met een vorm van autosomaal recessief overervende, juvemele 
blindheid Adeno-geassocieerd virus, hier als vector voor het ongemuteerde RPE65 gen, 
werd in het oog ingebracht om dysfunctionerend pigmentepitheel van het netvlies te 
herstellen De dysfunctie werd veroorzaakt door een deletie van vier baseparen, met als 
gevolg uitschakeling van het flPE65gen 19 
Tenslotte dienen nog twee andere gebieden van potentieel belang genoemd te 
worden Toepassing van neurotrofe factoren in de cochlea zou een rol kunnen spelen bij het 
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behoud van auditieve neuronen Zo bleek bijvoorbeeld in vitro therapie met een cerebrale 
neurotrofe factor, getransporteerd via een onschadelijk gemaakt herpesvirus als vector, het 
spruiten van auditieve neuronen te stimuleren 20 Verder is haarcelregeneratie een onderwerp 
dat in de belangstelling blijft staan Al sinds het eind van de jaren tachtig van de vorige eeuw 
toonden vele experimentele studies met vogelmodellen het regeneratieve vermogen van 
haarcellen aan, bijvoorbeeld na lawaaibeschadigmg21 Meer recent suggereerden 
vergelijkbare bevindingen met betrekking tot vestibulair epitheel bij zoogdieren dat ook hier 
(binnen het labyrint) haarcelregeneratie mogelijk zou zijn,22 hoewel vooralsnog niet in het 
orgaan van Corti23 Wel werd vorig jaar in vitro transfectie van weefsel van de cochlea en de 
utnculus van de rat beschreven, met een plasmide als vector voor Mathl Dit is een van de 
genen die betrokken zijn bij de morfogenese van het oor en bij haarceldifferentiatie De 
toevoeging van dit gen leidde tot overproductie van haarcellen 2A 
Op dit moment blijven, ondanks voorzichtige successen, vele belangrijke vragen 
onbeantwoord Het langetermijn-resultaat van in eerste instantie optredende gen-
therapeutische effecten zal nog bewezen moeten worden, evenals het uitblijven van ernstige 
bijwerkingen Ook zal uitgezocht moeten worden tot welke leeftijd en in welke mate 
regeneratie of herstel van zmtuigfunctie mogelijk zal zijn Verder zullen in vitro resultaten ook 
in vivo getoetst moeten worden en zullen diermodellen vertaald moeten worden naar 
klinische studies, hetgeen vraagt om verfijning van bestaande en het ontwikkelen van 
alternatieve vectoren Nadere identificatie van de erfelijke factoren die ten grondslag liggen 
aan de verschillende fenotypen van slechthorendheid en de ontrafeling van de betrokken 
pathofysiologische mechanismen zijn andere essentiële voorwaarden Dergelijke 
verworvenheden zouden slechthorenden uiteindelijk een perspectief kunnen bieden dat 
verder gaat dan voorlichting alleen 
189 
6.1 
Literatuur 
1. Morton NE. Genetic epidemiology of hearing impairment. Ann NY Acad Sc 1991 ;630:16-31. 
2. De Kok YJM, Bom SJH, Brunt TM, Kemperman MH, Van Beusekom E, Van der Velde-Visser 
SD, Robertson NG, Morton CC, Huygen PLM, Verhagen WIM, Brunner HG, Cremers CWRJ, 
Cremers FPM. A Pro51Ser mutation in the COCHgene is associated with late onset autosomal 
dominant progressive sensorineural hearing loss with vestibular defects. Hum Mol Genet 
1999;8:361-6. 
3. Trexler M, Bânyai L, Patthy L. The LCCL module. Eur J Biochem 2000;267:5751-7. 
4. Liepinsh E, Trexler M, Kaikkonen A, Weigelt J, Bânyai L, Patthy L, Ottmg G. NMR structure of 
the LCCL domain and implications for DFNA9 deafness disorder. EMBO J 2001;20:5347-53. 
5. Boulassel MR, Tornasi JP, Deggouj N, Gersdorff M. COCH5B2 is a target antigen of anti-inner 
ear antibodies in autoimmune inner ear diseases. Otol Neurotol 2001;22:614-8. 
6. Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harns JP. Assessment of serum 
antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's 
disease. Laryngoscope 1995;105:1347-52. 
7. Bespalova IN, Van Camp G, Bom SJH, Brown DJ, Cryns K, DeWan AT, Erson AE, Flothman K, 
Kunst HPM, Kurnool P, Sivakumaran TA, Cremers CWRJ, Leal SM, Burmeister M, Lesperance 
MM. Mutations in Wolfram syndrome 1 gene (WFS1) are a common cause of low-frequency 
sensorineural hearing loss. Hum Mol Genet 2001, in press. 
8. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, Mueller RF, Leigh IM. 
Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 
1991:387.80-3. 
9. Zelante L, Gasparim P, Estivili X, Melchionda S, D'Agroma L, Govea N, Mila M, Della Monica M, 
Lotfi J, Shohat E, Delgrosso K, Rappaport E, Surrey S, Fortina Ρ Connexin-26 mutations 
associated with the most common form of non-syndromic neurosensory autosomal recessive 
deafness (DFNB1) in Mediteraneans. Hum Mol Genet 1997;6:1605-9. 
10. Dreyer B, Tranebjaerg L, Brox V, Rosenberg T, Möller C, Beneyto M, Weston MD, Liu X, 
Cremers C, Kimberlmg WJ, Nilssen 0. A common ancestral origin of the frequent and 
widespread 2299delG USH2A mutation. Am J Hum Genet 2001 ;69:228-34. 
11. Marcel T, Grausz JD The TMC Worldwide gene therapy enrollment report, end 1996, Hum 
Gene Ther 1997;8:775-800. 
12. Roth DA, Tawa NE, O'Brien JM, Treco DA, Seiden RF. Nonviral transfer of the gene encoding 
coagulation factor VIM in patients with severe hemophilia A Ν Eng J Med 2001 ;344:1735-42. 
13. Verma IM, Somia Ν Gene therapy - promises, problems and prospects. Nature 1997;389:239-
42 
14. Raphael Y, Frisancho JC, Roessier BJ. Adenoviral-mediated gene transfer into guinea pig 
cochlear cells in vivo. Neurosci Lett 1996;207:137-41. 
190 
Samenvatting en conclusies 
15 Jero J, Mhatre AN, Tseng CJ, Stern RE, Colmg DE, Goldstein JA, Hong Κ, Zheng WW, Hoque 
ATMS, Lalwani AK Cochlear gene delivery through an intact round window membrane in 
mouse Hum Gene Ther 2001,12 539-48 
16 Waremg M, Mhatre AN, Han JJ, Pettis RM, Hong K, Zheng WW, Lalwani AK Catiomc liposome 
mediated transgene expressen in the guinea pig cochlea Hear Res 1999,128 61-9 
17 Lalwani AK, Mhatre AN Cochlear Gene Therapy In Kitamura K, Steel KP, eds Genetics in 
otorhmolaryngology Advances in Oto-Rhmo-Laryngology Basel Karger, 2000,56 275-8 
18 Fujiyoshi T, Hood L, Yoo TJ Restoration of brain stem auditory evoked potentials by gene 
transfer in shiverer mice Ann Otol Rhinol Laryngol 1994,103 449-56 
19 Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kellmg SE, Anand 
V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J Gene therapy restores vision 
in a canine model of childhood blindness Nature genetics 2001,28 92-5 
20 Geschwind MD, Hartnick CJ, Liu W, Amat J, Van de Water TR, Federoff HJ Defective HSV-1 
vector expressing BDNF in auditory ganglia elicits neunte outgrowth model for treatment of 
neuron loss following cochlear degeneration Hum Gene Ther 1996,7 173-82 
21 Cotanche DA Regeneration of the tectorial membrane in the chick cochlea following severe 
acoustic trauma Hear Res 1987,30 197-206 
22 Rubel EW, Dew LA, Roberson DW Mammalian vestibular hair cell regeneration Science 
1995,267 701-3 
23 Roberson DW, Rubel EW Cell division in the gerbil cochlea after acoustic trauma Am J Otol 
1994,15 28-34 
24 Zheng LJ, Gao WQ Overexpression of Mathi induces robust production of extra hair cells in 
postnatal rat inner ears Nature Neurosci 2000 3,580-6 
191 

Dankwoord 
Professor Cremers, als dit proefschrift mijn wetenschappelijk rijbewijs zou zijn - zoals u het 
noemt - dan was u mijn hoofdinstructeur. Dreigde ik uit de bocht te vliegen, dan trapte u op 
de rem; maar geregeld wist u ook de gaspedaal te vinden. Dank dat u mij hier, met een 
bijzondere inzet en betrokkenheid, doorheen hebt weten te loodsen. 
Maar zonder een aantal belangrijke instructeurs, met ieder op hun eigen gebied zeer 
veel rijervaring, had dit proefschrift zijn huidige vorm nooit gekregen: 
Allereerst Patrick Huygen, toch een beetje homo universalis, als ik het zo mag zeggen. 
Bijzonder om zo intensief met jou samengewerkt te hebben aan de fundamenten van dit 
proefschrift: altijd ruimte voor discussie (ook over heel andere zaken), een verfrissende dosis 
gezond opportunisme en bovenal je loyaliteit en opbouwende kritiek. 
Wim Verhagen, de vader van DFNA9: vele versies heb je voorzien van commentaar, waarbij 
je heldere blik en compacte formuleringen regelmatig tot bijsturing aanleiding gaven, terwijl je 
omgekeerd ook alle ruimte bood mee te denken in jouw werk. Leuk dat je eerste co-
promotorschap mij heeft mogen betreffen. 
Guy Van Camp, de plezierige en vriendschappelijke samenwerking met jou is me veel waard 
geweest en was een constante en betrouwbare factor in de voortgang van het onderzoek. 
Frans Cremers, ik wil je bedanken voor het steeds belangeloos leveren van commentaar op 
de diverse stukken die met name uit die ene grote familie voortvloeiden en alles wat daar 
verder bij kwam kijken. 
Professor Graamans, ik waardeer het zeer dat u, naast uw functie van opleider in de kliniek, 
ook zitting heeft willen nemen in de manuscriptcommissie voor dit proefschrift. 
Professor Van den Broek, dank voor de gelegenheid die u mij bood in Nijmegen mijn KNO-
opleiding te starten en te werken aan dit promotie-onderzoek, als ook de getoonde interesse 
hiervoor. 
Geen rijervaring zonder bereidwillige passagiers; niet in de laatste plaats wil ik de 
vele leden van de diverse families betrokken bij dit onderzoek heel hartelijk danken voor hun 
medewerking en (nog steeds aanhoudende) interesse. 
Diverse personen en instanties binnen en buiten de Nijmeegse afdeling KNO: R.J.C. 
Admiraal, Audiologisch Centrum Tilburg, E. van Beusekom, A.J. Bosman, G. Caethoven, K. 
Cryns, E. Fransen, B. van den Helm, H. Koch, Y.J.M, de Kok, R. Koldewijn, E.M.R. De 
Leenheer, F.X. Lemaire, M.W.J. Luijendijk, H.A.M. Marres, M.G.M. Nicolasen, A.F.M. Snik, 
S.D. van der Velde-Visser, M. Verbruggen, W. Wolters. 
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En verder: 
De Nijmeegse KNO-assistenten, voor jullie gezelligheid én collegialiteit. En in het bijzonder 
Martijn Kemperman (computerconsulent), Capi Wever (on English) en Dirk Kunst 
(rijervaring...). 
Diny Helsper-Peters voor het klaren van de layout-klus en je gastvrijheid, thuis achter de 
computer. 
Peter Vlietstra, voor je gedegen correcties op het Engels bij meerdere artikelen. 
Mijn ouders, mijn trouwste supporters, al 32 jaar lang, mijn broer en paranimf Marnix en 
natuurlijk mijn vrienden (voor alles wat niet met dit proefschrift te maken heeft), waaronder 
niet in de laatste plaats mijn andere paranimf én collega Robert Bettman. 
Marije (you are an excellent driver!), wat fijn dat jij ook altijd zo druk was; 't zal wennen zijn 
zo zonder promotie-onderzoek. 
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Curriculum vitae 
De auteur werd geboren op 17 oktober 1969 te Scherpenzeel. Na het behalen van het 
eindexamen in 1988, studeerde hij gedurende twee trimesters aan de University of East-
Angha (Language and Humanities) in Norwich en één trimester aan de Université de 
Franche-Comté (Faculté des Lettres) m Besançon In 1989 werd begonnen met de studie 
Geneeskunde aan de Rijksuniversiteit Groningen De co-schappen werden doorlopen in 
Enschede, het keuze co-schap in het Antoni van Leeuwenhoek ziekenhuis in Amsterdam. 
Het artsexamen werd einde 1997 behaald. In het kader van zijn opleiding tot Keel-, Neus en 
Oorarts aan het Academisch Ziekenhuis Nijmegen werd in februari 1998 gestart met het 
onderzoek dat ten grondslag ligt aan dit proefschrift 
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Dmedico, Bectro Medical Instruments, Entermed, Faazen Schoonenberg Hoortoestellen, Garant Optiek, 
QaxcWdlcome, GN Resound, Groeneveld, De Haan Hoorapparaten, Hans Anders Hoortoestellen, Horen 
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^ V . r^%. 
1. Aanvankelijk wordt DFNA6/14 audiometrisch gekenmerkt door een vroegkinderlijk, 
perceptief, laagfrequent gehoorverlies van 40-50 decibel. Nadien bijkomende 
presbyacusis en progressie van de aandoening leiden tot een vlak audiogram op 
middelbare leeftijd en een aflopend audiogram na het zestigste levensjaar (dit 
proefschrift, Pennings et al., submitted). 
2. Erfelijke, vroegkinderlijke slechthorendheid die beperkt is tot de lage- en 
middenfrequenties wordt meestal veroorzaakt door mutaties in het - binnen de 
DFNA6/14 regio gelegen - WSF1 gen (dit proefschrift, Cryns et al., submitted). 
3. Voor DFNA9 is onder meer kenmerkend dat hierbij zeer ernstige slechthorendheid of 
doofheid en vestibulaire areflexie optreden. Van jongs af aan is er al een hoogfrequent 
gehoorverlies tot 30 decibel aanwezig. De verergering van het gehoorverlies begint 
rond het veertigste levensjaar (dit proefschrift). 
4. Progressie van slechthorendheid bij DFNA9 kan in het begin gepaard gaan met 
asymmetrie van gehoordrempels en met episoden van duizeligheid met vegetatieve 
verschijnselen (dit proefschrift). 
5. Wanneer een autosomaal dominant overervende, asymmetrisch verlopende, 
progressieve slechthorendheid gepaard gaat met stoornissen van het evenwicht en 
Ménièriforme klachten dient gedacht te worden aan DFNA9, zodat mutatie-analyse 
voor het COCH gen zinvol is (dit proefschrift). 
6. Patiënten met een vergevorderd stadium van DFNA9 blijken na cochleaire implantatie 
meestal bovengemiddeld te presteren (Merchant et al., Adv ORL 2000;56:212-7, Van 
de Heyning et al., Abstracts First European Conference Cochlear Brainstem Implants 
2001 ;17-8). 
7. Analyse van het spraakverstaan bij DFNA2, DFNA5 en DFNA9 toont aan dat een 
gelijke toonaudiometrische drempel met tot een zelfde spraakverstaanscore hoeft te 
leiden (dit proefschrift, De Leenheer et al., Ann Otol Rhinol Laryngol, in press). 
Het visualiseren van het gehoorverlies in de tijd in audiogram-vorm ("age-related 
typical audiograms") maakt het vergelijken van verschillende typen van erfelijke, 
perceptieve slechthorendheid eenvoudiger. 
Bij oudere patiënten met erfelijke slechthorendheid is het moeilijk het aandeel van de 
presbyacusis bij het kwantificeren van het gehoorverlies vast te stellen. Het 
eenvoudigweg corrigeren aan de hand van de mediane drempels in het 
toonaudiogram, zoals vastgesteld voor leeftijd en geslacht, kan dan tot overcorrectie 
leiden. 
Het is jammer dat het fenotype van slechts een beperkt deel van de nu bekende 
DFNA-genotypen goed beschreven is. Immers, een goed gedefinieerde genotype-
fenotype correlatie kan de identificatie van nieuwe lijders - en zo van nieuwe mutaties 
in de betrokken DFNA-genen - vergemakkelijken en daardoor zou de kwaliteit van de 
erfelijkheidsvoorlichting verbeterd kunnen worden. 
Door de explosieve toename van het étantal bekende vormen van niet-syndromale, 
erfelijke slechthorendheid lijkt de huidige DFN-nomenclatuur - op basis van alleen het 
genotype - minder nuttig; de clinicus zal steeds meer gebaat zijn bij een nomenclatuur 
die zowel aan het genotype als aan het fenotype recht doet. 
Zinvolle geneeskunde is niet hetzelfde als kosten-effectieve geneeskunde. 
Een proefschrift zonder stellingen getuigt niet van een stellige stellingname. 


